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In this study, a bioinspired silification strategy has been successfully developed to 
synthesize PEOlated silica nanocapsules at room temperature and near-neutral pH 
environment by using PEO-based block copolymer micelles as templates, mimicking 
the process of silica skeleton formation of marine organisms. The success of this 
approach lies on the encapsulation of the silica precursors in the core of the polymeric 
micelles, which results in the confinement of the silica shell formation at the interface 
between the core and corona of the polymeric micelles. Such strategy allows the 
synthesized silica nanocapsules to be intrinsically covered by a layer of free PEO 
chains that enable them to exhibit excellent colloidal stability in aqueous environment.  
 
On top of being used for formation of pure silica nanocapsules, the bioinspired 
silification is also employed as a general platform for synthesis of functional silica 
nanocapsules by encapsulating functional hydrophobic compounds in the core of the 
silica nanocapsules. For example, superparamagnetic silica nanocapsules have been 
prepared by encapsulating hydrophobic iron oxide nanocrystals inside the core of the 
silica nanocapsules, forming PEOlated Fe3O4@SiO2 nanoparticles. The silica shell 
formation did not cause any detrimental effect on the encapsulated iron oxide 
nanocrystals with respect to their size, morphology, crystallinity, and magnetic 
properties, clearly demonstrating the benign characteristics of the bioinspired 
silification approach. These superparamagnetic silica nanocapsules are demonstrated 
to exhibit excellent colloidal stability and thus an excellent candidate as magnetic 
resonance imaging (MRI) contrast agent. In addition to iron oxide nanocrystals, 
Summary 
 x 
fluorescent conjugated polymers have been successfully loaded into the core of the 
silica nanocapsules. The fluorescent silica nanocapsules are shown to exhibit large 
absorption coefficient and high quantum yield, which suggest that they possess the 
required brightness for fluorescence cellular imaging. Indeed, upon incubation with 
breast cancer cells, the fluorescent silica nanocapsules were internalized by the cells, 
which can then be visualized by using confocal laser scanning microscopy. Moreover, 
by conjugating folic acid on the surface of the fluorescent silica nanocapsules, 
targeted imaging of the breast cancer cells is demonstrated, indicating their potentials 
as probes for early cancer detection.  
 
Finally, the bioinspired silification has been employed to integrate the fluorescence of 
conjugated polymers and superparamagnetism of iron oxide nanocrystals inside the 
silica nanocapsules, forming a new class of bi-functional magnetic silica 
nanocapsules. The synthesized bi-functional silica nanocapsules are shown to exhibit 
the desired dual functionality of fluorescence and superparamagnetism in a single 
entity, which make them potentially to be used as dual mode cellular imaging contrast 
agent. The applicability of the bi-functional silica in cellular imaging was studied by 
incubating them with human liver cancer cells, the result of which demonstrated that 
the cells could be visualized via dual mode of fluorescence and magnetic resonance 
imaging. Furthermore, the superparamagnetic behavior of the bi-functional silica 
nanocapsules was successfully exploited for in vitro magnetic guided delivery of the 
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In 2009, World Health Organization (WHO) reported that cancer accounted for 7.4 
million deaths (approximately 13% of all deaths) in 2004 and predicted that the 
number would rise to 12 millions in 2030.
[1]
 Similarly, Singapore Cancer Registry 
reported that about one in four deaths in Singapore is caused by cancer.
[2]
 These facts 
reflect that cancer is and will be a major public health problem in Singapore and many 
other countries. The main reason for such concern is that cancer is often detected at 
the late stage of the illness, where the primary tumor has metastasized and led to 
systemic toxicity and many adverse effects, most of which are then difficult to treat.
[3-
4]
 Another reason is that the most commonly employed cancer therapy currently, 
which includes chemo- and radiation therapy, lack of specificity towards cancer cells, 
therefore causing non-specific systemic distribution of the antitumor drugs, which 
consequently reduce the required concentration of drugs to kill the tumors,
[3-4]
 and 
thus the lack of efficacy of the treatment. As a result, chemotherapy drugs are 
normally administered at very high dosage, which bring about numerous side effects, 
such as nausea, low immune system, and hair loss, all of which greatly reduce the 
quality of life of cancer patients. Therefore, there is an urgent need to find a new, 
better, and safer way to treat and cure cancer patients, and more importantly to detect 
the presence of cancer cells in human body when they are in early stage. 
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To address this challenge, nanotechnology has been exploited and investigated 
extensively in the past decade to develop new strategies for cancer therapy and 
diagnosis.
[5-8]
 Development of novel nanomaterials as a carrier for antitumor drugs, 
for instance, represents one of the most active research topics in the area of cancer 
nanotechnology. The interest mainly stems from the possibility to deliver drug more 
effectively to the cancerous tissues and minimize exposure to the surrounding healthy 
cells. As an example, liposomes, an artificial vesicle with an aqueous core surrounded 
by lipid bi-layer membrane, have been successfully used to encapsulate 
doxorubicin,
[9]
 an antitumor drug, and are currently employed clinically to treat breast 
cancer and refractory ovarian cancer.
[10-11]
 Nano-sized carriers also show a larger 
intracellular uptake in comparison to that of the micron-sized counterpart. 
Labhasetwar and colleagues,
[12]
 for example, demonstrated that 100 nm biodegradable 
polylactic polyglycolic acid (PLGA) nanoparticles exhibit 2.5 to 6 fold higher uptake 
by Caco-2 colon cancer cells than that of 1 and 10 μm microparticles, respectively. 
Such result shows that nanomaterials clearly have advantage over those of micron-
sized particles in delivering drugs to the targeted site, especially for those therapeutics 
that require intracellular activity in order for them to be effective, such as small 
interfering RNA (siRNA).    
 
In the course of development of these nanocarriers, materials innovation is often an 
integral and inseparable part of the research. Of the various explored materials, silica-
based nanostructured materials have been intensively investigated as potential carriers 
for various therapeutics and diagnostic agents in the human body.
[13-14]
 The interest in 
silica nanomaterials as an integration platform is due to the fact that silica, in 
particular amorphous silica, shows biocompatibility, together with the desired low 
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toxicity, high chemical and mechanical stability as well as being optically 
transparent.
[15-18]
 In fact, silica is generally recognized as safe by US Food and Drug 
Administration (FDA) and has been used regularly as food additives
[13]
 and 
components of vitamin supplements.
[14]
 Furthermore, silica nanomaterials are 
normally synthesized by using sol-gel technique, which endows the surface of the 
resultant particles to be rich in hydroxyl group (-OH) that can be exploited to 
introduce specific targeting ligands on the surface of the particles.  
 
To date, several different architectures of silica, such as spherical particles,
 
mesoporous particles, and capsules have been studied for various biomedical 
applications. The nanocapsule structure, in particular, is attractive as nanocarriers, 
owing to its large core volume for encapsulating various therapeutics and diagnostic 
agents to form a multi-functional delivery vehicle. A number of synthesis strategies 







 Despite the success of 
formation of silica nanocapsules, most of these techniques are faced with several 
challenges, including re-filling the hollow core with functional compounds and re-
dispersion of the resultant silica capsules into an aqueous environment, especially 
when calcination at elevated temperature is involved. It is therefore of particular 
interest to develop an innovative synthesis methodology, which is able not only to 
produce silica nanocapsules as has been done up to now, but also to functionalize 
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1.2 Objective and Scope of Thesis  
 
In the design of nanomaterials as an intravascular injectable nanocarriers for cancer 
therapy and diagnosis, it is widely known to impart the surface of the materials with 
hydrophilic functional groups in order to avoid early particle uptake by 
reticuloendothelial cells, which will remove the injected nanocarriers from the 
bloodstream and therefore prevent the nanocarriers from reaching its target. In 
particular, there has been a great emphasis on decorating the surface of the 
nanomaterials with polyethylene glycol (PEG) or polyethylene oxide (PEO) 
polymeric chains, because they have been demonstrated to be able to prolong the 
circulation of nanocarriers in human body.
[28]
 Therefore, following this rule of thumb, 
the objectives of this thesis are: 
(i) To develop a novel synthesis strategy to prepare silica nanocapsules that are 
decorated by a layer of free PEO chains on their outer surfaces. 
(ii) To impart the functionality to the PEOlated silica nanocapsules by 
incorporating functional compounds, such as iron oxide nanocrystals or 
fluorescent conjugated polymers, into the core of the nanocapsules. 
(iii) To study the feasibility of employing the resultant functional PEOlated silica 
nanocapsules as both fluorescent cellular imaging and magnetic resonance 
imaging (MRI) contrast agents.   
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1.2.1 Design and synthesis of PEOlated silica nanocapsules via bioinspired 
silification approach 
 
Inspired by the biosilification process of the skeleton of marine organisms, a unique 
synthesis strategy is proposed and designed to simultaneously prepare silica 
nanocapsules and coat their surfaces with a layer of free PEO chains, forming 
PEOlated silica nanocapsules. The synthesis is conducted by using PEO-based block 
copolymer micelles as templates for the formation of the nanocapsules. Moreover, the 
synthesis is done at room temperature and near-neutral pH aqueous environment, 
which are highly benign synthesis conditions. The rationale behind the strategy will be 
discussed and various characterizations be performed to confirm the structure of the 
resultant silica nanocapsules. Additionally, the effects of key synthesis parameters on 
the structure and size distribution of the nanocapsules are studied.   
 
1.2.2 Synthesis of PEOlated Fe3O4@SiO2 nanoparticles (PEOFSN) for magnetic 
resonance imaging  
 
An important aspect of the project is being able to functionalize the synthesized 
PEOlated silica nanocapsules with appropriate functional components for biomedical 
applications. In this project, Fe3O4 (magnetite) nanocrystals is successfully 
incorporated into the core of the PEOlated silica nanocapsules by employing the 
developed bioinspired silification approach above to prepare PEOlated Fe3O4@SiO2 
nanoparticles (PEOFSN). The effect of the encapsulation procedures on the Fe3O4 
nanocrystals with respect to their size, shape, and magnetic behavior is investigated 
systematically. In addition, as the thus prepared PEOFSN exhibit superparamagnetic 
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behavior with excellent aqueous colloidal stability, their feasibility as magnetic 
resonance imaging (MRI) contrast agent is evaluated by using a clinical 1.5 Tesla 
magnetic resonance scanner.    
 
1.2.3 PEOlated silica nanocapsules encapsulating fluorescent conjugated polymers 
for cellular imaging 
 
Fluorescent conjugated polymers are a unique class of materials that exhibit electronic 
and optical properties of semiconductor with mechanical behavior and ease processing 
of polymers.
[29]
 They are typically used in display and electronic industries. In this 
project, however, their usage as fluorescent probe is explored by encapsulating them 
inside the core of the PEOlated silica nanocapsules via the developed bioinspired 
silification. The resultant optical behavior of the encapsulated conjugated polymers is 
studied and compared to those of the free conjugated polymers dissolved in 
tetrahydrofuran (THF). The potential of the thus synthesized fluorescent PEOlated 
silica nanocapsules as fluorescent probes is then evaluated by incubating them with 
breast cancer cells and observed by using confocal microscopy. In addition, targeting 
cellular imaging is investigated by conjugating folic acid on the surface of the silica 
nanocapsules and studying their interaction with the breast cancer cells.   
 
1.2.4 Bi-functional silica nanocapsules of fluorescent conjugated polymers and 
superparamagnetic nanocrystals for dual mode cellular imaging 
 
Integrating multiple functionalities into a single nanostructure has always been one of 
the main objectives in the design of nanomaterials for biomedical applications. In the 
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last section of this project, the unique fluorescent behavior of conjugated polymers is 
combined with the superparamagnetic property of iron oxide nanocrystals into the 
PEOlated silica nanocapsules, forming a new family of bi-functional magnetic 
fluorescent silica nanocapsules. The bi-functional fluorescent and superparamagnetic 
behaviors of the obtained silica nanocapsules are then characterized thoroughly. The 
applicability of the bi-functional silica nanocapsules as dual mode cellular imaging 
contrast agent is examined by incubating them with human liver cancer cells and 
observing the uptake behavior through confocal fluorescence and magnetic resonance 
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Chapter 2   
LITERATURE REVIEW 
 
2.1 Overview of cancer nanotechnology  
 
Over the past decade, nanotechnology has grown enormously because of its wide 









 and data storage.
[5]
 In biomedical 
field, one particular interest is in the application of cancer therapy and diagnosis, 
which is more commonly known as cancer nanotechnology. According to National 
Nanotechnology Initiative (NNI), nanotechnology is defined as a scientific field that 
concerns with the study, design, characterization, synthesis and application of 
materials in the size regime of 1 – 100 nm, at least in one of their dimensions.[6] 
However, in the field of cancer nanotechnology, the word „nano‟ is frequently used to 





 suggested that the definition of nanotechnology in the field of 
biotechnology should be based on the functionality of the synthesized particles or 
device to meet a specific need in biological applications, instead of using the 
conventional size limitation. In concert with their suggestion, the definition of 
nanotechnology based on functionality is used in this thesis to refer to material 
structures with potential applications in biomedical field. 
 
In general, the interest in nanotechnology lies on the unique physical behavior arisen 
from size limitation of conventional materials in nanometer scale, which often behave 
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differently from their bulk counterparts. For instance, platinum nanoparticles exhibit 
catalytic activity, despite the fact that bulk platinum is inert.
[9]
 When the size of a 
material is in nanometer regime, quantum confinement effect may take place. 
Quantum confinement effect appears when the length scale of a particle is comparable 
to the de Broglie wavelength of the valence electron. At this state, the electron 
behaves like a particle in a box, meaning that the energy levels become more discrete 
rather than continuous band and the band gap of the material becomes size dependent. 
Semiconductor nanoparticles, such as cadmium selenide (CdSe) quantum dots (QDs), 
are especially suitable to demonstrate visibly this effect. The absorption band of the 
CdSe QDs shifts to shorter wavelengths with decreasing particle size, which indicates 
that the band gap of the semiconductor becomes larger. As a result, they exhibit a 





Recently, the application of nanotechnology in medical fields, especially in cancer-
related diseases, has been growing because it provides unique opportunities to address 
many of the current challenges in cancer therapy and early diagnosis. The interests in 
cancer nanotechnology are largely fueled by the fact that many of the developed 
anticancer drugs are hydrophobic, and therefore require special means to deliver them 
effectively to the cancerous tissues. Moreover, these anticancer drugs are highly toxic 
and known to bind to lipid cell membrane without any differentiation between healthy 
and cancerous cells, thus potentially lead to overall systemic toxicity.
[11]
 In order to 
circumvent this issue, hence, a great deal of efforts have been dedicated to develop 
multi-functional nanomaterials as intravenous injectable drug nanocarrier.  
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It has been reported that the usage of nanomaterials as drug carriers can improve the 
bioavailability of poorly water-soluble anticancer drugs, protect them from enzymatic 
or environmental degradation, prolong their circulation time in the body (in the 
blood), control their release at a sustained rate, and deliver them to a specific cell or 
tissue in a targeted manner, all of which consequently lead to minimal side effects to 
the surrounding healthy tissues.
[11-12]
 An example for such development is the use of 
block copolymer micelles of poly(ethylene oxide) (PEO) and poly(aspartic acid) to 
encapsulate doxorubicin for metastatic pancreatic cancer treatment.
[13]
 Besides 
therapy, a significant amount of efforts has also been devoted to develop 
nanomaterials as diagnostic contrast agents.
[14-15]
 These contrast agents can provide a 
non-invasive pathway to detect the presence of malignant cells that are in the early 
stage of development, especially when linked with tumor targeting ligands (e.g., 
monoclonal antibody, peptides, or small molecules). For instance, Herceptin-
conjugated iron oxide nanoparticles have been successfully used to reveal and image 
breast cancer cells growing in mice through T2-weighted magnetic resonance imaging 
(MRI).
[16]
 In some cases, these contrast agents can also be used for therapeutic 





 nanoparticles, are the two most common examples for such treatment, 
namely hyperthermia and photothermal ablation, respectively. Furthermore, there has 
been a considerable interest to integrate the imaging contrast agents with anticancer 
drugs into a single nano-object, the purpose of which is to obtain real-time feedback 
regarding the effectiveness of the therapy in stopping the progression of the tumors.
[19]
 
The realization of such integrated functionalities would no doubt make nanomaterials 
a mighty tool in the fight against cancer. 
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2.2 Engineering design of nanocarrier 
 
The major challenge in designing nanomaterials to be used as an intravenous 
injectable nanocarrier is to have control on their particle size and surface properties. 
This is because the particle size and surface properties of the materials are known to 
determine the fate and biodistribution of the nanomaterials after being injected into 
the bloodstream. This consideration is highly important to achieve delivery in a cell- 
or tissue specific manner. Over the years, different targeting strategies have been 
explored to achieve this objective, which can be classified into two broad categories, 
namely passive and active targeting.  
 
2.2.1 Passive targeting 
 
In 1986, Maeda and colleagues
[20]
 reported that polymer-drug conjugate nanoparticles 
were accumulated in tumor tissues in larger amount than in normal healthy tissues. 
This phenomenon was attributed to the extravasation and localization of the 
nanoparticles in the tumor tissues owing to the leaky characteristics of tumor 
vasculature, which is more commonly known as enhanced permeability and retention 
(EPR) effect.   
 
In the growth of tumors, tumor cells excrete a number of proteins and small molecules 
to form new blood vessels (neovascularisation) that supply the required oxygen and 
nutrients, in a process called angiogenesis.
[21-22]
 These angiogenic blood vessels are 
typically defective and have „porous‟ lining endothelial cells; with the gap between the 
cells can be as large as 600 – 800 nm.[23] Consequently, such large gaps provide an 
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opportunity for nanocarrier  to extravasate and penetrate through the tumor interstitial 
space. Furthermore, tumors are known to have impaired lymphatic drainage 
system,
[24]
 which causes the extravasated nanocarriers to be retained and accumulated 
inside the tumor tissues. This mechanism of targeting that exploit the leaky 
characteristic of tumor blood vessels, and therefore allow accumulation of nanoscale 
carriers inside tumors through EPR effect is called passive targeting and illustrated in 




Figure 2.1 A schematic diagram illustrating the enhanced permeability and retention effect of 
nanocarriers in tumors. Unlike in normal tissue vasculatures, where endothelial cells are lined in a 
tight arrangement; the endothelial cells of tumor vasculatures are spaced out with one another, thus 
allowing preferential accumulation of nanocarriers inside the tumor interstitial space, which is called 
passive targeting. The effectiveness of passive targeting is highly dependent on the size of the 
nanocarriers. (Adapted from references [6] and [25])  
 
 
In order to achieve the passive targeting, it is essential for nanocarriers to be able to 
circulate in human body for long period of time, and therefore increasing the 
likelihood of the nanocarriers in penetrating leaky tumor tissues. It is widely known, 
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however, that nanocarriers can be rapidly removed from the bloodstream by the 
reticuloendothelial system (RES),
[26-27]
 which is a major biological barrier for any 
nanocarriers administered parenterally. The RES is a physiological defense 
mechanism, comprising of monocytes and macrophages cells located in various parts 
of human body, such as liver, spleen, and lymphatic system. It is responsible for 
phagocytosis, which is a process to engulf and clear foreign particles or substances 
from the bloodstream. It is of note that phagocytosis is initiated by adsorption of 
plasma proteins (opsonin) onto the surface of the particles, giving signal to the RES to 
evacuate those foreign entities from the body.
[28]
 Thus, it is important to first prevent 
or minimize the adsorption of opsonins in order to prolong circulation time of 
nanocarriers in vivo. This strategy is usually achieved by coating the surface of the 
nanocarriers with hydrophilic polymers or surfactants, such as poly(ethylene glycol) 
(PEG) or poly(ethylene oxide) (PEO),
[29-32]
 both of which are built from non-ionic 
ethylene oxide unit. While there is no structural difference between the two polymers, 
PEG is more commonly used for oligomer or polymer of ethylene oxide with 
molecular weight less than 10,000 g/mol, while PEO is reserved for higher molecular 
weight of the same polymer.
[33-34]
 In this thesis, however, no distinction would be 
made between these two polymers. PEO has been widely used as a surface modifier of 
various nanocarrier systems because it forms a dynamic „cloud‟ of hydrophilic and 
neutral chains that are effective in repelling opsonins.
[33, 35-36]
 Additionally, PEO 
chains exhibit rapid chain movement with large exclusion volume and low interfacial 
energy with water, which impart steric stabilization and colloidal stability to the 
coated nanocarriers.
[36]
 More importantly, PEO chains are non-cytotoxic, and therefore 
has been widely used to improve the biocompatibility of foreign materials in the 
body.
[37]
 As a result, surface PEOlation is currently regarded as the standard strategy 
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2.2.2 Active targeting 
 
Although passive targeting forms the foundation in the design of intravenous 
injectable nanocarriers, targeting tumor cells by relying on passive targeting alone 
may not always be a feasible strategy because of the random nature of the approach, 
which provides no means to control the process.
[40]
 This targeting mechanism is 
particularly challenging if tumor cells exhibit resistance towards one or more of the 
encapsulated drugs, a situation of which is called multi-drug resistance (MDR), which 
inevitably lead to a lower efficacy of the chemotherapy treatment.
[41]
 In addition, some 
tumors do not exhibit EPR effect because of the low degree of neovascularisation, 
thereby making it difficult to target these tumors passively.
[42]
 Hence, to overcome 
these challenges, numerous attempts have been made to decorate the surface of the 
nanocarriers with a targeting component that able to recognize and bind to specific 
receptor on the cell surface. It is expected that the bound nanocarriers are then 
internalized by the cells through endocytosis process and release their content inside 
the cells.
[43-45]
 This approach of targeting is called active targeting and summarized in 
Figure 2.2. 
 
Different targeting agents have been explored to target tumor cells and can be broadly 
classified into three groups, namely proteins (antibodies),
[46-47]
 nucleic acids 
(aptamers),
[48]
 and other ligands (peptides, vitamins, and carbohydrates).
[49-52]
 The 
choice of a targeting agent is based on the presence and abundance of specific 
molecular markers (antigen or receptor) that are uniquely expressed on the cell surface 
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in comparison to normal healthy cells. For instance, folic acid, which is a vitamin B9, 
has been increasingly become popular ligand to target various cancer cells, such as 
ovarian, brain, kidney, breast, and lung.
 [51,53]
 This interest is largely fueled by the fact 
that folic acid bind strongly to the folate receptors, which are over-expressed on the 
surface of cancer cells but not in normal healthy cells. As a result, many folic acid-
conjugated nanocarrier systems have been reported to target various cancer cells both 






Figure 2.2 An illustration showing delivery of nanocarriers into tumor regions through passive and 
active targeting mechanism. Once nanocarriers have extravasated into the tumor regions through leaky 
vasculature, they can bind to the tumor cells or tissues through ligand-receptor interaction. The 
nanocarriers are then internalized by the cells via receptor-mediated endocytosis process, after which 
the encapsulated drug will be released intracellularly. (Adapted from reference [40])  
 
Chapter 2: Literature Review 
 18 
2.2.3 Rationale design of nanocarriers 
 
In light of the two targeting mechanisms briefly discussed above, namely passive and 
active targeting, the design for an ideal nanocarrier system for cancer therapy and 
diagnosis should be based on these following guidelines: 
i. The surface of the nanocarriers should be covered by a biocompatible and 
hydrophilic surfactant, mainly but not limited to PEO, to evade the RES and 
prolong their circulation time in vivo. 
ii. The overall size of the nanocarriers should be small enough to allow 
accumulation of the carriers in the leaky tumor tissues via the EPR effect. 
iii. The surface of the nanocarriers should be decorated by specific targeting 
agents that are able to recognize and bind to receptors on the surface of tumor 
cells, thus improving site-specific delivery.  
iv. The nanocarriers should be able to carry one or more therapeutic agents, 
preferably together with imaging contrast agents, which allow evaluating the 
effectiveness of the therapy through non-invasive technique.  
This ideal nanocarrier system is summarized in Figure 2.3 below.  




Figure 2.3 A schematic diagram illustrating an ideal multi-functional nanocarrier system that is able to 
carry multiple drugs and/or contrast agents and decorated with hydrophilic surfactants (PEO) to evade 
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2.3 Synthesis methodologies of silica nanocapsules 
 
In view of the rationale design of nanocarriers discussed above, hollow nanocapsules 
are highly attractive for development of colloidal nanocarriers. This is because 
nanocapsules possess large core volume that can be used to encapsulate and release 
various compounds, such as drugs, biomolecules, and dyes.
[57]
 Moreover, the surface 
of the nanocapsules can be functionalized with specific targeting moiety,
[58]
 and 
therefore facilitating their usage for drug delivery in a targeted manner. Nanocapsules 
also exhibit other interesting characteristics, such as low density, high surface-to-
volume ratio, low coefficients of thermal expansion and refractive index,
[57]
 all of 









Liposomes, which is an artificial vesicle of spherical shape, represent an important 
class of nanocapsules that have been widely used as delivery vehicles of various 
antitumor drugs.
[62-63]
 Liposomes are prepared from natural non-toxic phospholipid 
through self-assembly process, resulting in a particle with core-shell structure that 
composed of an aqueous core enclosed in one or more phospholipid layer.
[62]
 
Hydrophilic compounds can be loaded into the aqueous core of the liposomes, 
whereas hydrophobic substances are normally partitioned in their lipid membrane. 
There are, however, remain a number of problems concerning their physicochemical 
stability that may limit their clinical usage.
[64]
 For example, the phospholipid 
membranes of the liposome are prone to hydrolysis by ester bonds,
[65]
 which results in 
change in the permeability of the membrane.  
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In addition to liposomes, silica nanocapsules are currently gaining popularity and have 
been recognized as promising alternative candidate for development of novel colloidal 
nanocarriers. Silica, especially in the amorphous form, is an inert, non-toxic as well as 
biocompatible compound.
[66-69]
 It is also “generally recognized as safe” (GRAS) by 
the US Food and Drug Administration (FDA),
[68]
 as demonstrated by its common 
usage in the food additives and vitamin supplements.
[66]
 Additionally, enzyme and 
mammalian cells have been shown to retain their metabolic activity after 
encapsulation in porous silica,
[70-71]
 therefore confirming that silica is highly 
compatible with biological system. The surface of amorphous silica is normally rich in 
hydroxyl group, which render them to be intrinsically hydrophilic.
[72]
 The hydroxyl 
groups can also be used to attach targeting moieties on the surface of the silica by 
using various silane-coupling reactions. Moreover, silica does not exhibit any swelling 
or porosity changes with alteration in the pH of the medium, which shows that it is 
mechanically and chemically more stable.
[73]
 All of these features make silica 
nanocapsules a unique and promising candidate as multi-functional nanocarriers. 
 
There are a number of strategies that have been developed for the fabrication of silica 
nanocapsules, most of which are based on template-assisted approach. In general, 
template-assisted synthesis involves three major steps,
[57]
 as illustrated in Figure 2.4: 
(i) preparation of the template; (ii) coating of the silica shell on the template either by 
controlled surface chemical precipitation of silica precursors from solution or by 
physical adsorption of small silica nanoparticles; and followed by (iii) template 
removal either by calcination at high temperature or dissolution with suitable solvent 
to generate the cavity inside the shell. 
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Figure 2.4 A schematic diagram illustrating the general approach of template-assisted strategy in the 
synthesis of silica nanocapsules. (Adapted from reference [57]) 
 
The silica shell is commonly obtained by employing sol-gel technique,
[74-75]
 which 
makes use of low molecular weight alkoxysilanes, such as tetramethoxysilane 
(TMOS) or tetraethoxysilane (TEOS), as the silica precursors. The sol-gel reaction 
can be described as two-step processes:  
i) Hydrolysis 
                                                           (1) 
ii) Condensation  
 (2) 
                                                        (3) 
The hydrolysis of the alkoxysilane precursors occurs by the nucleophilic attack of the 
oxygen in water molecule on the silicon atom, producing silanol groups (Si-OH). 
Hydrolysis reaction can be catalyzed by adding either acid or base into the system.
[75]
 
As soon as silanol groups are formed, the condensation reaction will commence by 
involving the silanol groups to produce siloxane bond (Si-O-Si) and by-product 
alcohol (ROH) or water. Sol-gel is a popular method to form silica because the 
hydrolysis and condensation of silicon alkoxides in aqueous solution can be well 
controlled.  
 
To date, different templates have been explored for the preparation of silica 
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nanocapsules, which can be classified into two main categories: hard and soft 
templates. Hard templates include polystyrene latex
[76-80]
 and inorganic oxide 
particles,
[81-90]





 surfactant vesicles, and polymeric micelles. In this section of literature 
review, the principle for each of these approaches is discussed and their respective 
advantages or disadvantages are pointed out where appropriate.  
 
2.3.1 Hard templates 
 
Templating against hard (solid) particles for the fabrication of silica nanocapsules has 
been widely explored since the pioneering work done by Caruso and co-workers
[76]
 in 
colloidal templating of hollow spheres. They laid down the foundation of hard 
templating approach, which usually involves multi-step process: preparation of the 
templates, functionalization/modification of the template surface to attract/confine the 
silica precursors, followed by consolidation of the silica shell and finally removal of 
the templates. The most commonly employed hard templates are polystyrene latex 
beads and inorganic nanoparticles.  
 
2.3.1.1 Polystyrene (PS) beads 
 
The usage of polystyrene (PS) beads as a template was first demonstrated by Caruso 
and co-workers
[76]
 in their seminal Science articles on the preparation of hollow 
inorganic and hybrid silica nanocapsules. The silica shell of the nanocapsules was 
obtained via layer-by-layer (LbL) assembly, which is an approach to form a coating 
material onto a substrate through sequential deposition of oppositely charged 
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compounds. In his experiment, Caruso made use of the electrostatic interaction 
between positively charged poly(diallyldimethylammonium chloride) (PDADMAC) 
polymer and negatively charged pre-formed silica nanoparticles to form a hybrid silica 
layer on the PS templates. The layer-by-layer deposition was repeated numerous times 
to obtain multi-layer hybrid silica coating with well-defined thickness. To attain the 
corresponding hollow structure of the silica nanocapsules, the PS templates were then 
evacuated from the composite either by pyrolysis at high temperature or solvent 
extraction using tetrahydrofuran (THF). The procedure of the LbL synthesis above is 
summarized in Figure 2.5 below.  
 
 
Figure 2.5 Illustration of synthesis of silica nananocapsules by layer-by-layer (LbL) assembly approach 
of the positively charged poly(diallyldimethylammonium chloride) (PDADMAC) and negatively 
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Apart from the LbL approach, the silica shell surrounding the PS templates can also 
be formed by the controlled precipitation of silica precursors through sol-gel process. 
In this approach, the surface of the PS templates needs to be first modified with 
specific functional groups that have strong affinity with silica.
[77-80]
 The functionalized 
PS templates are typically prepared by co-polymerization of the styrene monomer 
with functional co-monomer bearing the specific functional groups of interest, as 
illustrated in Figure 2.6. Such surface functionalization strategy is essential for 
obtaining a good coverage and uniform coating of the silica shell. For example, 
silanol- (SiOH-)
[77,79]
 and amine- (NH2-)
[78,80]
 modified PS templates have been 
successfully used to template silica, whereas no precipitation of silica shell was 




 Subsequently, similar to the LbL 
approach above, the capsule structure was then realized by firing the composite 
particles at high temperature or immersing them in appropriate etchant solution. 
 
Although the PS templating approach is a rather simple and versatile method to 
synthesize silica nanocapsules, it has several intrinsic disadvantages. For instance, the 
core size of the silica nanocapsules is largely determined by the size of the PS 
templates, which is typically in the sub-micron range. As a result, it is difficult to 
obtain silica nanocapsules with a core size smaller than 100 nm. Additionally, the 
silica shell obtained from this method generally lacks of mechanical integrity,
[57]
 and 
therefore may collapse when the PS templates are removed.   




Figure 2.6 Schematic illustration of synthesis of silica nanocapsules by using functionalized 
polystyrene latex particles and sol-gel reactions. (Adapted from reference [77,80]) 
 
2.3.1.2 Inorganic nanoparticles 
 
In recent years, inorganic nanoparticles have emerged as a new and promising class of 
hard templates for the fabrication of hollow silica nanocapsules because they are very 
small (typically < 100 nm) and highly monodispersed. As a result of these attractive 
features, uniform and smaller silica nanocapsules (i.e., sub-100 nm) can be obtained 
through inorganic nanoparticles templating approach. Indeed, different inorganic 
nanoparticles have been investigated for such a purpose, for instance: silver (Ag),
[81-82]
 




 iron oxides (Fe2O3; Fe3O4),
[84-87]





 and gadolinium oxide carbonate (Gd2O(CO3)2).
[90]
 These 
materials are selected because they can be dissolved in particular etchant (e.g., 
hydrochloric acid), in which silica is not soluble, thus allowing selective dissolution of 
the templates without affecting the formed silica shell.  
 
Inorganic nanoparticles templates can be classified into two main categories, namely 
hydrophilic and hydrophobic nanoparticles. The difference in the surface 
characteristics of these nanoparticles demands different approaches on how the silica 
shell can be coated onto the nanoparticles. In the case of hydrophilic nanoparticles, 
the deposition of silica shell is a rather straightforward procedure, which typically 
involves dispersing the nanoparticles in a medium that contain precursors for the sol-
gel reactions. Such simple approach can be afforded because the surface of these 
nanoparticles are typically covered by hydroxyl (-OH) groups,
[67,90]
 which make them 
readily coated by hydrolysis and condensation of the silica precursors without any 
surface modification. On the other hand, the surface of hydrophobic nanoparticles is 
capped by long-alkyl chains that make them dispersible only in organic solvent, and 
therefore it is necessary to first modify the surface properties of these nanoparticles in 
order to facilitate the sol-gel silica coating process. The surface modifications were 
done by wrapping these nanoparticles inside a second layer of amphiphilic surfactants 
such as cetyltrimethylammonium bromide (CTAB)
[86]
 and polyethylene glycol 
nonylphenyl ether (Synperonic NP 5).
[84,88]
 The principle of this approach is based on 
the universal hydrophobic interactions between the long-alkyl chains of the capping 
molecules and the hydrophobic component of the surfactants, whilst the other 
hydrophilic ends of the surfactants render the nanoparticles to be dispersible in water. 
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In addition to functioning as water-solubilization agent, the hydrophilic end of the 
surfactants plays an important role in confining the silica shell condensation 
surrounding the nanoparticles through electrostatic interaction (positively charged 
ammonium of CTAB and negatively charged of silica) or hydrogen bonding 
(polyethylene glycol of NP5 and silanol). Subsequently, the hollow structure of the 
silica nanocapsules was realized by immersing the silica coated inorganic 
nanoparticles into hydrochloric acid to dissolve away the nanoparticles core. This 




Figure 2.7 Schematic illustration of the synthetic procedure of silica nanocapsules by using 
hydrophobic inorganic nanoparticles as templates. (Adapted from reference [86]) 
 
Chapter 2: Literature Review 
 29 
2.3.2 Soft templates 
 
Although hard templating is arguably an effective, and probably the most common, 
method for the synthesis of silica nanocapsules, it suffers from several drawbacks, 
which include complicated multi-step process, low integrity of the silica wall, and 
difficulties in re-filling the hollow core with active compounds (e.g., therapeutics 
drugs, nanoparticles contrast agents, and dyes).
[57]
 In this regard, templating against 
soft (liquid and gas) templates are very attractive and have been investigated 
extensively for the fabrication of silica nanocapsules because of the following 
advantages: simple synthesis procedure (i.e., particularly one-pot synthesis approach), 
a more gentle template removal process at room temperature and with “ordinary” 
solvents like ethanol, and more importantly it offers the possibility of in-situ 
encapsulation of active compounds during the synthesis of the nanocapsules, thus 
avoiding the complication of re-filling step. A number of soft templates have been 
examined for this purpose, including for example emulsion droplets, polymer 
aggregates/vesicles, gas bubbles, and supramolecular polymeric micelles. In this part 
of literature review, the use of some of these soft templates for the preparation silica 
nanocapsules is discussed, with emphasis on the application polymeric micelles as 
templates.    
 
2.3.2.1 Emulsion droplets 
 
Emulsion can be defined as a heterogeneous system composed of two immiscible 
liquids, in which one of the liquids is dispersed into another through mechanical 
agitation either by shaking, stirring, or sonication.
[91]
 Generally, emulsions are 
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thermodynamically unstable. The droplets tend to coalesce with one another to form 
two separated bulk liquids, which possess minimum interfacial surface energy. To 
prevent the phase separation, surfactants are normally employed to lower the 
interfacial energy of the droplets, and thus creating stable colloidal emulsion 
droplets.
[92-95]
 Since most of the emulsion systems involve water or an aqueous 
solution as one of the liquids, emulsion can be categorized into two main groups, 
namely oil-in-water (O/W) or water-in-oil (W/O), where the first description 
mentioned represents the dispersed phase and the second is the continuous phase. 
 
Over the years, several different emulsion systems have been employed for the 
preparation of silica nanocapsules. Despite the difference in the details of the 
synthesis, the basic idea of emulsion templating is to selectively deposit silica shell at 
the interface between the emulsion droplets and the continuous phase. Sol-gel 
processes of silicon alkoxides are commonly employed for the fabrication of the silica 
shell. Considering the fact that silicon alkoxides are hydrophobic, the presence of 
emulsion droplet interface naturally helps to achieve the objective above by limiting 
the hydrolysis reaction of the alkoxide precursors at the interfacial region, where they 
make contact with water. The challenge, however, is to confine the condensation 
reaction of the hydrolyzed alkoxide precursors at the interfacial region as well. Hence, 
to resolve this issue, several research groups employed surfactants or co-surfactants 
that have affinity to the silica precursors either through electrostatic interaction or 
hydrogen bonding.  
 
One of the early attempts in employing emulsion templating for the preparation of 
silica nanocapsules was reported by Fowler et al.
[96-97]
 They employed O/W emulsion, 
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where TEOS was simply added into an alkaline solution containing CTAB. The 
surfactant (CTAB) molecules are responsible for stabilization of the TEOS droplets 
and templating the silica shell through electrostatic interaction. Moreover, by simply 
mixing organo-functional silanes with TEOS prior to injection into water, the 
approach was extended for the preparation of fluorescent hollow silica microspheres, 
the shell walls of which were impregnated with dinitrophenylamino groups that are 
able to give out fluorescence. Nevertheless, the silica capsules derived from this 
approach typically have sizes in the micrometer range and possess rather broad size 
distribution.  
  
Alternatively, Hah et al.
[98]
 reported a novel O/W emulsion strategy to prepare 
monodispersed hybrid silica nanocapsules via a two-step sol-gel process of 
phenyltrimethoxysilane (PTMS) without employing any surfactants, an approach of 
which is called self-templating. Intrigued by the unique mechanism by which the 
synthesis was designed, Ahn et al.
[99]
 and Wang et al.
[100]
 further investigated the self-
templating approach and found that the key to obtain the hollow structure of the silica 
nanocapsules by self-templating is the rapid and consecutive acid-hydrolysis and 
base-condensation treatment of the PTMS droplets to form a thin layer of porous 
hybrid silica shell on its outer surface. Accordingly, the silica shell thus formed causes 
the hydrolysis and condensation of un-reacted PTMS to proceed inwards from the 
liquid-solid interface to the interior of PTMS droplets. The hollow structure of the 
silica nanocapsules is then realized by extracting out the un-reacted PTMS with 
ethanol.  
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Figure 2.8 Reaction scheme of preparing silica nanocapsules through self-templating approach. 
(Adapted from reference [100]) 
 
Similarly, Zoldesi et al.
[101-102]
 designed a O/W emulsion strategy for the synthesis of 
silica hollow particles with no surfactants being used. In his approach, Zoldesi first 
synthesized highly monodisperse low-molecular-weight polydimethylsiloxane 
(PDMS) silicone oil droplets, the diameters of which are in the range of 0.6 – 2.0 μm. 
The oil droplets were then used as templates for the silica shell formation, which was 
formed through hydrolysis and condensation of TEOS, after which the liquid cores 
could be easily removed either by solvent extraction or evaporation.
[101-103]
 
Furthermore, the silica shell was functionalized with organic dyes to yield fluorescent 
silica nanocapsules that could be useful for biosensing purposes.
[102]
   
 
On top of the O/W emulsion, numerous efforts have been made to synthesize silica 
nanocapsules through W/O emulsion route.
[104-109]
 In this approach, water droplets are 
initially formed and stabilized by surfactants and/or co-surfactants. Silicon alkoxide 
precursors were then added into the emulsion system, which upon contact with the 
water/oil interface, the precursors are hydrolyzed and condensed to form the silica 
shell surrounding the water droplets. As an example, Song et al. prepared silica 
nanocapsules through hydrolysis and condensation of TEOS at the water/oil 
(kerosene) droplet interface,
[108-109]
 as illustrated in Figure 2.9. The sol-gel process of 
TEOS was catalyzed by water-soluble alkyl-amine and templated by cationic 
surfactant (CTAB) and non-ionic co-surfactant (alkyl-phenol polyoxyethylene; OP-4) 
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at the interfacial region. The diameter and shell thickness of the resultant silica 
nanocapsules could be varied by employing alkyl amines with different hydrocarbon 
chain lengths, such as triethylamine, n-butylamine, and dibutylamine. Nevertheless, 
the silica nanocapsules thus produced are not uniform and exhibit ill-defined 
morphology, presumably due to rapid deformation under vacuum.   
 
 
Figure 2.9 Schematic illustration of the formation of silica nanocapsules through W/O emulsion.  
(Adapted from reference [109]) 
 
Despite the ease of template removal and its core functionalization, it is still very 
challenging to obtain uniform emulsion droplets with size smaller than 100 nm 
because of the droplet coalescence and Ostwald ripening process. Consequently, the 
silica nanocapsules prepared through emulsion templating typically exhibit sizes in 
sub-micrometer range with relatively large size distribution. Furthermore, the size of 
emulsion droplet is affected by many factors, for instance the choice of the oil phase, 
the presence of surfactants and/or co-surfactants, and the means and strength of 
mechanical agitation. As a result, lengthy optimization process is often required to 
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2.3.2.2 Gas bubbles 
 
Gas bubbles are an interesting class of soft templates because they can be generated 
easily by subjecting a solution to a high-intensity ultrasonic irradiation. The chemical 
effect of sonication treatment, however, does not arise from interaction of the acoustic 
wave and matter at molecular level.
[110]
 Instead, it is based on the acoustic cavitation, 
which is a process of forming, growth, and implosive collapse of bubbles. During 
cavitation, bubble collapse generates local hot spots of high temperature and pressure 
that supply energy for chemical reactions.
[111-112]
 In the case of synthesis of silica 
nanocapsules, the gas bubbles were stabilized by the surfactants at the gas-liquid 
interface, which served as template for the formation of hollow structure.
[113-115]
 The 
presence of surfactants at the bubbles interface also acted to template and confine 
silica condensation surrounding the bubbles, as illustrated in Figure 2.10. The 
ultrasound-generated heat near the vapor-liquid interface could then accelerate the sol-
gel reactions of the silica precursor, resulting in a shorter preparation time. The silica 
nanocapsules prepared via templating against gas bubbles were reported to possess 
wide size distribution, in the range of 50 to 500 nm. The outer diameter and shell 
thickness of the silica nanocapsules could be tuned by varying the sonochemical 
processing time, where more gas bubbles were available as templates with longer 
ultrasound irradiation time.
[115]
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Figure 2.10 Illustration of the formation of silica nanocapsules templated by gas bubbles created 
through acoustic cavitation process.   
 
2.3.2.3 Surfactant vesicles 
 
In 1992, Kresge and co-workers
[116-117]
 demonstrated the usage of cationic surfactant 
(CTAB) as a template for the formation of mesoporous silica. Since then, numerous 
works have focused on exploiting low-molecular-weight surfactant molecules self-
assembly as directing and structuring agents in the synthesis of novel materials with 
different composition and morphologies. Surfactants are amphiphilic molecules, 
which consist of hydrophobic and hydrophilic groups that are able to self-assemble 
into various structures, including micelles, cylindrical, lamellar, vesicles, and liquid 
crystal.
[91]
 Among those structures, vesicles are particularly interesting as templates 




 were among the first who reported successful vesicle 
templating approach for preparation of silica nanocapsules. They employed neutral 
amine bolaamphiphile surfactants that have two polar head groups linked by a 
hydrophobic alkyl chains as the structure directing agent to form vesicles with 
multilamellar shells and TEOS as the silica precursors. In view of the neutral 
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characteristics of the employed surfactant, the sol-gel reactions of TEOS were 
conducted in near-neutral pH environment in order to obtain neutral silanol 
(Si(OC2H5)4-xOHx) groups. These neutral silanol groups then penetrated the vesicles 
layer, diffused into the multilamellar shells, and interacted with the surfactants 
through hydrogen bonding. This strategy resulted in the formation of ultrastable silica 




Figure 2.11 The reaction scheme of preparing silica nanocapsules through self-templating approach. 
(Adapted from reference [118]) 
 
Alternatively, Hubert et al.
[121]
 synthesized single shell silica nanocapsules by 
employing unilamellar vesicles of dioctadecyldimethylammonium bromide (DODAB) 
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bearing quartenary ammonium groups that facilitate the deposition of thin silica shell 
surrounding it.
 
It is known, however, that unilamellar vesicles formed from simple 
surfactant system in water is thermodynamically unstable.
[122]
 In this aspect, 
catanionic vesicles, which is spontaneously formed by mixing surfactants with 
oppositely charged head groups, represent an interesting alternative class of vesicle 
templates.
[123]
 The catanionic vesicles are characterized by high stiffness of the bi-
layer structure owing to the strong electrostatic interaction between the positively and 
negatively charged head groups. As a result, catanionic vesicles are more stable than 
the former vesicle system. Lootens et al.,
[124]
 for instance, demonstrated the 
preparation of faceted silica nanocapsules by using icosahedral catanionic vesicles as 
templates. The bi-layer structure of these vesicles was built by employing cationic 
cetyltrimethylammonium hydroxide (CTAOH) and anionic myristic acid (C13COOH) 
surfactants. Independently, Hentze et al.
[125]
 synthesized spherical silica nanocapsules 
by using catanionic vesicles built from CTAB and sodium perfluorooctanoate (FC7), 
as well as cetyltrimethylammonium tosylate (CTAT) and sodium 
dodecylbenzenesulfonate (SDSB).  
 
It is important to point out, however, that the structure and stability of vesicles are 
highly sensitive to the changes in the pH, solvent polarity, and ionic strength of the 
solution.
[57]
 The use of excessive silica precursors (TEOS), for example, could break 
up the vesicle structure as a result of the increasing amount of ethanol generated by 
hydrolysis of the TEOS.
[124]
 Additionally, it is impossible to use soluble silicate as 
silica precursors because the high ionic strength of this silica solution will cause 
destabilization of the ionic vesicles.
[121]
 As a consequence, such sensitivity makes 
vesicles templating a generally challenging approach.  
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2.3.2.4 Polymeric micelles 
 
Similar to low-molecular-weight surfactants, polymeric micelles are a unique class of 
materials that are formed from block copolymers consisting of two clearly distinct 
hydrophobic and hydrophilic segments. At very low concentration or temperature, 
these amphiphilic copolymers exist as individual chains, which are commonly known 
as unimers. As the concentration or temperature increases, the amphiphilic copolymer 
chains will spontaneously self-assemble to form polymeric micelles that are composed 
of a core of hydrophobic blocks stabilized by a corona of hydrophilic polymeric 
chains. The concentration of the block copolymers or temperature at which polymer 
micelles are formed is called critical micelles concentration (CMC) or critical micelles 
temperature (CMT), respectively.
[126]
 Above the CMC or CMT, the polymeric micelles 
are in equilibrium with the unimers. This micellization process is summarized and 
illustrated in Figure 2.12 below.  
 
 
Figure 2.12 A general scheme of micelle formation from an amphiphilic block copolymer. (Adapted 
from reference [126]) 
 
As in the case of any natural occurring processes, the self-assembly of block 
copolymer chains forming polymeric micelles is a thermodynamically governed 
Chapter 2: Literature Review 
 39 
process. Micellization process is affected by various intermolecular forces, which 
include hydrophobic, steric, electrostatic, hydrogen bonding, and Van der Waals 
interactions.
[127]
 The main attractive force results from the hydrophobic interactions 
associated with the hydrophobic segment of the block copolymers,
[128]
 whereas the 
main opposing repulsive force stems from steric and/or electrostatic interactions of the 
hydrophilic segment. The major driving force behind micellization is the decrease in 
free energy of the system, as a result of the reduced interfacial area between the 
hydrophobic segments and the surrounding aqueous environment.
[129]
 Nevertheless, 
such association would also decrease the entropy of the whole system, thus increasing 
the free energy. As a result, micellization is a delicate and dynamic process, which 
occurs only at certain conditions, namely above CMC or CMT value.  
 
Polymeric micelles are of particular interest as soft templates for the fabrication of 
silica nanocapsules because their size is normally between 50 – 100 nm, which is an 
ideal dimension for nanocarriers extravasating into leaky tumor tissues to achieve 
passive targeting.
[126]
 Additionally, numerous polymeric micelles employ PEO as the 
hydrophilic corona, which is known to be well soluble and highly hydrated, as well as 
provide protection against early recognition by RES, thus imparting long circulating 
behavior. Furthermore, the hydrophobic compartment of the polymeric micelles can 
be filled in with various functional hydrophobic compounds, such as anti-tumor drugs 
and contrast agents, thereby opening the possibility to functionalize the silica 
nanocapsules prior to the formation of the silica shell. More interestingly, polymeric 
micelles have been used to template various silica-based nanostructured materials, 
especially in the field of mesoporous silica,
[130-131]
 therefore demonstrating their 
compatibility to direct the formation of silica. As a result, there has been increasing 
Chapter 2: Literature Review 
 40 
interest to employ polymeric micelles as structure directing agent for fabrication of 
hybrid silica nanocapsules, which are aimed for development of novel intravenous 
injectable nanocarriers.  
 
In general, there are two approaches that have been developed for preparation of silica 
nanocapsules via polymeric micelles templating. First, it involves synthesizing a new 
block copolymer bearing specific functional groups through organic synthesis process. 
These functional groups are distributed along the corona of the polymeric micelles 
and serve as reservoir for adsorption of silica precursors, thereby confining the silica 
condensation in the corona segment of the micelles. For example, Koh and co-
workers
[132]
 synthesized a new amphiphilic block copolymer that is terminated with 
silanol groups at the end of the hydrophilic segment of the polymeric chains, namely 
poly(methyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether 
monomethacrylate)-b-poly(poly(ethylene glycol) methyl ether monomethacrylate-r-
methacryloxypropyltrimethoxysilane) (PMMA-PPEGMA-poly(PEGMA-r-MOPS). 
Upon the formation of polymeric micelles, the silanol groups are consequently located 
at the outermost region of micelles, which serve as reactive points for the formation of 
the silica shell, as illustrated in Figure 2.13. It has been shown that the resultant hybrid 
silica nanocapsules exhibit particle sizes of about 25 nm, which is consistent with the 
DLS result of free polymeric micelles, demonstrating that the silica shell was indeed 
deposited at the outer rim of the micelles.  
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Figure 2.13 A schematic diagram of synthesis of a new block copolymer functionalized with silanol 
group for preparation of hybrid silica nanocapsules. (Adapted from reference [132]) 
 
Similarly, Yuan and co-workers
[133-134]
 synthesized cationic diblock copolymer of 
poly(2-(diisopropyl-amino)ethyl methacrylate)-b-2-(dimethylamino)ethyl 
methacrylate (PDPA-PDMA), in which the tertiary amine groups on the PDMA block 
could be partially (or fully) quarternised using methyl iodide. This results in the 
formation of polymeric micelles with PDPA chains as the hydrophobic core and the 
cationic PDMA chains as the micelles corona. The cationic character of the PDMA 
chains does not function only as water solubilization and colloidal stabilization agent, 
but also as physical scaffold for deposition of the silica shell. Interestingly, the 
cationic character of the PDMA corona is able to catalyze the hydrolysis and 
condensation reactions of TMOS at neutral pH and room temperature environment, 
eliminating the need of employing catalyst such as acid and base.  
 
Meanwhile, Khanal and co-workers
[135]
 adopted a similar strategy by employing ABC 
type tri-block copolymers of poly(styrene-b-2-vinyl pyridine-b-ethylene oxide) (PS-
PVP-PEO) that are able to form polymeric micelles with a core-shell-corona structure. 
In their strategy, the silica precursors is designed to selectively adsorb on the shell 
segment of the polymeric micelles, thus keeping the PEO corona free to provide 
stabilization to the hybrid silica nanocapsules. This strategy was realized by ionizing 
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the hydrophilic PVP units in low pH (< 5) environment. The protonated PVP shell 
then served two important functions: (i) to act as an acid catalyst site for the 
hydrolysis of TMOS; and (ii) to serve as reservoir for adsorption of the hydrolyzed 
silica precursor due to electrostatic interaction with the negatively charged silica. 
Although the resultant silica nanocapsules appear to be aggregated to one another, the 
average size of the core and outer diameter of the nanocapsules are very uniform, 
which is about 11 and 30 nm, respectively.  
 
Even though chemical modifications of block copolymers have been successfully used 
to prepare hybrid silica nanocapsules, this approach generally incurs a complicated 
organic synthesis procedure, which are lengthy and time-consuming. As compared to 
the sophisticated modification of polymer structures, an easier way would be to utilize 
commercially available block copolymers that have good affinity with silica. A good 
candidate for such purpose is PEO-based block copolymers, such as Pluronic
®
 (PEO-
PPO-PEO) family, because PEO is known to form crown-ether-type complexes with 
the silanol groups of hydrolyzed silica through hydrogen bonding.
[136]
 In fact, PEO-
based block copolymers have been widely used to prepare mesoporous silica in 




 were the first who reported the preparation of hybrid silica 
nanocapsules by using F127 (PEO106-PPO70-PEO106) block copolymers as templates 
for the silica shell formation. In their approach, the synthesis was carried out at highly 
acidic condition (pH < 1) in order to protonate the PEO unit, which became 
adsorption sites for the silica precursors through electrostatic interaction. The highly 
acidic condition was also necessary to suppress the condensation reactions between 
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the silanol groups, thus providing enough time for the silanol groups to interact with 
the PEO chains. To prevent inter-particle cross-linking (aggregation), the 
condensation reaction was then terminated by using diethoxydimethylsilane 
(DEDMS). As a result, the silica shell was formed surrounding the core of the F127 
micelles, keeping part of the PEO corona free in solution to serve as steric 
stabilization agent, as illustrated in Figure 2.14. In addition, they also demonstrated 
the uptake and release of various hydrophobic drugs and dyes from the resulting silica 
nanocapsules and the silica shell appeared to be effective in slowing down the 
diffusional release rates of these compounds.  
 
 
Figure 2.14 A schematic diagram illustrating the preparation of hybrid silica nanocapsules by using 
F127 block copolymer as templates in highly acidic condition (top) and in high temperature and 
pressure condition (bottom). (Adapted from reference [137] and [138]) 
 
Alternatively, Liu and co-workers
[138]
 also prepared hybrid silica nanocapsules by 
using F127 micelles as the templates. They reported that the monodispersed silica 
nanocapsules could be formed only in phosphate buffered solution, followed by 
heating the polymeric micelles and silica precursor together in an autoclave vessel at 
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100 ~ 120 °C for 24 hours.
[138]
 These steps were taken because the F127 micelles 
could only be stabilized in the presence of inorganic salts in the solution, whereas the 
hydrothermal treatment was necessary to promote formation of core-shell structure of 
the resultant silica nanocapsules. The guest compounds were then loaded into the 
nanocapsules through adsorption process to the micropores of silica wall. 
Unfortunately, although silica nanocapsules were successfully prepared through this 
approach, they were heavily aggregated together, thus negating their purpose for 
intravenous injectable nanocarriers.   
 
2.3.3 Summary and concluding remarks 
 
Various templating strategies for the preparation of silica nanocapsules have been 
discussed in this chapter. Despite the difference in the mechanism of template 
formation or silica shell deposition, the success of any templating strategy requires the 
use of templates that are stable and possess some sort of directing influence on the 
growth of silica shell. Among those aforementioned templating strategies, polymeric 
micelles templating is one of the most promising approaches for synthesizing silica 
nanocapsules because the resultant nanocapsules can be covered intrinsically with 
hydrophilic polymers (i.e., PEO) and loaded with active guest compounds (e.g., drugs 
and dyes) prior to the formation of silica shell,
[157]
 thus opening the possibility to form 
multi-functional silica nanocapsules according to the rationale design of nanocarriers 
for biomedical application. However, the copolymer templating techniques that were 
previously reported employed a complicated organic synthesis procedure or harsh 
synthesis condition which could significantly limit their practical applications, since 
most of the active compounds are highly sensitive to strong acidic, high temperature, 
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and high pressure environments. Therefore, there remains an urgent need to develop a 
new synthesis methodology that is able to prepare silica nanocapsules not only in a 
more practical and friendly manner but also in accordance with the engineering design 




[1] D. F. Emerich and C. G. Thanos, Expert Opin. Biol. Ther. 2003, 3, 655 – 663. 
[2] J. Martinez-Duart, R. J. Martin-Palmer, and F. Aqullo-Rueda, Nanotechnology 
for Microelectronics and Optoelectronics, Elsevier Science, 2005.  
[3] H. H. Kung and M. C. Kung, Catal. Today 2004, 97, 219 – 224. 
[4] Y. Zhang, Z. Xie, and J. Wang, ACS Appl. Mater. Interfaces 2009, 1, 2789 – 
2795. 
[5] H. Okumura, D. J. Twisselmann, R. D. McMichael, M. Q. Huang, Y. N. Hsu, D. 
E. Laughlin, and M. E. McHenry, J. Appl. Phys. 2003, 93, 6528 – 6530. 
[6] O. C. Farokhzad and R. Langer, ACS Nano 2009, 3, 16 – 20. 
[7] D. A. La Van, T. McGuire, and R. Langer, Nature Biotechnol. 2003, 21, 1184 – 
1191. 
[8] G. M. Whitesides, Nature Biotechnol. 2003, 21, 1161 – 1165. 
[9] R. Narayanan and M. A. El-Sayed, Nano Lett. 2004, 4, 1343 – 1348. 
[10] I. L. Medintz, H. T. Uyeda, E. R. Goldman, and H. Mattoussi, Nature Mater. 
2005, 4, 435 – 446. 
[11] M. J. Alonso, Biomed. Pharmacother. 2004, 58, 168 – 172. 
[12] P. Couvreur and C. Vauthier, Pharm. Res. 2006, 23, 1417 – 1450.   
[13] Y. Matsumura, T. Hamaguchi, T. Ura, K. Muro, Y. Yamada, Y. Shimada, K. 
Chapter 2: Literature Review 
 46 
Shirao, T. Okusaka, H. Ueno, M. Ikeda, and N. Watanabe, Brit. J. Cancer 2004, 
91, 1775 – 1781. 
[14] S. Mornet, S. Vasseur, F. Grasset, and E. Duguet, J. Mat. Chem. 2004, 14, 2161 
– 2175. 
[15] K. -T. Yong, I. Roy, M. T. Swihart, and P. N. Prasad, J. Mat. Chem. 2009, 19, 
4655 – 4672. 
[16] T. -J. Chen, T. -H. Cheng, C. -Y. Chen, S. C. N. Hsu, T. -L. Cheng, G. -C. Liu, 
and Y. -M. Wang, J. Biol. Inorg. Chem. 2009, 14, 253 – 260.  
[17] R. Hergt, S. Dutz, R. Müller, and M. Zeisberger, J. Phys.: Condens. Matter 
2006, 18, S2919 – S2934.   
[18] A. O. Govorov and H. H. Richardson, Nano Today 2007, 2, 30 – 38. 
[19] K. Sokolov, D. Nida, M. Descour, A. Lacy, M. Levy, B. Hall, S. 
Dharmawardhane, A. Ellington, B. Korgel, and R. Richards-Kortum, Adv. 
Cancer Res. 2006, 96, 299 – 344. 
[20] Y. Matsumura and H. Maeda, Cancer Res. 1986, 46, 6387 – 6392.  
[21] R. S. Kerbel, Carcinogenesis 2000, 21, 505 – 515. 
[22] S. V. Lutsenko, S. M. Kiselev, and S. E. Severin, Biochemistry (Mosc). 2003, 68, 
286 – 300. 
[23] T. M. Allen and P. R. Cullis, Science 2004, 303, 1818 – 1822. 
[24] H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori, J. Control. Release 2000, 65, 
271 – 284. 
[25] S. Nie, Y. Xing, G. J. Kim, and J. W. Simons, Annu. Rev. Biomed. Eng. 2007, 9, 
12.1 – 12.32. 
[26] A. L. Klibanov, K. Maruyama, V. P. Torchilin, and L. Huang, FEBS Lett. 1990, 
268, 235 – 237. 
Chapter 2: Literature Review 
 47 
[27] V. P. Torchilin, V. G. Omelyanenko, M. I. Papisov, A. A. Bogdanov Jr., V. S. 
Trubetskoy, J. N. Herron, and C. A. Gentry, BBA-Biomembranes 1994, 1195, 11 
– 20. 
[28] D. E. Owens III and N. A. Peppas, Int. J. Pharm. 2006, 307, 93 – 102. 
[29] V. S. Trubetskoy and V. P. Torchilin, Adv. Drug Deliv. Rev. 1995, 16, 311 – 320. 
[30] M. Vittaz, D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard, F. Puisieux, and 
D. Labarre, Biomaterials 1996, 17, 1575 – 1581. 
[31] S. M. Moghimi, A. C. Hunter, and J. C. Murray, Pharmacol. Rev. 2001, 53, 283 
– 318. 
[32] S. Kommareddy and M. Amiji, J. Pharm. Sci. 2007, 96, 397 – 407.    
[33] P. Wang, K. L. Tan, and E. -T. Kang, J. Biomater. Sci. Polym. Ed. 2000, 11, 169 
– 186. 
[34] F. Zhang, E. -T. Kang, K. G. Neoh, and W. Huang, J. Biomater. Sci. Polym. Ed. 
2001, 12, 515 – 531. 
[35] S. I. Jeon, J. H. Lee, J. D. Andrade, and P. G. De Gennes, J. Colloid Interface 
Sci. 1991, 142, 149 – 158.    
[36] J. H. Lee, H. B. Lee, and J. D. Andrade, Prog. Polym. Sci. 1995, 20, 1043 – 
1079. 
[37] M. Zhang, X. H. Li, Y. D. Gong, N. M. Zhao, and X. F. Zhang, Biomaterials 
2002, 23, 2641 – 2648. 
[38] R. Langer and D. A. Tirrell, Nature 2004, 428, 487 – 492. 
[39] R. A. Petros and J. M. DeSimone, Nat. Rev. Drug Discov. 2010, 9, 615 – 627.   
[40] D. Peers, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, 
Nature Nanotech. 2007, 2, 751 – 759. 
[41] M. M. Gottesman, T. Fojo, and S. E. Bates, Nat. Rev. Cancer 2002, 2, 48 – 58. 
Chapter 2: Literature Review 
 48 
[42] X. Wang, L. Yang, Z. Chen, and D. M. Shin, CA Cancer J Clin 2008, 58, 97 – 
110. 
[43] F. Marcucci and F. Lefoulon, Drug Discov. Today 2004, 9, 219 – 228. 
[44] J. K. Vasir, M. K. Reddy, and V. D. Labhasetwar, Curr. Nanosci. 2005, 1, 47 – 
64. 
[45] C. H. J. Choi, C. A. Alabi, P. Webster, and M. E. Davis, Proc. Natl. Acad. Sci. 
USA 2010, 107, 1235 – 1240. 
[46] P. Carter, Nat. Rev. Cancer 2001, 1, 118 – 129. 
[47] N. Takahashi, A. Haba, F. Matsuno, and B. K. Seon, Cancer Res. 2001, 21, 7846 
– 7854. 
[48] T. O. Pangburn, M. A. Petersen, B. Waybrant, M. M. Adil, and E. Kokkoli, J. 
Biomech. Eng. – T. ASME 2009, 131, 074005: 1 – 20.  
[49] T. M. Allen, Nat. Rev. Cancer 2002, 2, 750 – 763. 
[50] Z. M. Qian, H. Li, H. Sun, and K. Ho, Pharmacol. Rev. 2002, 54, 561 – 587.  
[51] P. S. Low, W. A. Henne, and D. D. Doorneweerd, Acc. Chem. Res. 2008, 41, 120 
– 129. 
[52] R. Kannagi, M. Izawa, T. Koike, K. Miyazaki, and N. Kimura, Cancer Sci. 
2004, 95, 377 – 384. 
[53] A. Gabizon, H. Shmeeda, A. T. Horowitz, and S. Zalipsky, Adv. Drug Deliv. Rev. 
2004, 56, 1177 – 1192.  
[54] C. P. Leamon and P. S. Low, Drug Discov. Today 2001, 6, 44 – 51. 
[55] C. P. Leamon and J. A. Reddy, Adv. Drug Deliv. Rev. 2004, 56, 1127 – 1141. 
[56] M. Ferrari, Nat. Rev. 2005, 5, 161 – 171. 
[57] X. W. Lou, L. A. Archer, and Z. Yang, Adv. Mater. 2008, 20, 3987 – 4019. 
[58] K. An and T. Hyeon, Nano Today 2009, 4, 359 – 373. 
Chapter 2: Literature Review 
 49 
[59] S. -W. Kim, M. Kim, W. Y. Lee, and T. Hyeon, J. Am. Chem. Soc. 2002, 124,   
7642 – 7643. 
[60] Y. Du, L.E. Luna, W. S. Tan, M. F. Rubner, and R. E. Cohen, ACS Nano 2010, 4, 
4308 – 4316. 
[61] X. W. Lou, Y. Wang, C. Yuan, J. Y. Lee, and L. A. Archer, Adv. Mater. 2006, 18, 
2325 – 2329. 
[62] V. P. Torchilin, Nat. Rev. 2005, 4, 145 – 157. 
[63] M. L. Immordino, F. Dosio, and L. Cattel, Int. J. Nanomedicine 2006, 1, 297 – 
315. 
[64] B. Heurtault, P. Saulnier, B. Pech, J. -E. Proust, and J. -P. Benoit, Biomaterials 
2003, 24, 4283 – 4300.  
[65] M. Grit and D. J. A. Crommelin, Chem. Phys. Lipids 1993, 64, 3 – 18.  
[66] C. Barbé, J. Bartlett, L. Kong, K. Finnie, H. Q. Lin, M. Larkin, S. Calleja, A. 
Bush, and G. Calleja, Adv. Mater. 2004, 16, 1959 – 1966. 
[67] J. F. Chen, H. M. Ding, J. X. Wang, and L. Shao, Biomaterials 2004, 25, 723 – 
727. 
[68] Y. Piao, A. Burns, J. Kim, U. Wiesner, and T. Hyeon, Adv. Funct. Mater. 2008, 
18, 1 – 14. 
[69] J. Kim, Y. Piao, and T. Hyeon, Chem. Soc. Rev. 2009, 38, 372 – 390. 
[70] Y. Wei, J. Xu, Q. Feng, H. Dong, and M. Lin, Mater. Lett. 2000, 44, 6 – 11. 
[71] K. S. Finnie, J. R. Bartlett, and J. L. Woolfrey, J. Mat. Chem. 2000, 10, 1099 - 
1101. 
[72] D. Brühwiler, Nanoscale 2010, 2, 887 – 892. 
[73] T. K. Jain, I. Roy, T. K. De, and A. Maitra, J. Am. Chem. Soc. 1998, 120, 11092 
– 11095. 
Chapter 2: Literature Review 
 50 
[74] R. K. Iler, The Chemistry of Silica: solubility, polymerization, colloid and 
surface properties, and biochemistry, John Wiley & Sons, New York, 1979. 
[75] C. J. Brinker and G. W. Scherer, The physics and chemistry of sol-gel 
processing, Academic Press Inc., San Diego, 1990.  
[76] F. Caruso, R. A. Caruso, and H. Möhwald, Science 1998, 282, 1111 – 1114. 
[77] I. Tissot, J. P. Reymond, F. Lefebvre, and E. Bourgeat-Lami, Chem. Mater. 
2002, 14, 1325 – 1331. 
[78] J. J. L. M. Cornelissen, E. F. Connor, H. -C. Kim, V. Y. Lee, T. Magibitang, P. 
M. Rice, W. Volksen, L. K. Sundberg, and R. D. Miller, Chem. Commun. 2003, 
1010 – 1011. 
[79] X. Ding, K. Yu, Y. Jiang, H. Bala, H. Zhang, and Z. Wang, Mater. Lett. 2004, 58, 
3618 – 3621. 
[80] J. Yang, J. U. Lind, and W. C. Trogler, Chem. Mater. 2008, 20, 2875 – 2877. 
[81] K. Aslan, M. Wu, J. R. Lakowicz, and C. D. Geddes, J. Am. Chem. Soc. 2007, 
129, 1524 – 1525. 
[82] K. Aslan, M. Wu, J. R. Lakowicz, and C. D. Geddes, J. Fluoresc. 2007, 17, 127 
– 131.    
[83] M. Aslam, S. Li, and V. P. Dravid, J. Am. Ceram. Soc. 2007, 90, 950 – 956. 
[84] D. K. Yi, S. S. Lee, G. C. Papaefthymiou, and J. Y. Ying, Chem. Mater. 2006, 18, 
614 – 619. 
[85] J. Yang, J. Lee, J. Kang, K. Lee, J. -S. Suh, H. -G. Yoon, Y. -M. Huh, and S. 
Haam, Langmuir 2008, 24, 3417 – 3421. 
[86] J. Kim, H. S. Kim, N. Lee, T. Kim, H. Kim, T. Yu, I. C. Song, W. K. Moon, and 
T. Hyeon, Angew. Chem. Int. Ed. 2008, 47, 8438 – 8441. 
[87] Y. Chen, H. Chen, L. Guo, Q. He, F. Chen, J. Zhou, J. Feng, and J. Shi, ACS 
Chapter 2: Literature Review 
 51 
Nano 2010, 4, 529 – 539. 
[88] M. Darbandi, R. Thomann, and T. Nann, Chem. Mater. 2007, 19, 1700 – 1703. 
[89] H. Ma, J. Zhou, D. Caruntu, M. H. Yu, J. F. Chen, C. J. O‟Connor, and W. L. 
Zhou, J. App. Phys. 2008, 103, 07A320: 1 – 3. 
[90] I. -F. Li, C. -H. Su, H. -S. Sheu, H. -C. Chiu, Y. -W. Lo, W. -T. Lin, J. -H. Chen, 
and C. -S. Yeh, Adv. Funct. Mater. 2008, 18, 766 – 776. 
[91] D. Myers, Surfaces, Interfaces, and Colloids: Principles and Applications, 
Wiley-VCH, New York, 1991. 
[92] J. Israelachvili, Colloids Surf. A 1994, 91, 1 – 8. 
[93] J. Soma and K. D. Papadopoulos, J. Colloid Interface Sci. 1996, 181, 225 – 231. 
[94] V. Schmitt, C. Cattelet, and F. Leal-Calderon, Langmuir 2004, 20, 46 – 52. 
[95] Y. Kong, A. Nikolov, and D. Wasan, Ind. Eng. Chem. Res. 2010, 49, 5299 – 
5303. 
[96] C. E. Fowler, D. Khushalani, and S. Mann, J. Mat. Chem. 2001, 11, 1986 – 
1971. 
[97] C. E. Fowler, D. Khushalani, and S. Mann, Chem. Commun. 2001, 2028 – 2029. 
[98] H. J. Hah, J. S. Kim, B. J. Jeon, S. M. Koo, and Y. E. Lee, Chem. Commun. 
2003, 1712 – 1713. 
[99] B. Y. Ahn, S. I. Seok, I. C. Baek, and S. -I. Hong, Chem. Commun. 2006, 189 – 
190. 
[100] Q. Wang, Y. Liu, and H. Yan, Chem. Commun. 2007, 2339 – 2341. 
[101] C. I. Zoldesi and A. Imhof, Adv. Mater. 2005, 17, 924 – 928. 
[102] C. I. Zoldesi, C. A. van Walree, and A. Imhof, Langmuir 2006, 22, 4343 – 4352. 
[103] H. Wang, P. Chen, and X. Zheng, J. Mater. Chem. 2004, 14, 1648 – 1651. 
[104] W. Li, X. Sha, W. Dong, and Z. Wang, Chem. Commun. 2002, 2434 – 2435. 
Chapter 2: Literature Review 
 52 
[105] S. Mishima, M. Kawamura, S. Matsukawa, and T. Nakajima, Chem. Lett. 2002, 
31, 1092 – 1093. 
[106] J. -H. Park, S. -Y. Bae, and S. -G. Oh, Chem. Lett. 2003, 32, 598 – 599. 
[107] J. -H. Park, C. Oh, S. -I. Shin, S. -K. Moon, and S. -G. Oh, J. Colloid Interface 
Sci. 2003, 266, 107 – 114. 
[108] L. Song, X. Ge, and Z. Zhang, Chem. Lett. 2005, 34, 1314 – 1315. 
[109] L. Song, X. Ge, M. Wang, and Z. Zhang, J. Non-Cryst. Solids 2006, 352, 2230 – 
2235. 
[110] K. S. Suslick and G. Price, Annu. Rev. Mater. Sci. 1999, 29, 295 – 326. 
[111] K. S. Suslick, Science 1990, 247, 1439 – 1445. 
[112] K. S. Suslick, S. B. Choe, A. A. Cichowlas, and M. W. Grinstaff, Nature 1991, 
353, 414 – 416. 
[113] R. K. Rana, Y. Mastai, and A. Gedanken, Adv. Mater. 2002, 14, 1414 – 1418. 
[114] W. Fan and L. Gao, J. Colloid Interface Sci. 2006, 297, 157 – 160. 
[115] J. -G. Wang, F. Li, H. -J. Zhou, P. -C. Sun, D. -T. Ding, and T. -H. Chen, Chem. 
Mater. 2009, 21, 612 – 620.  
[116] C. T. Kresge, M. E. Leonowicz, W. J. Roth, J. C. Vartuli, and J. S. Beck, Nature 
1992, 359, 710 – 712. 
[117]  J. S. Beck, J. C. Vartuli, W. J. Roth, M. E. Leonowicz, C. T. Kresge, K. D. 
Schmitt, C. T. W. Chu, D. H. Olson, E. W. Sheppard, S. B. McCullen, J. B. 
Higgins, and J. L. Schenker, J. Am. Chem. Soc. 1992, 114, 10834 – 10842. 
[118] P. T. Tanev and T. J. Pinnavaia, Science 1996, 271, 1267 – 1269. 
[119] P. T. Tanev, Y. Liang, and T. J. Pinnavaia, J. Am. Chem. Soc. 1997, 119, 8616 – 
8624. 
[120] S. S. Kim, W. Zhang, and T. J. Pinnavaia, Science 1998, 282, 1302 – 1305. 
Chapter 2: Literature Review 
 53 
[121] D. H. W. Hubert, M. Jung, P. M. Frederik, P. H. H. Bomans, J. Meuldijk, and A. 
L. German, Adv. Mater. 2000, 12, 1286 – 1290. 
[122] S. A. Safra, P. A. Pincus, D. Andelman, and F. C. MacKintosh, Phys. Rev. A 
1991, 43, 1071 – 1078. 
[123] S. Šegota and Đ. Težak, Adv. Colloid Interface Sci. 2006, 121, 51 – 75.  
[124]  D. Lootens, C. Vautrin, H. Van Damme, and T. Zemb, J. Mat. Chem. 2003, 13, 
2072 – 2074. 
[125] H. -P. Hentze, S. R. Raghavan, C. A. McKelvey, and E. W. Kaler, Langmuir 
2003, 19, 1069 – 1974. 
[126] V. P. Torchilin, J. Control. Release 2001, 73, 137 – 172. 
[127] J. N. Israelachvili, Intermolecular and surface forces, Academic Press, London, 
1992.   
[128] C. Tanford, The hydrophobic effect: formation of micelles and biological 
membranes, Wiley, New York, 1980. 
[129] M. -C. Jones and J. -C. Leroux, Eur. J. Pharm. Biopharm. 1999, 48, 101 – 111. 
[130] D. Zhao, Q. Huo, J. Feng, B. F. Chmelka, and G. D. Stucky, J. Am. Chem. Soc. 
1998, 120, 6024 – 6036. 
[131] G. J. A. A. Soller-Illia, E. L. Crepaldi, D. Grosso, and C. Sanchez, Curr. Opin. 
Colloid In. 2003, 8, 109 – 126.  
[132] K. Koh, K. Ohno, Y. Tsuji, and T. Fukuda, Angew. Chem. Int. Ed. 2003, 42, 
4194 – 4197. 
[133] J. -J. Yuan, O. O. Mykhaylyk, A. J. Ryan, and S. P. Armes, J. Am. Chem. Soc. 
2007, 129, 1717 – 1723. 
[134] Y. Li, J. Du, and S. P. Armes, Macromol. Rapid Commun. 2009, 30, 464 – 468. 
[135] A. Khanal, Y. Inoue, M. Yada, and K. Nakashima, J. Am. Chem. Soc. 2007, 129, 
Chapter 2: Literature Review 
 54 
1534 – 1535. 
[136] D. Zhao, J. Feng, Q. Huo, N. Melosh, G. H. Fredrickson, B. F. Chmelka, and G. 
D. Stucky, Science 1998, 279, 548 – 552. 
[137] Q. Huo, J. Liu, L. -Q. Wang, Y. Jiang, T. N. Lambert, and E. Fang, J. Am. Chem. 
Soc. 2006, 128, 6447 – 6453. 
[138] J. Liu, Q. Yang, L. Zhang, H. Yang, J. Gao, and C. Li, Chem. Mater. 2008, 20, 
4268 – 4275.  
Chapter 3: Design and synthesis of PEOlated Silica Nanocapsules  
 55 
Chapter 3  
DESIGN AND SYNTHESIS OF PEOLATED SILICA 





Silicon, the second most abundant element on Earth, is commonly found in 
combination with oxygen in the form of silica or silicates minerals.
[1]
 It is an 
important technological compound that has been widely used in a variety of 











 and biomedical fields.
[7]
 The preparation of synthetic silica 
for these applications typically requires high temperature and pressures or the use of 
strong acidic or alkaline media. In contrast, biological formation of silica 
(biosilification) on the skeleton of various marine organisms, such as diatoms and 
sponges, takes place at highly benign physiological conditions of near-neutral pH and 
room temperature.
[8]
 Moreover, by properly controlling the precipitation process, these 
organisms are able to form silica skeletons with morphology and structure that are 
much more complex than those obtained through artificial means. Intrigued by those 
exquisite architectures, many scientists have tried to investigate the mechanism 
underlying the formation of silica skeleton of these organisms and apply those 
principles for production of silica with better control over their structure and 
morphology. 
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In order to reveal and understand the biosilification process, macromolecules 
associated with the formation of biosilica were isolated through selective dissolution 
of the silica structure in aqueous hydrofluoric acid.
[1]
  It was identified that proteins 
and polysaccharides of these organisms are responsible for regulating their skeleton 
formation by spatially confining the chemical reactions and templating the 
condensation of silica on their bodies.
[9]
 Sillafins of diatoms, for example, are 
composed of polycationic peptide molecules that exhibit a high degree of affinity 
towards silica and thus promote the silicic acid condensation.
[10]
 Meanwhile, the 
silicatein of sponges can hydrolyze and condense the precursor molecule TEOS to 
form silica structures with controlled shapes at ambient conditions.
[11]
 Inspired by 
these understandings, several different analogue synthetic molecules were then 
designed and used to mimic the behavior of those proteins in synthesizing silica 







 and cationic block copolymers.
[17]
 Similar to the derived proteins, 
these synthetic molecules are able to catalyze and regulate the hydrolysis and 
condensation of silica precursors at rather mild synthesis conditions. In addition, some 
of them have the capability to template and direct the silica condensation leading to 





 and hollow particles.
[17]
 The application of block copolymers, in particular, 




Motivated by the aforementioned bioinspired silification processes, a facile and 
benign strategy has been successfully developed in this project to synthesize PEOlated 
silica nanocapsules (hereafter, denoted as PEOSN) at room temperature and near-
neutral pH aqueous environment by using F127 block copolymer micelles as the 
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templating agent. F127 is a tri-block copolymer consisting of poly(propylene oxide) 
(PPO) and poly(ethylene oxide) (PEO) blocks arranged in ABA structure. It is 
selected because it is recognized as a highly biocompatible polymeric material and has 
been extensively used in various biomedical and pharmaceutical applications.
[24]
 The 
main idea of the designed bioinspired silification strategy is to form silica shell solely 
at the interface between the core and corona of the F127 micelles. This strategy 
consequently gives rise to the formation of hybrid silica nanocapsules that are 
intrinsically covered by a layer of free PEO chains, namely PEOlated silica 
nanocapsules (PEOSN). Each of the PEOSN thus consists of a PPO core, a thin silica 
shell, and an outer layer of PEO chains. Hence, through the bioinspired silification 
strategy, the PEOSN can combine the high chemical and mechanical integrities of the 
silica shell with the steric stabilization and antifouling behavior of PEO, which are in 
accordance with the rationale engineering design of nanocarriers for biomedical 
applications, as discussed in the section 2.2 of literature review.  
 





 L121 (PEO5PPO70PEO5), P123 (PEO20PPO70PEO20), 
F127 (PEO106PPO70PEO106), tetramethoxysilane (TMOS; 98%), tetrahydrofuran 
(THF), pyrene, potassium bromide, and phosphotungstic acid (PTA) were purchased 
from Sigma Aldrich. Fetal Bovine Serum (FBS) was purchased from Hyclone. 10 × 
Phosphate Buffered Saline (PBS) solution was purchased from 1
st
 Base. 1 × PBS was 
prepared by diluting the 10 × PBS with Milli-Q deionized water (DI H2O). 
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3.2.2 Synthesis of PEOlated silica nanocapsules (PEOSN) 
 
75 mg of F127 was first dissolved into 900 μL THF to form a clear solution. 65 μL of 
TMOS was then added. The mixture solution was injected into a 10 g of deionized 
water immersed in water-bath under ultra sonication in three minutes. The solution 
was further sonicated for ten minutes, followed by stirring at room temperature for 
four days to evaporate off THF and ensure a complete hydrolysis of TMOS at the 




Transmission electron microscopy (TEM, JEM-2010F, 200 kV) was employed to 
study the morphology of the synthesized PEOSN. Dynamic light scattering (DLS) was 
performed with Malvern Zetasizer Nano-S using a HeNe laser (633 nm) to measure 
the nanocapsule size and size distribution. The spectrometer was calibrated by using a 
standard polystyrene suspension of 60 nm. All measurements were conducted using 
water as the dispersant in a glass cuvette. The average hydrodynamic diameter and the 
width of the distribution (polydispersity index) are obtained from the cumulant 
analysis. The polydispersity index (PdI) is a dimensionless number, which range from 
0 to 1, where 1 indicates that the samples are highly polydisperse. The structure of the 
PEOSN was characterized using Fourier Transform Infrared Spectroscopy (Perkin-
Elmer Spectrum GX). Disc samples were prepared by pressing the mixture of 
nanocapsules and dried potassium bromide. 
29
Si NMR characterization was carried 
out with a Bruker Avance 400 (DRX400) NMR spectrometer at 400 MHz at room 
temperature. The sample was loaded into 4.0 mm Zirconia PENCIL
TM
 rotors and 
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capped tightly. The 
29
Si spectrum was recorded at 79.489 MHz with repetition delay 
10 s, 35 ms acquisition time, spinning rate of 10,000 rps, and 3000 number of scans. 
Chemical shift of 
29
Si NMR was referenced to tetramethylsilane as 0 ppm. 
Thermogravimetric Analysis (TGA) was performed by using TGA Q500 Thermal 
Instrument with a heating rate of 10 °C/min to 800 °C in air ambient. 
Photoluminescence spectra were measured by using a Shimadzu RF-5301 PC 
spectrophotometer at room temperature. 
 
3.2.4 Sample preparation for TEM studies 
 
40 μL of the aqueous suspension containing PEOSN was diluted with 200 μL of DI 
H2O. A drop of this diluted solution was pipetted directly onto a 200-mesh carbon-
coated copper grid. After two minutes, the excess solution was removed by touching 
the grid edge using a Kimwipe delicate wipe. The sample was finally dried at room 
temperature. 
 
In order to reveal the PEO chains on the outer surface of the PEOSN, the as-
synthesized PEOSN was treated with a phosphotungstic acid (PTA) aqueous solution 
(1%). The PTA staining has been widely used to improve the contrast of PEO-based 
block copolymer for TEM observation,
[25-27]
 which otherwise cannot been shown by 
the conventional TEM as a result of the high transparence to electron beam. 180 μL of 
the diluted solution containing PEOSN was mixed with 20 μL of phosphotungstic acid 
(PTA) aqueous solution (1%) through a vortex. A drop of this mixture solution was 
then cast onto a 200-mesh carbon-coated copper grid. After two minutes, the excess 
solution was removed by touching the edge of the grid by using a Kimwipe delicate 
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wipe. The sample was finally dried at room temperature. As a control, a TEM sample 
of PTA-stained F127 micelles was also prepared by following the same procedure. 
The F127 micelles were synthesized in the same way as the PEOSN without the 
addition of TMOS.      
 
3.2.5 Antifouling study 
 
F127 micelles and PEOSN were incubated in PBS containing 10% (v/v) fetal bovine 
serum (FBS) at 37 °C in water bath, which is corresponding to the physiological 
condition.
[28]
 In this study, FBS was used as a model protein. DLS was then used to 
monitor the change in the particle size of the both systems during the incubation 
period. 
 
3.2.6 Particle stability study 
 
Pyrene-loaded F127 micelles and PEOSN were prepared via the bioinspired 
silification approach, as described above. The final concentration of pyrene is 1 × 10
-5
 
M. Upon dilution, the fluorescence spectra of pyrene were immediately recorded by 
using an excitation wavelength (λex) of 336 nm. The intensity ratio of the first 
emission band at 372 nm (I1) to the third emission band at 384 nm (I3) is used to 
determine the location of pyrene in the micelles. A high I1/I3 ratio value of ~1.7 
indicates that F127 micelles have disintegrated and the pyrene molecules have made 
contact with water. In contrast, a consistent I1/I3 ratio value of ~1.4 indicates that F127 
micelles are stable and the pyrene molecules are still encapsulated inside the micelles. 
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3.3 Results and discussion 
3.3.1 Preparation and characterizations of PEOSN 
 
 
Scheme 3.1 Schematic showing the formation of PEOlated silica nanocapsules (PEOSN) via 
bioinspired silification approach. 
 
The basic idea behind the bioinspired silification approach is to effectively confine the 
hydrolysis and condensation reactions of the silica precursors at the interface between 
the core and the corona of the micelles, in which the remained free PEO blocks 
provide steric stabilization to the nanocapsules. In order to realize this idea, F127, a 
representative of non-ionic PEO-based block copolymer, and TMOS are dissolved 
together in THF (Scheme 3.1A). Upon injecting the mixture solution into an aqueous 
environment, polymeric micelles are spontaneously formed with PPO blocks as the 
core and PEO blocks as the corona. The micellization process is simultaneously 
accompanied by segregation of TMOS into the core of the polymeric micelles due to 
its hydrophobic characteristic (Scheme 3.1B). As a consequence of this encapsulation, 
the hydrolysis of TMOS is confined to occur at the interface between the core and the 
corona of the micelles, where TMOS encounter with water. The silanol groups of 
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hydrolyzed TMOS are further confined at the interfacial region by forming complexes 
with the PEO blocks of F127 through hydrogen bonding.
[29-30]
 Subsequently, the 
silanol groups condense at the interfacial region to form a thin silica shell surrounding 
the core of the micelles. (Scheme 3.1C). As the process progresses, the un-reacted 
TMOS in the core of the micelles reacts with water at the interfacial region, diffuse, 
and condense onto the outer surface of the silica shell. Therefore, the growth of the 
silica nanowall proceeds from the inner side to the outer surface of the wall, forming 
hybrid silica nanocapsules with PEO chains of F127 protruding out into the water, 
which is named as PEOlated silica nanocapsules (PEOSN) (Scheme 3.1D). The 
PEOSN consists of three layers, namely the PPO core, a thin silica shell and free PEO 
chains dangling on the silica shell outer surface (Scheme 3.1E). The bioinspired 
silification scheme using non-ionic PEO-based block copolymer micelles to 
synthesize PEOSN has several advantages, namely (i) a highly benign synthesis 
environment in a near-neutral pH aqueous environment and at ambient temperature, 
(ii) ease for the active hydrophobic compounds to be loaded into the core of the 
nanocapsules by prior dissolution of the compounds in the aqueous miscible organic 
solvent, (iii) high mechanical stability due to the presence of silica nanoshell which 
prevent disintegration of the micelles upon dilution in the body,
[22]
 and (iv) retention 
of free PEO chains extending out from the surface of the nanocapsules to provide 
aqueous stabilization and prevent recognition of the nanocapsules against 




The morphology of the as-synthesized PEOSN that were successfully achieved 
through the bioinspired silification in the present work was investigated by using 
transmission electron microscopy (TEM), as shown in Figure 3.1 (a).  The observed 
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doughnut shape with clear contrast between bright PPO core and dark silica shell in 
all particles shows a typical capsule morphology. The silica appears darker in the 
TEM micrograph because its electron density is significantly higher than that of the 
PPO blocks, which are carbon-based materials. The PEOSNs are uniform with an 
average outer diameter of ~14 nm for silica shell and an average core diameter of ~6 
nm. The observed core diameter is in good agreement with the size of PPO core of 
pure F127 micelles, reported in a previous cryo-TEM and SANS study.
[33]
 Hence, this 
suggests that the silica shell of the PEOSN is deposited surrounding the core of 
individual F127 micelle.  
 
 
Figure 3.1 (a) Transmission electron micrograph of the PEOSN synthesized via the bioinspired 
silification approach. The inset shows the high magnification of a PEOlated silica nanocapsule, (b) 
Particle size distribution of the aqueous suspension of F127 micelles and PEOSN measured by using 
dynamic light scattering (DLS). The F127 micelles were prepared in the same way as the PEOSN 
without the addition of TMOS.  
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Figure 3.2 TEM images of (a) the pure F127 micelles and (b) the PEOSN stained by PTA, which 
enhance the electron beam contrast of the PEO.  
 
Meanwhile, dynamic light scattering (DLS) measurement can provide additional 
information about the structure of the PEOSN and the result is shown in Figure 3.1 
(b). The intensity-average hydrodynamic diameter of the PEOSN was measured to be 
29 nm, which is very similar to that of pure F127 micelles prepared in the same way 
(25 nm), suggesting that the hydrodynamic diameter of the micelles is not changed 
after the formation of the silica shell. Nevertheless, the hydrodynamic diameter of the 
PEOSN is larger than the outer diameter measured by TEM. Since DLS provides 
information on hydrated size of a particle, this difference is likely attributed by the 
extension of the hydrated free PEO chains from the surface of the silica nanocapsules 
into the water.  In contrast, the PEO chains are highly transparent to electron beam, 
and therefore, a proper image contrast cannot be generated to show the existence of 
these polymeric segments in the conventional TEM. In order to reveal the PEO outer 
layer (PEO chains dangling on the silica shell outer surface), which is hydrophilic, the 
PEOSN were treated (stained) with phosphotungstic acid (PTA), and the resulting 
TEM image is shown in Figure 3.2 (b). Upon staining by PTA, a dark contrast is 
generated as a result of the interaction between PTA and PEO chain,
[25]
 giving rise to 
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particles sizes in the range of 25 to 30 nm. Indeed, this size range is similar to that of 
pure F127 micelles stained in the same way, as shown in Figure 3.2 (a). The existence 
of the PEO outer layer on the surface of silica shell is thus clearly demonstrated by the 
size difference between the unstained PEOSN and those stained by PTA. Therefore, 
based on the size studies of the TEM and DLS, it is reasonable to conclude that the 
silica shell formation of the PEOSN is indeed confined at the interface area between 
the core and corona of F127 micelles, leaving part of the PEO chains of the micelles 




Figure 3.3 (a) FT-IR spectra of pure F127 and PEOSN. Filled circle () shows the silica vibrational 
band, and (b) thermogravimetric analysis of the PEOSN in air.  
 
The hybrid structure of the PEOSN was investigated using Fourier Transform Infrared 
(FT-IR) spectroscopy. As shown in Figure 3.3 (a), the hybrid structure is demonstrated 
by the presence of both the characteristic bands of silica and F127 block copolymer 
simultaneously in the spectrum of PEOSN. The characteristic silica bands appear at 
465 cm
-1
 (Si-O-Si bending), 956 cm
-1 





 whereas the those bands at 2900 cm
-1
 (C-H stretching), 
1470 cm
-1
 (C-H bending), 1350 cm
-1
 (C-H wagging), and 845 cm
-1
 (C-H rocking) 
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correspond to F127 block copolymer. This nanohybrid structure is also verified by 
thermogravimetric analysis (TGA) of the PEOSN in Figure 3.3 (b), which shows a 
weight loss of 75.5% corresponding to the decomposition of F127 at around 200°C. 
This weight loss is in close agreement with theoretical calculation of 74%, with the 
assumption of complete condensation of TMOS to SiO2. Thus, the TGA result 
indicates that TMOS has been completely hydrolyzed and formed the silica shell 





Si NMR spectrum of the PEOSN with Q
2
 (-O2Si(OH)2) and Q
3
 (-O3Si(OH)) represent 
partially condensed silica, whereas Q
4
 (-O3-Si-O-) designate the complete condensation of silica. The 




The silica nanowall surrounding the core of the micelles was further studied by using 
29
Si NMR spectroscopy.  Figure 3.4 shows the three peaks being detected at -92, -103, 






, respectively, where Q
4
 being 
the highest degree condensation of silicate. The relatively broad peaks indicate a wide 
range of Si-O-Si bond angles. This is not surprising by considering the amorphous 
nature of the silica nanowall as a result of the sol-gel reaction at room temperature. 
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The spectrum was further deconvoluted by using Gaussian distribution, in order to 






) ratio is 
calculated to be 0.76, which reflects a relatively low degree of cross-linking of the 
silica wall.
[35]
 This result indicates that PEOSN is of potential for the controlled 
release by exploiting diffusion process of hydrophobic drug from the core of the 
nanocapsules to the surrounding environment through a rather porous silica wall.  
 
3.3.2 Stability study of PEOSN against dilution 
 
It is widely known that polymeric micelles will spontaneously dissociate when they 
are diluted below the CMC value.
[31]
 This phenomenon thus could be used to verify 
whether the silica shell of PEOSN has been formed properly through the bioinspired 
silification. It is hypothesized that a proper silica shell formation surrounding the core 
of the F127 micelles would prevent the micelles disintegration even though the 
polymer concentration falls below the CMC.  
 
In order to investigate the stability of the PEOSN against dilution, fluorescence probe 
pyrene was used in this study because its emission is highly sensitive on the polarity 
of the microenvironment. The emission spectrum of pyrene consists of five primary 
bands, normally known as I1–I5, from shorter to longer wavelength. The I1/I3 ratio of 
pyrene is known to be dependent strongly on the polarity of the local environment,
[36]
 
in which it resides. A high I1/I3 ratio (about 1.5 to 1.7) indicates that the surrounding 
of the pyrene is hydrophilic, whereas a low I1/I3 ratio (about 1.2 to 1.4) signifies a 
hydrophobic environment. In the context of polymeric micelles stability, the 
hydrophobic environment means that the pyrene molecules are located inside the 
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micellar core, while the hydrophilic environment suggests that micelles have 
disintegrated and the pyrene molecules are no longer trapped inside the micelles. 
 
 
Figure 3.5 a) and b) The PL spectrum of pyrene encapsulated inside pure F127 micelles and PEOSN, 
respectively; c) changes in the fluorescence intensity of the I1/I3 ratio of pyrene during dilution of pure 
F127 micelles and PEOSN. 
 
 
Figure 3.5 shows the variation in the fluorescence intensity ratio of pyrene, I1/I3, as a 
function of F127 concentration. The concentration of F127 was adjusted by dilution 
against deionized water. It can be observed that at the initial concentration, the I1/I3 of 
both pure F127 micelles and PEOSN is about 1.4, indicating that the pyrene 
molecules are inside the core of the F127 micelles. When the pure F127 micelles is 
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diluted for 10 times, its I1/I3 ratio increases rapidly to about 1.7, indicating that the 
F127 micelles have disintegrated and the pyrene molecules have made contact with 
water. On the other hand, the I1/I3 ratio of the PEOSN is relatively stable at about 1.4. 
This result clearly demonstrates that the silica shell has been formed properly 
surrounding the core of the F127 micelles and it is robust to prevent the dissociation 
of the micelles upon dilution.  
 
3.3.3 Antifouling behavior of PEOSN 
 
In the design of nanocarriers for biomedical applications, it is highly desirable to 
decorate the surface of the nanocarriers with PEO chains.
[37]
 This is because PEO is 
known to bestow antifouling property by minimizing non-specific adsorptions of 
proteins onto nanocarriers, and thus reducing their early uptake by RES.
[31-32]
 Hence, 
to demonstrate the effectiveness of the free PEO chains on the surface of the PEOSN 
in imparting antifouling behavior, the colloidal stability of the PEOSN was evaluated 
by incubating them in phosphate buffered saline (PBS) medium containing 10% Fetal 
Bovine Serum (FBS) at 37 °C, which mimics the physiological condition.
[38]
 FBS was 
used as a model protein in this study. Figure 3.6 shows the changes in the particle size 
of the pure F127 micelles and PEOSN, monitored by using DLS. It can be observed 
that there is no significant variation in the hydrodynamic diameter of the pure F127 
micelles and PEOSN upon incubation for 24 hours, demonstrating their antifouling 
behavior owing to the presence of free PEO. Otherwise, the particle size would 
increase quickly due to the non-specific binding of protein on silica surface.  
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Figure 3.6 Hydrodynamic size changes of the F127 micelles and PEOSN incubated in PBS plus 10% 
FBS at 37 °C for 24 hours.  
 
 
3.3.4 Effect of synthesis parameters 
 
Table 3.1 tabulates a series of experiments that were done to investigate the effects of 
different synthesis parameters on the resulting PEOSN with respect to their size and 
size distribution. The parameters investigated are the concentration of F127 block 
copolymer and silica precursor (TMOS), the total amount of precursors, and the 
length of PEO blocks of the polymeric micelles. The size and size distribution of the 
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3.3.4.1 Effect of TMOS concentration 
 
Figure 3.7 shows the TEM micrographs of PEOSN prepared at different TMOS 
concentrations ranging from 25 to 125 μL. It can be observed that the core-shell 
morphology of the PEOSN prepared at higher TMOS concentration is well defined. 
This is because the PEOSN prepared at high TMOS concentration have a thicker silica 
shell, which is able to prevent deformation of the capsule morphology due to the 
drying effect of TEM sample preparation. Additionally, the average core size and 
outer diameter of PEOSN increases from ~5 to 7 nm and ~13 to 16.5 nm, respectively, 
when TMOS concentration was increased from 25 to 125 μL. The increase in the core 
diameter of the PEOSN can be attributed to the swelling of PPO core as a 
consequence of the encapsulation of additional amount of TMOS. This behavior is 
consistent with the understanding that TMOS acts as a simple hydrophobic solute that 
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prefers to accumulate in micelles core in aqueous solution. Similar to the case of 
small-molecule solute swelling of polymer micelles,
[39]
 the core size of PEOSN scales 
with the concentration of encapsulated TMOS. Meanwhile, the increase in the outer 
diameter of PEOSN with increase in TMOS concentration is due to additional silica 
being deposited surrounding the core of F127 micelles. 
 
 
Figure 3.7 Transmission electron micrographs of the PEOSN synthesized at different concentration of 
TMOS: a) 25 μL, b) 50 μL, c) 75 μL, d) 100 μL, and e) 125 μL. The average outer and core diameters of 




Chapter 3: Design and synthesis of PEOlated Silica Nanocapsules  
 73 
 
Figure 3.8 DLS result of the PEOSN prepared at different TMOS concentrations. 
 
The DLS result of PEOSN prepared at different TMOS concentration is presented in 
Figure 3.8. Initially, there are no significant changes in the hydrodynamic diameter of 
PEOSN when TMOS was varied from 25 to 75 μL. The measured hydrodynamic 
diameter varies between 23 to 27 nm, which is within the range of hydrodynamic 
micelles diameter of pure F127 micelles (20 to 30 nm). This result therefore suggests 
that the silica shell is most likely deposited in the inner region of PEO corona and part 
of the PEO chains is still free to provide steric stabilization to the resultant silica 
nanocapsules. The hydrodynamic diameter of PEOSN, however, starts to increase 
when TMOS is increased to 100 μL, which is about 31 nm. This value increases 
further to 55 nm when 125 μL of TMOS is used for the synthesis. Such huge increase 
in the hydrodynamic diameter of the PEOSN is unlikely caused by the enlargement of 
a single silica nanocapsules because the change is only a few nanometers in the outer 
diameter of the PEOSN, as shown by their TEM images in Figure 3.7. Instead, it is 
more likely that the large increase is resulted from the aggregation among the silica 
nanocapsules. Such aggregation can occur because the effective length of free PEO 
chains is reduced as more silica is deposited on the PEO corona region. As a result of 
shortened free PEO chains, the steric protection on the silica nanocapsules is greatly 
compromised, which subsequently can lead to the aggregation among the silica 
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nanocapsules. In fact, the aqueous suspensions of PEOSN that were prepared at 100 
and 125 μL of TMOS appeared cloudy, which was a clear sign of the aggregation 
process. Additionally, the aggregation is also shown by the increase in the 
polydispersity index of the DLS measurement, suggesting that the samples are more 
polydisperse. Therefore, it is important to control the concentration of TMOS to 
obtain a colloidally stable PEOlated silica nanocapsules.  
 
3.3.4.2 Effect of F127 block copolymer concentration 
 
 
Figure 3.9 Transmission electron micrographs of the PEOSN synthesized at different concentration of 
F127 block copolymer: a) 25 mg, b) 50 mg, c) 75 mg, d) 100 mg, and e) 125 mg. The average outer and 
core diameters of the resultant PEOSN as well as their size distributions are measured and summarized 
in f). 
 
The TEM micrographs of PEOSN prepared at different concentrations of F127 block 
copolymer are shown in Figure 3.9. It can be observed that the core-shell morphology 
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of the PEOSN becomes poorer as the concentration of F127 block copolymer is 
increased. Additionally, this morphological change is accompanied by a reduction in 
the average core size and outer diameter of the PEOSN with the increase in F127 
block copolymer concentration. The average core size of the PEOSN decreases from 
~8 to 5 nm when F127 block copolymer is increased from 25 to 125 mg, respectively. 
Meanwhile, the average outer diameter of the PEOSN also decreases from ~18 to 12 
nm. This phenomenon is consistent with the result obtained from different TMOS 
concentrations, where a larger ratio of TMOS/F127 leads to a larger silica 
nanocapsule with better morphology due to the additional silica being deposited in the 
PEO corona region of F127 polymeric micelles.    
 
 
Figure 3.10 DLS result of the PEOSN prepared at different F127 block copolymer concentrations. 
 
Figure 3.10 shows the DLS result of PEOSN prepared at different concentrations of 
F127 block copolymer. As can be observed, the hydrodynamic diameter of the 
PEOSN decreases from 49 to 25 nm when the F127 block copolymer is increased 
from 25 to 75 mg. However, there is no further change in the hydrodynamic diameter 
of the PEOSN, which is about 25 nm, as the F127 block copolymer is increased 
further to 100 and 125 mg. Again, this behavior is consistent with what is observed for 
the different TMOS concentrations, where a larger hydrodynamic diameter of PEOSN 
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is observed at higher TMOS/F127 ratio owing to the aggregation among the silica 
nanocapsules. In addition, a cloudy suspension was observed for the PEOSN prepared 
at 25 and 50 mg of F127, confirming that the aggregation indeed took place.  
 
3.3.4.3 Effect of total amount of precursors 
 
 
Figure 3.11 Transmission electron micrographs of the PEOSN synthesized at different total amounts of 
precursors (F127/TMOS): a) 25 mg / 25 μL, b) 50 mg / 50 μL, c) 75 mg / 75 μL, d) 100 mg / 100 μL, 
and e) 125 mg / 125 μL. The average outer and core diameters of the resultant PEOSN as well as their 
size distributions are measured and summarized in f). 
 
From the two sets of experiment discussed above, namely the different TMOS and 
F127 block copolymer concentrations, it can be concluded that the optimum condition 
for the synthesis of PEOSN is at 75 mg of F127 and 75 μL of TMOS. Therefore, it 
would be of interest to investigate whether the total amounts of precursors (F127 and 
TMOS) have any effect on the morphology, core size, and outer diameter of the 
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resultant PEOSN. From the TEM images shown in Figure 3.11, it is appreciated that 
there is no noticeable changes in the core-shell morphology of the prepared PEOSN. 
Furthermore, the size measurement of these PEOSN reveals that there is no significant 
variation in their average core sizes and average outer diameters, indicating that the 




Figure 3.12 DLS result of the PEOSN prepared at different total amounts of precursors. 
 
Meanwhile, the DLS results of these PEOSN are presented in Figure 3.12. Similar to 
the TEM result, there is no considerable change in the hydrodynamic diameter of the 
PEOSN prepared at different total amounts of precursors, which is about 25 nm. 
However, a slightly larger hydrodynamic diameter was measured for PEOSN prepared 
at 25 mg of F127 and 25 μL of TMOS, which is about 31 nm. It is very unlikely that 
such slight increase is caused by the aggregation of silica nanocapsules, as the 
aqueous suspension of this PEOSN (25 mg/ 25 μL) is clear. Therefore, the enlarged 
hydrodynamic diameter observed for PEOSN prepared at 25 mg of F127 and 25 μL of 
TMOS is the intrinsic property. Additionally, there is a general trend that the 
polydispersity index (PdI) of the PEOSN increases with an increase in the total 
amounts of the precursors, which reflects a wider size distribution. This behavior 
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could be accounted by the fact that increasing the total amount of precursos raises the 
number of silica nanocapsules in the suspension, which then enhances the probability 
of coalescence among the nanocapsules, which in turn could result in a wider size 
distribution.  
 
3.3.4.4 Effect of length of PEO block.  
 
It is postulated that the silica shell formation of the PEOSN is facilitated by the 
hydrogen bonding between the silanol groups of hydrolyzed TMOS and PEO blocks 
of F127 polymeric micelles.
[29-30]
 It would therefore be of interest to study the effect 
of the length of the PEO blocks in templating the silica shell formation. To realize this 
objective, L121 (PEO5PPO70PEO5) and P123 (PEO20PPO70PEO20) are employed in 
this study because they differ in the length of the PEO blocks; yet have the same 
length of PPO blocks as F127.  
  
The TEM images of the PEOSN derived from different block copolymers are shown 
in Figure 3.13. It is obvious from these images that the length of PEO blocks of the 
block copolymer has a significant impact on the morphology of the resultant PEOSN. 
The silica nanocapsules prepared from L121, for example, does not exhibit the typical 
core-morphology of nanocapsules. Instead, the particles look like an ordinary silica 
nanoparticles. Furthermore, the samples derived from the suspension underwent 
sedimentation, indicating that they were not colloidally stable in aqueous 
environment. Meanwhile, the silica nanocapsules templated by P123 do exhibit an 
appreciate degree of core-shell morphology, although they appear to be highly 
aggregated to one another. In fact, the aqueous suspension of the silica nanocapsules 
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prepared from P123 block copolymer appeared cloudy. Only silica nanocapsules that 
are prepared from F127 block copolymer show a proper core-shell morphology. 
Therefore, these results clearly demonstrate that the length of PEO blocks of the 
employed polymeric micelles plays a critical role in templating the silica shell 
formation through bioinspired silification, where long PEO chains are necessary to 
obtain the well-defined silica nanocapsules.  
 
 
Figure 3.13 TEM images of the PEOSN derived from a) L121, b) P123, and c) F127 block copolymers 
and d) their corresponding DLS result.     
 
The DLS measurement of the silica nanocapsules prepared from different block 
copolymers can provide additional information about the effect of the length of the 
PEO blocks. As presented in Figure 3.13 (d), the hydrodynamic diameters prepared 
from different block copolymers differ greatly. The silica nanocapsules that are 
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prepared from L121 have the largest hydrodynamic diameter, and followed by those 
that prepared from P123 and F127, consecutively. Such behavior is observed because 
the silica nanocapsules that are prepared from L121 and P123 are lacking of free PEO 
chains, and thus they undergo aggregation, which is reflected by their large 
hydrodynamic diameters. Hence, it can be concluded that the long PEO chains of the 
F127 indeed is essential not only to template for the silica shell deposition, but also to 
provide steric stabilization to the resultant silica nanocapsules, which is highly 




PEOlated silica nanocapsules (PEOSN) have been successfully synthesized by using 
F127 block copolymers via a facile and highly benign route of bioinspired silification. 
The key principles behind the approach is the confinement of the hydrolysis and 
condensation of the silica precursors at the interface between the core and the shell of 
the polymeric micelles, thus leaving part of the PEO block of the F127 micelles 
extending out from the surface of the silica nanowall into the solution. As a result, the 
synthesized PEOSN exhibit excellent colloidal stability both in aqueous environment 
and phosphate buffered solution containing proteins, indicating that they are of 
potential to be used as nanocarriers for various biomedical applications. 
 
A systematic investigation has been made into the effects of several of the key 
processing parameters involved in the bioinspired silification approach, and it reveals 
that the length of the PEO block of the copolymer is critical in templating the silica 
shell formation of the nanocapsules, where a longer PEO block is highly desirable for 
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the proper formation of nanocapsule structure. Furthermore, it is important to keep the 
ratio between the TMOS and F127 block copolymer at about 1 μL per 1 μg of the 
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Chapter 4  
SYNTHESIS OF PEOLATED Fe3O4@SiO2 
NANOPARTICLES (PEOFSN) FOR MAGNETIC 




Over the past two decades, considerable efforts have been made with the development 
of superparamagnetic iron oxide nanocrystals (SPION), such as magnetite (Fe3O4) and 
maghemite (γ-Fe2O3),
[1-3]
 owing to their important potentials in biomedical 







and magnetic resonance imaging (MRI).
[10-12] 
The investigation of SPION as contrast 
agent for MRI, in particular, has been the subject of extensive study because of their 
capability to enhance the proton relaxation of surrounding water molecules under 
influence of external magnetic field.
[13-15]
 This would allow for a more accurate and 
sensitive detection of diseased tissues by amplifying the signal of the target tissues in 
comparison to that of the surrounding tissues.
[16]
   
 
Many of the aforementioned applications require SPION to be monodispersed, highly 
crystalline, water-dispersible and biocompatible.
[17]
 For many years, SPION have 




 aqueous salt solutions 
by addition of an appropriate base.
[18]
 The control of the size, shape, and chemical 
compositions of the resultant nanoparticles is dependent on the type of the salts used 




 ions, pH, and ionic 
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strength of the solution.
[19]
 Yet, the SPION prepared through the co-precipitation 
method generally have large size distribution and their crystallinity is relatively 
low.
[18-19]
 To overcome this challenge, thermal decomposition of iron salts in the 
presence of certain surfactants have been developed recently.
[20-22]
 The SPION 
prepared through this method are typically monodispersed and possess high 
magnetization value. However, the resultant SPION are only dispersible in nonpolar 
organic solvents due to the hydrophobic nature of the coating surfactants. 
 
To employ the hydrophobic SPION for biomedical applications, various surface 
modification strategies have been investigated to develop water-dispersible SPION, 
including for example bifunctional ligand exchange,
[23-25]
 polymeric shell coating,
[26-
28]
 and silica coating.
[29-32]
 Among these techniques, silica coating is one of the 
promising approaches since it offers the encapsulated SPION not only a 
biocompatibility
[33]
 but also a greater chemical and mechanical stability against 
variation in pH or temperature of the environment.
[3]
 For example, silica coating has 
been shown to retard the oxidation of Fe3O4 nanocrystals to α-Fe2O3 at high 
temperature.
[34]
 In addition, the silanol groups on the surface of silica coating can be 
further utilized to introduce specific functional groups. For example, folic acid was 
attached to the surface of iron oxide coated silica nanoparticles in order to deliver 







 are the two most widely employed methods to prepare 
silica coated SPION. The silica formation (silification) is normally carried out at high 
pH condition, and in certain cases, a high temperature is also necessary for the 
formation of uniform particles. 
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In contrast to those previously investigated processes, the bioinspired silification 
approach developed in this project is able to synthesize PEOlated silica nanocapsules 
at highly benign synthesis condition, namely at room temperature and near-neutral pH 
aqueous environment.
[37-38]
 It will be therefore biotechnologically more useful if the 
bioinspired silification approach can be adopted to fabricate not only pure silica 
nanocapsules, but also functionalized silica nanostructures carrying specific 
properties, such as magnetism or fluorescence or both, for biomedical applications. In 
this chapter, the feasibility of preparing PEOlated Fe3O4@SiO2 nanoparticles 
(hereafter, denoted as PEOFSN) via the bioinspired silification approach by using 
F127 block copolymers as the simultaneous encapsulant and templating agent is 
studied. The PEOFSN are shown to exhibit a core-shell-shell structure, consisting of 
Fe3O4, silica (SiO2), and free PEO chains on the outer surface of the nanoparticles. As 
demonstrated in this study, F127 polymeric micelles are able to encapsulate 
hydrophobic Fe3O4 nanocrystals inside their PPO cores and template the silica 
condensation through the formation of hydrogen bonding between the hydrophilic 
PEO corona and silicic acid. The silica shell is formed solely at the interface between 
the core and the corona of the Fe3O4 nanocrystals loaded F127 micelles. As a result, 
the Fe3O4@SiO2 nanoparticles thus derived are intrinsically covered by a layer of free 
PEO chains, eliminating the need for a post-functionalization step. Through this 
bioinspired silification strategy, the PEOFSN can combine the high chemical and 
mechanical integrities of the silica shell with the steric stabilization and antifouling 
behavior of PEO. The PEOFSN thus synthesized are demonstrated to exhibit a 
remarkable colloidal stability both in the presence of magnetic field and upon 
incubation with proteins under the physiological condition. Furthermore, they are 
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shown to be non-cytotoxic and together with the desired high magnetization behavior, 
make a good candidate as a contrast agent in magnetic resonance imaging. 
 





 F127 (PEO106PPO70PEO106), tetramethoxysilane (TMOS; 
98%), tetrahydrofuran (THF), iron (III) acetylacetonate (Fe(aca)3), benzyl ether, 
oleylamine, oleic acid, 1,2-hexadecanediol, potassium bromide, and potassium 
ferrocyanide trihydrate were purchased from Sigma Aldrich. CellTiter 96 AQueous 
Non-Radioactive Cell Proliferation Assay MTS was procured from Promega. Fetal 
Bovine Serum (FBS) was obtained from Hyclone. Dulbecco‟s Modified Eagle‟s 
Medium (DMEM), sodium pyruvate, L-glutamin, Penicilin, and Streptomycin were 
purchased from PAA Laboratories GmbH, Austria. Ferucarbotran, a clinical MRI 
contrast agent, was purchased from Bayer Schering Pharma AG, Berlin, Germany. All 
chemicals were used as received without any further purification. 
 
4.2.2 Synthesis of hydrophobic Fe3O4 nanocrystals 
 
Magnetic Fe3O4 nanocrystals were prepared according to previously published 
reports.
[20-21]
 2 mmol of Fe(aca)3 dissolved in 20 mL of benzyl ether was mixed with 
10 mmol of 1,2-hexadecanediol, 6 mmol of oleic acid, and 6 mmol of oleylamine. The 
mixture solution was then heated at 200 °C for 2 hours under nitrogen protection and 
followed by refluxing at 300 °C for 1 hour. After cooling to room temperature, a dark-
brown mixture was precipitated by the addition of ethanol. The nanoparticles were 
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isolated through centrifugation and re-suspended in THF in the presence of oleic acid 
and oleyl amine. They were further subjected to two cycles of washing with pure THF 
and re-precipitation by adding ethanol. Finally, the purified Fe3O4 nanocrystals were 
re-suspended in THF to make a stock solution of concentration of 7.5 mg/mL.  
 
4.2.3 Synthesis of PEOlated Fe3O4@SiO2 nanoparticles (PEOFSN) 
 
15 mg of F127 was dissolved in THF and mixed with different amounts of Fe3O4 
stock solution, such as 300, 600, and 1200 μL for preparation of PEOFSN-01, -02, 
and -03, respectively. In the case of sample PEOFSN-01 and -02, additional THF was 
added to make up a total volume of 1200 μL. The mixtures were stirred at room 
temperature for 12 hours before adding 23 μL of TMOS. Subsequently, the mixture 
solution was vortexed for 1 minute and then injected slowly into 10 g of deionized 
water while stirring at 1000 rpm. The stirring was continued for an additional four 
days to evaporate THF and ensure a complete hydrolysis of TMOS to form PEOFSN. 
The resultant aqueous dispersion of PEOFSN was then dialyzed for 24 hours against 
deionized water using a molecular weight cut-off (MWCO 8000) dialysis tube to 
remove the un-condensed silica precursors. 
 
4.2.4 Antifouling study of PEOFSN 
 
The antifouling behavior of PEOFSN was evaluated by monitoring their 
hydrodynamic size changes upon incubation of the nanoparticles in PBS containing 
10% (v/v) FBS at 37 °C in a water bath, by following a similar procedure as that of 
PEOSN, as described in section 3.2.5. 
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4.2.5 Cell uptake experiment 
 
BV-2 brain macrophage cells were grown in culture medium at 37 °C in 5% CO2. The 
culture medium contains completed DMEM with glucose (4.5 g/g), sodium pyruvate 
and L-glutamin, 10% FBS, 100 units Penicillin and 100 μg/ml of Streptomycin. The 
BV-2 cells were seeded into chamber slides at a density of 20,000 cells/well. After 24 
hours of incubation, PEOFSN and ferucarbotran diluted in DMEM were added into 
the respective well at a final concentration of 0.23 mg Fe/mL. After two hours of 
incubation in the presence of the nanoparticles, each well was washed with 1×PBS, 
treated with of 0.5 mL of 4% paraformaldehyde solution for 10 minutes to fix the 
cells, and followed by washing with 1×PBS. The BV-2 cells were then stained with 
Prussian blue. To each well was added 1.0 mL of a mixture of 2% potassium 
ferrocyanide trihydrate and 2% HCl solution with a ratio of 1:1 (v/v), and then 
incubated for 20 minutes at 37 °C. Following the staining, each well was washed with 
1×PBS for three times. Finally, the chamber was removed and the cells were mounted 
with di-n- butyl phthalate in xylene mounting buffer.  The Prussian blue stained cells 
were assessed by using a light microscope. 
 
4.2.6 Cytotoxicity study 
 
The cytotoxicity of the PEOFSN was evaluated by determining the viability of HepG2 
hepatocellular carcinoma (HCC) cells using MTS assay (3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium). The HepG2 cells 
obtained from American Type Culture Collection (ATCC) were grown in culture 
medium at 37 °C in 5% CO2. The culture medium contains completed DMEM with 
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glucose (4.5 g/g), sodium pyruvate and L-glutamin, 10% FBS, 100 units Penicillin 
and 100 μg/mL of Streptomycin. The HepG2 cells were seeded into a 96 well plates at 
a density of 8,000 cells/well. The cells were then cultured at 37 °C in 5% CO2 in the 
presence of growth medium containing PEOFSN-02 with concentration of 0, 110, 
220, 330, and 440 μg/mL, respectively. After 24 hours of incubation, the growth 
medium was discarded and replaced by MTS/ phenazine methosulfate solution 
followed by incubation for another three hours. The optical absorbance of each well 
was then measured at 490 nm on a Benchmark Plus microplate spectrophotometer 
(Bio-RAD). The results were normalized with respect to the result obtained without 
addition of PEOFSN. The presented data were averaged from three experiments for 
each PEOFSN concentration. 
 
4.2.7 MRI relaxivity measurement 
 
MRI evaluation was performed at 23 °C in a clinical MR scanner (Symphony, 1.5 
Tesla, Siemens Medical Solutions, Erlangen, Germany). To measure the T1 and T2 
relaxivities of PEOFSN-02, the nanoparticles were dispersed in water at Fe 
concentrations of 0, 0.01, 0.05, 0.10, 0.20, 0.30, and 0.50 mM. As a comparison, the 
T1 and T2 relaxivities of ferucarbotran were measured under similar condition. T2 
relaxation times were determined from a multi-echo spin-echo sequence (32 echoes; 
repetition time (TR): 3000 ms; echo times (TE): 8–256 ms). T1 relaxation times were 
determined from a saturation recovery experiment using spin-echo images obtained 
with a number of TRs (7 TRs; TR: 100–6400 ms; TE: 15 ms). To investigate the 
stability of PEOFSN and the variation of its relaxivities, the relaxation time 
measurements were conducted after the PEOFSN dispersions were placed in the 
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magnetic field (1.5 T) for approximately 7 and 17 hours, respectively. The relaxation 
times for each sample were computed using in-house software (MATLAB V7.1, 
MathWorks, Natick, MA, USA) by non-linear least squares fitting of appropriate 
exponential functions to the MR signal as a function of TR or TE. Longitudinal and 
transverse relaxivities (r1 and r2, respectively) were computed as the slope of the lines 
fit by linear regression analysis (Microsoft EXCEL) to relaxation rates (1/T1 and 1/T2) 




The TEM, DLS, and FTIR characterizations of the PEOFSN were done by following 
similar experimental procedures as have been described in section 3.2.3 and 3.2.4. 
Meanwhile, the x-ray diffraction (XRD) patterns were recorded with a scanning speed 
of 2θ = 2 º/min over the range of 2θ = 15 – 80 º using Bruker D8 employing Cu Kα-
radiation (λ=1.5418 Å). The magnetic behavior of the samples were examined by 
using a vibrating sample magnetometer (VSM, Lakeshore 7300 Series, USA) at room 
temperature. The temperature-dependent magnetization curves were obtained by 
employing a superconducting quantum interference device (SQUID, MPMS XL5, 
Quantum Design, USA), where the temperature was varied from 5 to 300 K with a 
maximum applied field of 100 Oe. Inductive coupled plasma – atomic emission 
spectroscopy (ICP-AES) was used to determine the iron concentration in the 
synthesized PEOFSN. 5 g of PEOFSN was dissolved in the mixture of 2.0 mL of HCl, 
2.0 mL of HF, and 2.0 mL of HNO3. After complete dissolution, deionized water was 
added into the solution to a total volume of 100 mL. 10.0 mL of the diluted solution 
was then used to measure the concentration of iron. 
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4.2.9 Langevin fitting procedure 
 
The field-dependent magnetization behavior obtained from VSM at room temperature 
were fitted according to the Langevin equation,
[41]
 which is known to describe the 




 L()  coth()
1







                            (4.2) 
Ms is the saturation magnetization of the particle, μ is the magnetic moment of the 
particle, T is the absolute temperature, and kB is the Boltzmann constant. Fitting was 
performed according to the least-square method to obtain the average magnetic 
moment of the particles. Assuming that the particles are spherical, the average particle 
diameter could then be calculated according to the relationship:  

 M'sV                                                                                                                                     (4.3) 
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4.3 Results and discussion 
4.3.1 Preparation and characterizations of PEOFSN 
 
 
Scheme 4.1 Schematic showing the formation of PEOlated Fe3O4@SiO2 nanoparticles (PEOFSN) via 
the bioinspired silification at room temperature and near-neutral pH conditions. 
 
Scheme 4.1 illustrates the bioinspired silification approach for synthesizing PEOFSN. 
The main idea behind this approach is to spatially confine the formation of silica shell 
at the interface between the core and corona of the F127 block copolymer micelles as 
to retain free PEO chains to provide aqueous colloidal stability to the resultant 
PEOFSN. Initially, the TMOS is mixed with hydrophobic Fe3O4 nanocrystals and 
F127 block copolymers in THF, which is a desirable solvent for all the three 
components. Upon injection into water, the F127 block copolymers spontaneously 
self-assemble into polymeric micelles, with the hydrophobic PPO blocks forming the 
core of the micelles and the hydrophilic PEO blocks as the corona. At the same time, 
the TMOS and Fe3O4 nanocrystals segregate into the core of the micelles due to the 
non-covalent hydrophobic interaction with the PPO blocks. As a consequence of this 
encapsulation, the hydrolysis reaction of TMOS is confined to take place at the 
interfacial region between the core and corona of the micelles by taking advantage of 
the presence of nearby water for the hydrolysis reaction. The PEO blocks of F127 then 
work as templates for the silica condensation surrounding the core of the Fe3O4 
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nanocrystals loaded micelles by forming hydrogen bonding with silanol groups of 
hydrolyzed TMOS.
[43]
 Accordingly, a thin silica shell is formed at the interfacial 
region between the core and corona of the F127 micelles together with the 
encapsulated Fe3O4 nanocrystals in the core of the micelle and free PEO chains on the 
surface of the particles, forming PEOFSN. 
 
 
Figure 4.1 (a) Low and (b) high magnification of transmission electron micrographs of the as-
synthesized Fe3O4 nanocrystals and (c) the corresponding diffraction pattern indexed according to 
magnetite structure (JC-PDS 19-629). 
 
The TEM images in Figure 4.1 show that the as-synthesized Fe3O4 nanocrystals are 
relatively uniform with an average particle size of ~ 6.9 nm and standard deviation of 
~ 1.0 nm. These nanocrystals are also highly crystalline, as indicated by their strong 
diffraction rings in Figure 4.1 (c), each of which can be indexed according to the cubic 
structure of magnetite (JCPDS 19-629). To synthesize PEOFSN, the as-synthesized 
Fe3O4 nanocrystals are then dispersed in THF.    
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Figure 4.2 TEM images of (a) PEOFSN-01, (b) PEOFSN-02, (c) PEOFSN-03 synthesized via the 
bioinspired silification approach, while (d) showing a typical high resolution TEM image of PEOFSN 
showing the dark core of crystalline Fe3O4 and the bright shell of amorphous silica.    
 
The morphology of the as-synthesized PEOFSN was observed by using TEM and 
their images are presented in Figure 4.2. The PEOFSN exhibit a near spherical 
morphology with a typical core-shell structure, a dark core of Fe3O4 with a brighter 
shell of SiO2, as shown in Figure 4.2 (a) to (c). A typical high resolution TEM image 
of PEOFSN is provided in Figure 4.2 (d). The appearance of darker core is due to the 
higher electron density of Fe3O4 nanocrystals as compared to that of silica shell. The 
observed morphology demonstrates that F127 micelles have been successfully used to 
simultaneously encapsulate Fe3O4 nanocrystals inside their PPO cores and template 
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the silica condensation surrounding the core at room temperature and near-neutral pH 
environment, and therefore demonstrating the versatility of the bioinspired silification 
approach to prepare functional PEOlated silica nanocapsules. There is no significant 
change in the size and shape of the encapsulated Fe3O4 nanocrystals in PEOFSN with 
respect to the as-synthesized Fe3O4 nanocrystals. As the loading concentration of 
Fe3O4 nanocrystals increases, the size of PEOFSN increases too, from 22.1 ± 2.6, 26.3 
± 4.5, to 28.1 ± 8.0 nm for PEOFSN-01, PEOFSN-02, and PEOFSN-03, respectively. 
Additionally, the size increment is accompanied by a widening in the size distribution. 
It is observed that the particle size of PEOFSN is closely related to the number of 
encapsulated Fe3O4 nanocrystals inside each core. This behavior is consistent with the 
previous reports of encapsulation of hydrophobic nanocrystals using polymeric 
micelles in aqueous environment, where the particle size scales with the number of 





Figure 4.3 Hydrodynamic size distribution of the PEOFSN dispersion in aqueous environment 
measured by dynamic light scattering (DLS). 
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Figure 4.4 TEM images of untreated (left) and PTA-treated (right) of the PEOFSN (a and b) and the 
Fe3O4@F127 nanoparticles (c and d), prepared in the same way as PEOFSN-02 without the addition 
TMOS. Upon staining by PTA, an enhanced contrast is generated surrounding the (b) Fe3O4@SiO2 and 
(d) Fe3O4@F127 nanoparticles, showing the presence of PEO chains by the enlarged particle size, as 
compared to those of the unstained ones in (a) and (c). 
 
The size distribution of the PEOFSN dispersed in water was studied using dynamic 
light scattering (DLS). The respective intensity-average hydrodynamic diameters are 
43.5, 58.9, and 63.2 nm for PEOFSN-01, PEOFSN-02, and PEOFSN-03, as shown in 
Figure 4.3. Similar to the results obtained from TEM studies, the hydrodynamic 
diameter of PEOFSN increases with the increase in Fe3O4 loading concentration. 
However, these hydrodynamic diameters are larger than those measured by TEM. This 
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is because DLS measures the size of the particles in the hydrated state, which includes 
the free PEO chains extended from the surface of PEOFSN into the water. In contrast, 
the PEO chains are not observed in the TEM images due to their poor contrast with 
respect to the background as a result of their low electron density.
[45]
 In order to show 
the presence of PEO chains on the surface of the Fe3O4@SiO2 nanoparticles, 
PEOFSN-02, as a typical example, was treated (stained) with phosphotungstic acid 
(PTA), which improves the contrast of PEO chains owing to the interaction between 
PTA and PEO.
[39-40]
 Figure 4.4 (b) shows the enhanced contrast for the free PEO 
chains surrounding the Fe3O4@SiO2 nanoparticles upon staining by PTA, revealing 
the core-shell-shell structure of PEOFSN, namely Fe3O4 (core), SiO2 (shell), and PEO 
chains (shell) on the outer surface. The particle size of the PTA stained PEOFSN-02 is 
in the range 40 – 50 nm, which is apparently larger than those of the unstained ones 
(Figure 4.4 (a)). The observation is further verified by preparing Fe3O4@F127 
nanoparticles in the same way as the PEOFSN-02 but without the addition of TMOS, 
therefore there will be no thin silica shell formed. The TEM micrographs of the 
Fe3O4@F127 nanoparticles in Figure 4.4 (c) shows clustering of Fe3O4 nanocrystals 
inside the F127 micelles core in a roughly spherical manner. As expected, only Fe3O4 
nanocrystals are observed in the conventional TEM as the PEO chains of F127 
micelles exhibit a low electron density, thus a visible contrast cannot be generated to 
show their existence without staining. In addition, a similar morphology of the 
enhanced contrast surrounding the Fe3O4 clusters is observed after staining the 
Fe3O4@F127 nanoparticles by PTA (Figure 4.4 (d)), supporting the TEM observation 
of the PTA-stained PEOFSN. Therefore, based on the size and morphology study by 
TEM and DLS, it can be concluded that the bioinspired silification approach 
employed in the present work is effective in confining the silica shell formation at the 
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interface between the core and corona of the Fe3O4 nanocrystals loaded F127 micelles 
and retaining part of the PEO chains of F127 micelles to be free to function as the 
steric stabilization agent. 
 
 
Figure 4.5 (a) XRD spectra of the as-synthesized Fe3O4 nanocrystals and PEOFSN. Magnified view of 
the (311) diffraction peak of magnetite of (b) the as-synthesized Fe3O4 nanocrystals, and (c) PEOFSN, 
respectively. The full curves are fitted to the Gaussian distribution. 
 
The crystal structure of the as-synthesized Fe3O4 nanocrsytals and PEOFSN was 
investigated using X-ray Diffraction (XRD), the results of which are shown in Figure 
4.5 (a). The characteristic diffraction peaks of magnetite (Fe3O4) are present in both 
samples, which can be assigned to the (220), (311), (400), (422), (611), and (440) 
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planes according to JCPDS 19-629. Additionally, the broad peak at around 2θ = 21° 
indicates the presence of amorphous silica in the PEOFSN. The (311) peak of 
magnetite in each spectrum was further analyzed by fitting to a Gaussian distribution 
to obtain its fwhm (Figure 4.5 (b) and (c)). The average crystallite size can be 
calculated from the fwhm using the Scherrer equation. Both samples have similar 
average crystallite size of ~ 5.8 nm. This shows that the encapsulation process does 
not cause any detrimental effect to the Fe3O4 nanocrystals such as dissolution or 
unwanted growth of the crystals. Furthermore, the crystallite sizes thus measured are 
in good agreement with the average particle size measured using TEM. To further 
verify the formation of silica shell surrounding the encapsulated Fe3O4 in PEOFSN, 
Fourier transform infrared (FTIR) spectroscopy of the as-synthesized Fe3O4 and 
PEOFSN were measured. The presence of both silica and magnetite in PEOFSN is 









 in the 
PEOFSN spectrum, as shown in Figure 4.6. 
 
 
Figure 4.6 FTIR spectra of the as-synthesized Fe3O4 nanocrystals and PEOFSN. 
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4.3.2 Magnetic behavior of PEOFSN 
 
 
Figure 4.7 Field dependent magnetization curves of (a) as-synthesized Fe3O4 nanocrystals, (b) 
PEOFSN-01, (c) PEOFSN-02 and (d) PEOFSN-03, at room temperature (☐). The full curves are fit to 
a Langevin function. The inset figures show the ZFC and FC magnetization curves of each sample 
obtained from 5 – 300 K using SQUID. 
 
The magnetic behavior of the as-synthesized Fe3O4 nanocrystals and PEOFSN were 
studied using a vibrating sample magnetometer (VSM) at room temperature. The field 
dependent magnetization curves in Figure 4.7 show that all samples exhibit 
superparamagnetism with negligible hysteresis loop. Neither coercivity field nor 
remanent magnetism was observed. The temperature-dependent magnetization 
measurement by superconducting quantum interference device (SQUID) further 
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substantiate the observed superparamagnetism. The zero-field-cooled (ZFC) and field-
cooled (FC) magnetization curves were obtained under an applied field of 100 Oe 
between 5 and 300 K, from which the blocking temperature (Tb) can be determined. 
Blocking temperature signifies the transition from superparamagnetism to 
ferromagnetism, below which the thermal energy is insufficient to randomize the 
aligned magnetic dipole. The Tb is determined from the peak of ZFC curves in Figure 
4.7 (inset figures) and estimated to be about 56 and 34 K for the as-synthesized Fe3O4 
nanocrystals and PEOFSN, respectively. These Tb temperatures are significantly lower 
than room temperature, confirming the superparamagnetic behavior of the as-
synthesized Fe3O4 nanocrystals and PEOFSN at room temperature.  The saturation 
magnetization (Ms) of the as-synthesized Fe3O4 nanocrystals and PEOFSN obtained 
from VSM are summarized in Table 4.1. The Ms of PEOFSN is lower than that of the 
as-synthesized Fe3O4 nanocrystals, which is due to the lower density of magnetic 
component in the PEOFSN samples. In order to substantiate this argument, Langevin 
fitting was performed with each magnetization curve to calculate the particle size of 
the magnetic nanocrystals in each sample and the results are included in Table 4.1. It 
can be observed that the calculated magnetic particle sizes are very close to one 
another, which are about 6.7 nm. As the magnetization value of Fe3O4 is known to 
scale with the particle size,
[48]
 these results demonstrate that the reduction in the Ms of 
PEOFSN is indeed due to the lower relative content of magnetic component, 
otherwise a smaller magnetic moment and particle size would be obtained from the 
fitting process for the PEOFSN sample. Furthermore, these fitted particle sizes are 
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Table 4.1 The saturation magnetization (Ms) of the as-synthesized Fe3O4 nanocrystals and PEOFSN 
and their average magnetic moment (μ) and particle size (dLv) obtained from Langevin fitting of the 
field-dependent magnetization curves. 
 
 Ms [emu/g] μ [emu] dLv [nm] 
Fe3O4 56.13 6.7 × 10
-17
 6.51 
PEOFSN-01 5.69 7.0 × 10
-17
 6.61 
PEOFSN-02 10.05 7.4 × 10
-17
 6.73 




The response of the PEOFSN dispersions placed next to a permanent magnet (~1.0 T) 
is shown in Figure 4.8. All three PEOFSN dispersions were very stable and no particle 
segregation occurred under the external magnetic field. This behavior demonstrates 
the effectiveness of free PEO chains on the surface of the PEOFSN in providing steric 
stabilization, or else the PEOFSN would be quickly segregated close to the permanent 
magnet.
[49-50]
 In addition, upon careful examination, the air-water interfaces of 
PEOFSN-02 and PEOFSN-03 dispersions were found to tilt slightly towards the 
permanent magnet. This tilting indicates the presence of effective coupling between 
the magnetic core of PEOFSN and the surrounding water. The coupling is facilitated 
by the formation of hydrogen bonding between the free PEO and surrounding water 
molecules,
[51]
 creating a “bound-like” water sheath in the vicinity of the magnetic core 
of the PEOFSN. As a result, when a magnetic field is present, the magnetic field does 
not only attract the PEOFSN, but also the surrounding “bound-like” water sheath, 
giving rise to the movement of the whole dispersion. The extent of the movement, 
however, is dependent on the concentration of PEOFSN in the dispersion. All these 
behavior demonstrate that the PEOFSN dispersion can be magnetically manipulated. 
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Figure 4.8 Photograph of (a) PEOFSN-01, (b) PEOFSN-02 and (c) PEOFSN-03 dispersion in water 
(left) and their magnetic response placed in external magnetic field (right). 
 
4.3.3 Antifouling behavior and cytotoxicity of PEOFSN 
 
To demonstrate the effectiveness of the free PEO chains on the surface of PEOFSN in 
providing antifouling behavior, the particles were dispersed in PBS containing 10% 
Fetal Bovine Serum (FBS) and incubated at 37 °C, corresponding to the physiological 
condition.
[52]
 Dynamic light scattering was then used to monitor the changes in the 
hydrodynamic diameter of the particles at different incubation times and the results 
are presented in Figure 4.9. There is only a slight increase (~ 6 to 10 nm) in the 
hydrodynamic diameter of PEOFSN upon incubation in PBS containing 10% FBS in 
comparison to those in water. This increment could well be attributed to the 
interaction between the PEOFSN and FBS in the medium.
[25,52]
 Nevertheless, the 
interaction did not lead to further agglomeration as shown by the stability of the 
hydrodynamic diameter of the PEOFSN during incubation at 37 °C up to 24 hours. 
Therefore, these experimental results demonstrate that the free PEO chains on the 
surface of PEOFSN are effective in providing antifouling behavior by preventing 
particle agglomeration due to nonspecific binding to protein.  
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Figure 4.9 Hydrodynamic diameter of the PEOFSN dispersed in PBS containing 10% FBS as a 
function of incubation time at 37 °C.  
 
The antifouling behavior of PEOFSN was further verified by studying its uptaking by 
BV-2 brain macrophage cells in comparison to that of ferucarbotran. Ferucarbotran, a 
dextran coated SPION, is selected as a control because it has been used clinically for 
MRI with similar hydrodynamic diameter (~ 60 nm)
[53]
 as that of PEOFSN, thus 
minimizing the difference in the macrophage uptake due to size effects. To show the 
presence of iron oxide inside the cells, the macrophage cells were stained by Prussian 
blue after being incubated in the presence of ferucarbotran and PEOFSN for two 
hours, respectively. As shown in Figure 4.10, in the presence of ferucarbotran, more 
macrophage cells were stained in darker blue in comparison to those of PEOFSN, 
indicating that less PEOFSN was uptaken by the macrophage cells. This behavior is 
attributed to the antifouling behavior of free PEO on the surface of the PEOFSN, 
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Figure 4.10 In vitro Prussian blue stained images of BV-2 brain macrophages cells after being 
incubated with: (a) ferucarbotran and (b) PEOFSN at Fe concentration of 0.23 mg/mL for two hours at 
37 °C in 5 % CO2 environment. 
 
As PEOFSN are intended for biomedical applications, it is necessary to evaluate the 
possible cytotoxicity of these nanoparticles. MTS assay was thus used to determine 
the viability of HepG2 hepatocellular carcinoma (HCC) cells after incubation with 
different concentrations of PEOFSN. Figure 4.11 shows that the HepG2 cells are still 
viable after 24 hours incubation in the medium containing PEOFSN as high as 440 
μg/mL, indicating that the PEOFSN are non-cytotoxic. 
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Figure 4.11 Viability of HepG2 cells cultured in the presence of PEOFSN at different iron concentration 
using MTS assay. 
 
4.3.4 Magnetic resonance behavior of PEOFSN 
 
In view of the high colloidal stability, high saturation magnetization and low 
cytotoxicity, PEOFSN appears to be a suitable candidate for a T2-type magnetic 
resonance (MR) contrast enhancement agent. Figure 4.12 (a) shows the T2-weighted 
MR images of aqueous dispersions of PEOFSN with different Fe concentrations. The 
MR signal decreased with the increasing content of PEOFSN, demonstrating the 
efficiency of magnetic core of the PEOFSN in enhancing the transverse (T2) proton 
relaxation process. The efficacy and stability of the PEOFSN as a MR contrast agent 
was further evaluated by measuring the longitudinal (r1) and transverse (r2) 
relaxivities using a MR scanner. Figure 4.12 (b) shows the inverse relaxation times, 
1/T1 and 1/T2, as a function of the molar concentration of Fe. It was observed that the 
inverse relaxation times varied linearly with the Fe concentration and the slope is 
defined as the longitudinal (r1) and transverse (r2) relaxivities, respectively. The r1 of 
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Fe, which is smaller 
than that of ferucarbotran (12.3  0.4 s-1mM-1Fe) and other dextran coated SPION 






 The lower longitudinal relaxivity could 
be a result of the encapsulation of Fe3O4 nanocrystals inside the hydrophobic PPO 
blocks of F127, which reduces the close contact between water molecules and 





measured for PEOFSN in comparison to that of ferucarbotran (239  2 s-1mM-1Fe), 







relaxivity ratio, r2/r1, is another important aspect to evaluate the efficiency of T2-type 
contrast agent. A larger ratio is desirable, as it would limit the expression of T1-
weighting effects. For PEOFSN, the r2/r1 ratio is calculated to be ~ 33, which is larger 
than that of ferucarbotran (19) and those of other dextran coated SPION (3 to 19).
[55]
 
The stability of the PEOFSN under a 1.5 T magnetic field was studied by measuring 
the relaxation rates after being placed in the magnetic field for up to about 7 hours. 
From Figure 4.12 (b), it can be seen that there is no apparent variation in relaxivities 





Fe, respectively. A similar result was obtained when the PEOFSN dispersions 
were further kept in the magnetic field for 17 hours. This stability is attributed to the 
presence of free PEO chains on the surface of the PEOFSN, which are effective in 
reducing dipole-dipole attraction among the PEOFSN, thus prevent the aggregation 
under the high magnetic field. Therefore, PEOFSN could perform well as a T2-type 
MR contrast enhancement agent for cell or molecular imaging and diagnostic 
applications. 
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Figure 4.12 (a) T2 weighted MRI images (1.5 T, spin-echo sequence: repetition time TR = 3000 ms, 
echo time TE = 48 ms) of the aqueous dispersion of PEOFSN at different Fe concentrations and (b) T1 
and T2 relaxation rates (1/T1, 1/T2) of the PEOSN as a function of iron molar concentration obtained at 




Uniform and well-dispersed PEOlated Fe3O4@SiO2 nanoparticles (PEOFSN) have 
been successfully synthesized via a facile and effective bioinspired silification 
approach at room temperature and near-neutral pH aqueous environment. The success 
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of this approach lies in the simultaneous encapsulation of the hydrophobic Fe3O4 
nanocrystals and TMOS inside the core of F127 micelles, which give rise to the 
confinement of the hydrolysis and condensation reactions of TMOS at the interface 
region between the core and corona of the Fe3O4 nanocrystals loaded micelles. As a 
consequence, the Fe3O4@SiO2 nanoparticle surfaces are intrinsically decorated by 
free PEO chains of F127, which lead to the formation PEOFSN that is stable not only 
in aqueous environment, but also in the physiological buffered solution containing 
proteins. More importantly, the bioinspired silification approach did not cause any 
detrimental effects on the encapsulated Fe3O4 nanocrystals, with respect to their size, 
morphology, crystallinity and magnetic behavior. In vitro experiments have 
demonstrated that these PEOFSN are non-cytotoxic. They are also shown to be an 
effective T2-type MR contrast enhancement agent, as indicated by their high r2/r1 ratio 
with long term stability under high magnetic field. The bioinspired silification 
approach has the potential of being extended for preparation of functional silica 
nanostructures encapsulating other hydrophobic nanocrystals, such as quantum dots 
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Chapter 5  
PEOLATED SILICA NANOCAPSULES 
ENCAPSULATING FLUORESCENT CONJUGATED 




Over the past decade, cellular imaging using fluorescent probes has been an integral 
and inseparable part of medical and life science studies.
[1,2]
 Many of the cellular 
structures, intracellular events, and protein-receptor interaction have been identified 
and observed through this technique. Of the many fluorescent probes available, 
organic dyes are the most commonly used because of their small sizes and ease of 
usage.
[3-5]
 However, they have several drawbacks owing to their intrinsic optical 
properties, such as broad emission, poor photochemical stability, and rapid 
photobleaching under repeated exposure, which could limit their usage for long-term 
studies.
[4]
 In light of these pros and cons, a great deal of efforts have been made to 
develop fluorescent nanoparticles due to their unique functional properties that often 
differ from their bulk state. An excellent example of such development is quantum 
dots (QDs).
[6]
 QDs are attractive for use as fluorescent probes because they exhibit 
high fluorescence brightness and excellent photostability.
[7-10]
 Moreover, QDs have 
wide absorption spectrum with narrow emission line, thus opening the possibility to 
perform multiplex imaging of different target molecules using a single excitation 
wavelength.
[9]
 Nevertheless, despite all of these outstanding optical properties, QDs 
have not found widespread acceptance among biomedical community because they 
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typically contain heavy metals, such as cadmium (Cd) and selenide (Se), which are 
known to be highly toxic over living organisms.
[11]
 To alleviate those concerns, 
different surface passivation strategies have been developed to improve the 
biocompatibility of QDs by capping their core with an inorganic shell or coating them 
with biopolymers.
[12-14]
 Nevertheless, the hydrodynamic diameters of the modified 
QDs are likely to exceed the renal clearance limit of 5 nm, and thus the long-term 
toxicities are of still considerable concerns.
[15]
 Hence, there remains an urgent need to 
explore a new fluorescent emitting agent that exhibits good photostability and low 
cytotoxicity for fluorescence cellular imaging. 
 
Conjugated polymers are a unique class of polymers that exhibit semiconducting and 
fluorescent properties owing to the delocalization of the π-electrons along the polymer 
chains, giving rise to the formation of π-π* band structure.[16] When electrons are 
excited from the π-valence band to the π*-conduction band, it results in the formation 
of excitons, which facilitate the photo- and electroluminescent process in conjugated 
polymers. Currently, conjugated polymers are widely used in display and electronic 




 and light 
emitting devices (LED).
[21-22] 
This is because conjugated polymers possess excellent 
optical and emissive properties, such as large extinction coefficient, high fluorescence 
quantum yield, and short excited states lifetime,
[23]
 all of which indicate that 
conjugated polymers clearly meet the optical requirements of fluorescent probes. 
Nevertheless, the usage of conjugated polymers in fluorescent cellular imaging is still 
uncommon because they can only be dissolved in organic solvent due to their highly 
hydrophobic characteristic.
[24]
 Therefore, it would be indispensable to modify the 
surface characteristics of these conjugated polymers to be hydrophilic, which enable 
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them to be dissolved or dispersed in aqueous environment and subsequently used as 
fluorescent probes. 
 
One strategy to endow hydrophilicity to conjugated polymers is to attach hydrophilic 
functional groups along the conjugated polymer backbones through organic synthesis. 





 and poly(ethylene oxide) (PEO) 
moieities.
[29-30]
 Although these modified conjugated polymers are readily soluble in 
water, this approach requires complicated chemistry and specific organic synthesis 
steps.  
 
A rather practical approach is to prepare water-dispersible conjugated polymer 
nanoparticles by utilizing the existing commercially available conjugated polymers. 
Several strategies, based on different principles, have been developed for such 
purpose, for example: i) creating stable conjugated polymer dispersions through 
miniemulsion route,
[31-32]
 ii) preparing conjugated polymer dots via re-precipitation 
technique,
[33-35]
 and iii) encapsulating conjugated polymers within polymeric micelles 
or polymeric nanoparticles.
[36-38]
 Among these methods, the encapsulation approach 
by using polymeric micelles is perhaps more advantageous in comparison to others 
because the surface of the resultant conjugated polymer nanoparticles are covered by 
hydrophilic functional groups, such as poly(ethylene oxide) (PEO) or poly(acrylic 
acid) (PAA),
[37-38]
 which are important for the colloidal stability of nanoparticles. 
Additionally, polymeric micelles encapsulation is a versatile approach owing to the 
favorable hydrophobic interactions between the hydrophobic components of the block 
copolymer and conjugated polymers, therefore allowing different types of block 
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copolymers and conjugated polymers to be used without any chemical modification. 
More importantly, polymeric micelles have been widely used in biomedical 
applications,
[39]
 and therefore ensure the biocompatibility and safety in using these 
materials as encapsulant agent. 
 
Inspired by the aforementioned polymeric micelles encapsulation scheme, the 
bioinspired silification approach is used here to encapsulate fluorescent conjugated 
polymers inside PEOlated silica nanocapsules, forming fluorescent PEOlated silica 
nanocapsules (F-PEOSN). The development of F-PEOSN is conducted at room 
temperature and near-neutral pH aqueous environment by using Pluronic F127 block 
copolymer. One main advantage of employing the bioinspired silification strategy is 
the confinement of the silica shell formation at the interfacial region between the core 
and the corona of F127 polymeric micelles, therefore preserving part of the PEO 
chains to be free and provide the required aqueous solubilization to the resultant 
fluorescent nanocapsules. Such strategy is important because PEO is known to 
increase circulation lifetime of nanocarriers in vivo, as it decreases detection and 
clearance from the body by reticuloendothelial system (RES).
[40]
 Additionally, the 
silica coating could lead to improvement in the photostability of the conjugated 
polymers by limiting their contact with outside environment, especially soluble 
oxygen molecules.
[3]
 Furthermore, the bioinspired silification approach is a very 
versatile approach, which can be easily extended to encapsulate different conjugated 
polymers, thus enabling to tune the emission of the F-PEOSN across visible spectrum. 
The synthesized F-PEOSN were characterized thoroughly in terms of their physical 
and optical properties, the results of which show that they are uniform and truly 
nanosized (~ 14.0 nm) with excellent colloidal stability in aqueous environment. They 
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also exhibit large extinction coefficient and high quantum yield, suggesting that the F-
PEOSN demonstrate the required high fluorescence brightness for fluorescence 
imaging applications. The cell viability study using breast cancer cells (MDA-MB-
231) shows that the F-PEOSN do not pose any significant cytotoxicity, indicating that 
the F-PEOSN are safe for biomedical applications. Furthermore, the F-PEOSN were 
successfully internalized by the breast cancer cells, suggesting that the F-PEOSN are 
of potential to be used as fluorescence cellular imaging probes.  
 




PPV) and poly(9,9-dihexylfluorenyl-2,7‟-diylbithiophene) (PDHFBT) were kindly 
given by Dr Chen Zhi-Kuan and were synthesized according to previous reports.
[41-43]
 
Poly(9,9-dihexylfluorenyl-2,7-diyl) (PDHF) was purchased from American Dye 
Sources, Inc. Block copolymer Pluronic
®
 F127 (PEO106PPO70PEO106), poly(2-
methoxy-5-(2-ethyl-hexyloxy)-1,4-phenylenevinylene) (MEH-PPV), 
tetramethoxysilane (TMOS; 98%), succinic anhydride, N-Hydroxysuccinimide 
(NHS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC),  
dicyclohexylcarbodiimide (DCC), PEO-bis-amine, triethylene amine, tetrahydrofuran 
(THF), N,N-dimethyl acetamide (DMAC), and dimethylsulfoxide (DMSO)  were 
purchased from Sigma Aldrich. CellTiter 96 AQueous Non-Radioactive Cell 
Proliferation Assay MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium) was procured from Promega. Fetal Bovine Serum 
(FBS) was obtained from Hyclone. Dulbecco‟s Modified Eagle‟s Medium (DMEM), 
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sodium pyruvate, L-glutamin, Penicilin, and Streptomycin were purchased from PAA 
Laboratories GmbH, Austria. Vectashield aqueous mounting medium containing 4‟,6-
diamidino-2-phenylindole (DAPI) was obtained from Vector Laboratories. 10× PBS 
was purchased from 1
st
 Base and 1× PBS was prepared by diluting the 10× PBS with 
Mili-Q deionized water. All chemicals were used as received without any further 
purification. 
 
5.2.2 Synthesis of fluorescent PEOlated silica nanocapsules (F-PEOSN) 
 
A stock solution of PDHF, BP-PPV, PDHFBT, and MEH-PPV in THF was prepared 
by dissolving the respective conjugated polymers in THF at a concentration of 1.0 
mg/mL. 75 μL of this stock solution was mixed with 75 mg of F127 in 825 μL of THF 
to form a clear solution. The solution was further stirred at 45 °C for overnight to 
improve the mixing. Upon cooling to room temperature, 65 μL of TMOS was 
subsequently added. The mixture solution was then injected into 10 g of deionized 
water immersed in a water-bath under ultra sonication in three minutes. The solution 
was further sonicated for ten minutes, followed by stirring at room temperature for 
four days to evaporate off the THF and ensure a complete hydrolysis of TMOS at the 
interface between the core and corona of the F127 micelles. 
 
5.2.3 Synthesis of dicarboxylic acid modified F127 
 
12.6 g of F127 was first dried in vacuum at 100 °C for 24 hours in order to remove 
adsorbed water. It was then dissolved in 60 mL of anhydrous DMAC while being 
stirred and heated to 70 °C. Upon complete dissolution, 0.3 g of succinic anhydride 
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was added into the solution and stirred rapidly at 70 °C under nitrogen atmosphere. 
The reaction mixture was then heated rapidly to 90 °C and stirred for 24 hours at this 
temperature. After cooling to room temperature, the final dark brown reaction mixture 
was precipitated against excess cold diethyl ether in a dropwise manner. The 
precipitates were dissolved in deionized water and dialyzed for 48 hours using dialysis 
tube with MWCO of 1000 g/mol. The final solution was then freeze-dried to obtain 
the dicarboxylic acid modified F127 block copolymer.  
 
5.2.4 Synthesis of aminated-folic acid 
 
486 mg of anhydrous folic acid was first dissolved in 30 mL of anhydrous DMSO 
under nitrogen atmosphere. 140 mg of N-Hydroxysuccinimide (NHS) and 250 mg of 
dicyclohexylcarbodiimide (DCC) were then added under stirring. Subsequently, the 
reaction flask was shielded from light by using aluminium foil. The reaction was then 
allowed to proceed for 24 hours at room temperature under nitrogen atmosphere. After 
that, the white precipitates, i.e. the by-product dicyclohexylurea, were removed by 
filtration. The yellow DMSO solution of the NHS-folate was then stored at -20 °C 
until further use. 
 
The above NHS-folate solution was slowly added through a funnel into a mixture of 
1.5 g of PEO-bis-amine and 101 mg of triethylene amine in 15 mL of anhydrous 
DMSO, while being stirred under nitrogen protection at room temperature for a period 
of 6 hours. The reaction was allowed to proceed for another 24 hours under nitrogen 
protection at room temperature. The reaction flask and funnel were covered with 
aluminum foil during the whole course of the reaction. The final yellow reaction 
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mixture was filtered and dialyzed against deionized water using a dialysis membrane 
with MWCO of 1000 g/mol to remove by-products. The product FA-PEO-NH2 was 
then dried through freeze-drying to yield a yellow powder product. 
 
5.2.5 Folic acid conjugation of F-PEOSN 
 
15 mg of dicarboxylic acid modified F127 and 60 mg of F127 were first dissolved in 
900 μL THF that contain 75 μL of 1.0 mg/mL MEH-PPV THF stock solution. The 
mixture solution was then processed according to the bioinspired silification approach 
described earlier, resulting in the formation of aqueous suspension of carboxylic acid 
functionalized MEH-PPV loaded F-PEOSN.  
 
13.5 mg of EDC and 8.1 mg of NHS were then dissolved in the aqueous suspension of 
the carboxylic acid functionalized MEH-PPV loaded F-PEOSN and stirred for 30 
minutes. Meanwhile, 4.5 mg of FA-PEO-NH2 was dissolved separately in 50 μL 
DMSO and 700 μL DI H2O. The solution of the FA-PEO-NH2 was then added slowly 
into the aqueous suspension of the carboxylic acid functionalized MEH-PPV loaded 
F-PEOSN by using a syringe for a period of 30 minutes. The flask was then covered 
with aluminum foil and the reaction was allowed to continue at room temperature for 
another 48 hours. The final reaction mixture was then dialyzed against DI H2O by 
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5.2.6 Cytotoxicity study 
 
The cytotoxicity of the F-PEOSN was studied by determining the viability of breast 
cancer cells (MDA-MB-231) using the MTS assay, in accordance with the 
experimental protocol that has been described in section 4.2.6. The MDA-MB-231 
cells were obtained from American Type Culture Collection (ATCC). The 
concentration of the F-PEOSN used in this study was controlled in the range of 0 to 
8.0 mg/mL.  
 
5.2.7 Confocal fluorescence imaging study 
 
MDA-MB-231 cells were cultured in a 8 well chamber (LAB-TEK, Chambered 
Coverglass System) with culture medium at 37 °C in 5% CO2. The culture medium 
contains completed DMEM with 4.5 g/g of glucose, sodium pyruvate and L-glutamin, 
10% FBS, 100 units of Penicillin and 100 μg/mL of Streptomycin. The MDA-MB-231 
cells were seeded into chamber slides at a density of 15,000 cells/well. After 24 hours 
of incubation, the culture medium was replaced by fresh DMEM containing MEH-
PPV loaded F-PEOSN at different concentrations: 0, 2.0, 3.0, and 4.0 mg/mL. To 
investigate the capability of targeting imaging of the F-PEOSN, a separate set of 
MDA-MB-231 cells was cultured with the folic acid conjugated MEH-PPV loaded F-
PEOSN. After 24 hours of incubation in the presence of the MEH-PPV loaded F-
PEOSN, each well was washed with 1× PBS for three times, treated with of 0.5 mL of 
4% paraformaldehyde solution for 10 minutes to fix the cells, and followed by 
washing with 1× PBS for three times. The cells were then mounted using Vectashield 
mounting medium with DAPI. They were then imaged by using a confocal laser 
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scanning microscope (CLSM, Olympus Fluoview 1000). DAPI fluorescent image was 
acquired at λex = 345 nm and λem = 458 nm, while MEH-PPV loaded F-PEOSN 




The morphology and particle size of the F-PEOSN were studied by using TEM and 
DLS, which have been described in section 3.2.3 and 3.2.4. UV-vis-NIR absorption 
spectroscopy was measured by using a Shimadzu UV-3101 PC spectrometer at room 
temperature. Photoluminescence spectra were measured by using a Perkin-Elmer LS 
55 spectrophotometer at room temperature. The lifetime measurements of the samples 
were recorded by using a Time-correlated Single Photon Counting (TCSPC) Module 
and Picosecond Event Timer (PicoHarp 300). The samples were excited by using 405 
nm line of a picosecond pulsed laser diode head (PicoQuant PDL 800-B). The 
photoluminescence was dispersed through a monochromator (Acton SpectroPro 
2300i) and detected with a liquid N2 cooled CCD camera (Princeton, Spec-10:100). 
 
5.2.9 Quantum yield measurement 
 
Quantum yield was measured with respect to the fluorescence standard solution, 
namely quinine sulfate (0.1 M H2SO4; QY = 0.54), fluorescein (0.1 M NaOH; QY = 
0.79), and rhodamine 101 (Ethanol; QY = 1.0). Quinine sulfate was used as a 
reference for PDHF sample, whereas fluorescein used for BP-PPV sample, and 
rhodamine 101 used for PDHFBT and MEH-PPV sample. The procedures involved 
diluting the F-PEOSN and the fluorescence standard solution with their respective 
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solvent till their peak absorbance value reached 0.01. The wavelength at which both 
samples have the same absorption value was then used to excite and obtain the 
fluorescence spectra. The quantum yield of the F-PEOSN was obtained by comparing 
the integrated intensity of F-PEOSN with that of the standard solution. 
 
5.3 Results and discussion 
5.3.1 Preparation and physical characterizations of F-PEOSN 
 
 
Scheme 5.1 An illustration of the preparation of fluorescent PEOlated silica nanocapsules (F-PEOSN) 
encapsulating conjugated polymers via the bioinspired silification approach.  
 
Scheme 5.1 illustrates the synthesis of F-PEOSN via the bioinspired silification 
strategy. Initially, conjugated polymers are dissolved together with F127 and TMOS 
in a common water-miscible organic solvent, such as THF. The mixture solution is 
then injected into water under ultrasonication. As a result of the rapid change in the 
polarity of the surrounding environment, the F127 block copolymers immediately 
assume micellar structure with PPO blocks as the core and PEO blocks as the corona. 
At the same time, this micellization process is accompanied by compartmentalization 
of the conjugated polymers and TMOS into the PPO core of the F127 polymeric 
micelles owing to the hydrophobic interactions among these components. The 
hydrophobic conjugated polymers are entangled with the hydrophobic PPO chains of 
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F127, whereas the TMOS are hydrolyzed and condensed specifically at the interface 
between the core and the corona of the F127 polymeric micelles, where water is 
available for the sol-gel reaction to proceed. As a result, parts of the PEO blocks of 
the F127 micelles remain to be free and exposed to the surrounding medium, 
rendering the resultant fluorescent PEOlated silica nanocapsules (F-PEOSN) to be 
soluble in water.  
 
 
Figure 5.1 Chemical structures of the four conjugated polymers employed in the present study.  
 
In order to demonstrate the versatility of employing the bioinspired silification to 
prepare F-PEOSN, four different conjugated polymers with emission wavelength 
ranging from 350 – 600 nm, were used to tune the emission of the F-PEOSN across 
the visible spectrum. They are poly(9,9-dihexylfluorenyl-2,7-diyl) (PDHF), poly(2-
(2‟-phenyl-4‟,5‟-di(3”-methyl-butoxy)-phenyl-1,4-phenylenevinylene)) (BP-PPV), 
poly(9,9-dihexylfluorenyl-2,7‟-diylbithiophene) (PDHFBT) and poly(2-methoxy-5-
(2-ethyl-hexyloxy)-1,4-phenylenevinylene) (MEH-PPV). The chemical structures of 
these conjugated polymers are shown in Figure 5.1. Meanwhile, Figure 5.2 shows the 
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resultant aqueous suspension of the respective prepared F-PEOSN. It can be seen that 
the aqueous suspension of each F-PEOSN is transparent and stable. Neither 
precipitation nor aggregations were observed in the suspensions. Such excellent 
colloidal stability is attributed to the presence of free PEO chains on the surface of the 
F-PEOSN, which function well as steric stabilization agent. These results also indicate 
that the conjugated polymers were successfully encapsulated inside the core of the F-
PEOSN, or else the conjugated polymers would precipitate out in the suspensions due 
to their highly hydrophobic nature.
[25]
 When exposed to UV light (λexc = 365 nm), 




Figure 5.2 Optical micrographs of the aqueous suspensions of the PDHF, BP-PPV, PDHFBT, and 
MEH-PPV loaded F-PEOSN (left to right) under white light and UV light.  
 
The morphology of the thus prepared F-PEOSN was observed by using transmission 
electron microscopy (TEM) and the images are shown in Figure 5.3. It can be 
observed that all particles exhibit core-shell structure, which is the typical morphology 
for silica nanocapsules. The bright core in the centre can be assigned to the PPO 
blocks of the F127 micelles containing conjugated polymers, whereas the surrounding 
dark shell can be attributed to the silica shell. The silica shell appears darker because 
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it has significantly higher electron density than that of PPO blocks and conjugated 
polymers, both of which are carbon-based materials. The F-PEOSN were observed to 
be uniform with average core and outer diameter of ~ 6.0 and 14.0 nm, respectively. 
As shown in Table 5.1, there is no significant variation in the average core and outer 
diameter of the F-PEOSN, irrespective of the different loading of conjugated 
polymers. In addition, these sizes do not vary with the different amounts of loading of 
conjugated polymers. As a representative, the TEM images of the F-PEOSN 
encapsulating different amounts of MEH-PPV are presented in Figure 5.4. This 
behavior is rather in contrast to the general behavior of polymeric micelles in 
solubilizing small solutes, where the size of the micelles typically varies with the type, 
molecular weight and concentration of the solutes.
[44]
 Such close similarity in the 
physical dimensions among the different F-PEOSN could well be attributed by the 
confinement effect of the formed silica shell, which prevents the polymeric micelles 
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Figure 5.3 Transmission electron micrographs of a) PDHF, b) BP-PPV, c) PDHFBT, and d) MEH-
PPV loaded F-PEOSN, each was prepared at conjugated polymers concentration of 5.0 μg/mL. 
 
 
Table 5.1 Physical characteristics of the F-PEOSN encapsulating different conjugated polymers. 
 PDHF BP-PPV PDHFBT MEH-PPV 
Average core diameter (nm) 
[a]
 6.0 ± 1.0 6.0 ± 0.7 6.4 ± 0.9 6.3 ± 0.9 
Average outer diameter (nm)
 [a]
 14.1 ± 1.3 14.2 ± 1.1 14.1 ± 1.2 14.7 ± 1.3 
Hydrodynamic diameter (nm) 
[b]
 25.1 30.3 26.2 26.4 
Polydispersity Index (PdI) 
[b]
 0.15 0.17 0.12 0.16 
[a] The average core and outer diameters are determined from TEM images. [b] The hydrodynamic 
diameters and polydispersity index are obtained from DLS measurement. 
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Figure 5.4 TEM images of the F-PEOSN encapsulating different concentrations of MEH-PPV 
polymeric chains: a) 0.5 μg/mL, b) 1.0 μg/mL, c) 2.5 μg/mL, d) 5.0 μg/mL, and e) 7.5 μg/mL. 
 
 
Figure 5.5 DLS measurement of the hydrodynamic size distribution of a) F-PEOSN encapsulating 
different conjugated polymers and b) MEH-PPV loaded F-PEOSN at different loading concentration. 
 
In addition to TEM studies, the particle size of the F-PEOSN and their size 
distributions were investigated by using dynamic light scattering (DLS), the results of 
which are shown in Figure 5.5 and summarized in Table 5.1. There are no significant 
changes in the hydrodynamic diameter of F-PEOSN irrespective of the conjugated 
polymers encapsulated, which is in the range of 25 to 30 nm, corroborating the TEM 
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observation above. The F-PEOSN also have relatively narrow size distribution, as 
indicated by their low polydispersity index (PdI). In addition, the hydrodynamic 
diameters do not vary with the different concentrations of conjugated polymers, which 
further confirm the TEM result. Meanwhile, there is discrepancy between the particle 
sizes obtained from TEM and DLS measurement. This is because DLS measures the 
hydrated size of the particles when they are suspended in water, which includes the 
extension of the free PEO chains into water. In fact, the measured hydrodynamic 
diameters of the F-PEOSN are well within the reported hydrodynamic diameter of 
pure F127 micelles (20 to 30 nm),
[45]
 which suggests that the deposited silica shell did 
not change the size of the micelles. This means that the silica shell formation in the F-
PEOSN was indeed confined at the interfacial region between the core and the shell of 
the conjugated polymers loaded F127 polymeric micelles while maintaining part of 
the PEO shell remains free to provide aqueous solubilization and steric stabilization to 
the resultant F-PEOSN. 
 
5.3.2 Optical behavior F-PEOSN 
 
It is well known that the optical properties of conjugated polymers are strongly 
dependent on the physical conformation of the polymeric chains, and hence can be 
used to further evaluate whether the conjugated polymers are indeed encapsulated 
inside the F-PEOSN.
[16]
 Figure 5.6 (a) shows the absorption spectra of the F-PEOSN 
in comparison to those of conjugated polymer parent solutions in THF, measured at 
the same conjugated polymer concentration. It can be seen that the absorption spectra 
of the F-PEOSN are significantly broader than those of conjugated polymers in THF 
solution.  
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Figure 5.6 Normalized a) absorption spectra and b) PL spectra of the synthesized F-PEOSN (solid 
lines) and its respective conjugated polymer solution in THF (dashed lines) measured at conjugated 
polymer concentration of 5.0 μg/mL.   
 
Since absorption spectrum is a manifestation of the collective absorptions from 
conjugated polymer chains with different conjugation lengths, the broadened 
absorption spectra suggests that there is a widening in the conjugation length 
distributions of the polymeric chains encapsulated inside the F-PEOSN as compared 
to that of free conjugated polymer chains in THF solution. This means that the 
broadened absorption spectra are a direct result of the encapsulation of the conjugated 
polymer chains inside the core of the F-PEOSN, which can be rationalized as follows. 
During encapsulation process, the conjugated polymer chains undergo coiling and 
twisting in order to fit themselves into the PPO core of F127 micelles (~ 6 nm). This 
conformational change inadvertently results in the formation of defects along the 
polymer backbone that shorten the effective conjugation lengths of the polymeric 
chains,
[46]
 and thus cause the widening of the absorption band to the lower wavelength 
region.
[47]
 This effect is particularly pronounced in the PDHF loaded F-PEOSN, where 
the absorption peak of the sample exhibits a blue-shift. In addition to the formation of 
defects, the encapsulated conjugated polymer chains are bound to interact with one 
another, which causes further delocalization of the π-electrons over several polymeric 
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chains to form inter-chain aggregate states.
[16]
 Consequently, the aggregate state has a 
longer effective conjugation length, which is reflected by the widening of the 
absorption band to the longer wavelength region. Hence, it can be concluded that as a 
result of the encapsulation of the conjugated polymer chains inside the core of the F-
PEOSN, the conjugation length distributions of the polymeric chains are widened, 
which is reflected by broadening of the absorption band of the F-PEOSN. 
 
Meanwhile, Figure 5.6 (b) compares the photoluminescence (PL) behavior of the 
aqueous dispersions of F-PEOSN with that of the respective conjugated polymers 
solution in THF. It can be observed that there is a significant but polymer specific red-
shift in the emission peak of the F-PEOSN with respect to those of the conjugated 
polymers dissolved in THF. The red-shift in the emission of the F-PEOSN is ascribed 
to the increased inter-chain interactions as a result of the close packing of the 
conjugated polymeric chains inside the core of the F-PEOSN.
[48]
 These interactions 
allows for rapid energy transfer from high-energy and emissive short conjugation 
length segments to lower energy segments and weakly emissive aggregate states.
[16,49]
 
Because such energy transfer is a facile process, the PL of the F-PEOSN is therefore 
dominated by the emission from the aggregate states, which lead to the red-shift 
observed in the PL spectra of the F-PEOSN. This red-shift behavior is consistent with 
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Figure 5.7 Time-resolved photoluminescence decay of conjugated polymers dissolved in THF and 
encapsulated inside the core of F-PEOSN. 
 
To further understand the emission mechanism of the encapsulated conjugated 
polymers in the F-PEOSN, the PL decay lifetime of the main emission peak of each F-
PEOSN was measured and compared to that of respective conjugated polymers 
solution in THF, the results of which are shown in Figure 5.7. The main emission peak 
was selected as the base for comparison, because the emission comes from the same 
vibronic transition (0-0). It was found that all PL decay curves could be well fitted 
with a single exponential decay function and the obtained lifetimes are summarized in 
Table 5.2. It is observed that the lifetimes of conjugated polymers in the F-PEOSN are 
consistently larger than those of conjugated polymers dissolved in THF. For example, 
the lifetime of MEH-PPV in the F-PEOSN was determined to be 524 ps, whereas a 
lifetime of 328 ps was measured for MEH-PPV in THF. The longer lifetimes 
measured for the conjugated polymers encapsulated in the core of F-PEOSN are 
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consistent with their emission process, which is largely governed by the aggregate 
states.
[50]
 A longer lifetime is observed for the aggregate emission, as there is less 




In addition to the red shift behavior, the PL intensity of the F-PEOSN was reduced 
relative to those of THF solutions. To quantify this reduction, the quantum yield of 
each sample was measured with respect to that of fluorescence standards and the 
results are summarized in Table 5.2. The quantum yield of the F-PEOSN is lower than 
that of the respective conjugated polymer solution in THF. This behavior is not 
surprising, when one considers that the emission of F-PEOSN is mainly governed by 
long conjugation segment and aggregate states, which are known to exhibit weak 
emission.
[16,51]
 The reduced PL emission can also be attributed to the presence of 
defects, resulted from coiling and twisting of the conjugated polymers inside the F-
PEOSN. These defects then become trap sites, where nearby single chain excitons can 
rapidly migrate to and decay non-radiatively to ground states.
[52]
 Nonetheless, the 
measured quantum yield of the F-PEOSN is still quite high and comparable to those 
of water-dispersible conjugated polymer nanoparticles reported previously.
[35]
 In fact, 
a quantum yield as high as 0.60 was obtained for PDHF loaded F-PEOSN, which 
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Emission peak (nm)  414 423 486 502 525 554 548 584 
Fluorescence 
Lifetime (τ, ps) 
432 718 721 878 722 775 328 524 
Quantum Yield (QY) 0.91 0.60 0.78 0.53 0.38 0.15 0.25 0.09 
Extinction Coefficient  
(ε, L/g cm) 
N.D 95  N.D 38 N.D 64 N.D 65 
Extinction Coefficient 
(ε, × 106 M-1 cm-1) 
N.D 9.55 N.D 1.56 N.D 3.35 N.D 2.60 
N.D = Not determined 
 
Table 5.2 also summarizes the extinction coefficient of all conjugated polymers 
loaded inside F-PEOSN, which was obtained by measuring the absorption spectrum of 
the F-PEOSN, prepared at different conjugated polymer concentrations (0.5 to 7.5 
μg/mL), as shown in Figure 5.8. The peak absorbance value was then plotted against 
the conjugated polymer concentration and the result shows that the absorbance varies 
linearly with the polymer concentration, demonstrating that all conjugated polymer 
chains are well encapsulated inside the core of the F-PEOSN. A linear equation was 
then used to fit the data to obtain the slope, which represents the extinction coefficient 
of the conjugated polymers inside the F-PEOSN. The extinction coefficient of the 







These values are considerably large and highly comparable to other fluorescent 
probes. The extinction coefficient of QDs, for example, was reported to vary between 






, depending on the size of the crystals.
[53]
 Considering that 
fluorescence brightness is a product of quantum yield and extinction coefficient, the 
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results above suggest that the F-PEOSN should exhibit the desired high fluorescence 
brightness for fluorescence cellular imaging applications. 
 
 
Figure 5.8 Absorption spectra of a) PDHF, b) BP-PPV, c) PDHFBT, and d) MEH-PPV loaded F-
PEOSN prepared at different conjugated polymer concentrations. The inset figures show the linear fit 
of peak absorbance with respect to conjugated polymer concentrations.  
 
5.3.3 Cytotoxicity and cellular imaging studies 
 
As mentioned earlier, biocompatibility of fluorescent nanoparticles is a critical issue 
for their use in fluorescence cellular imaging.  In this study, the potential cytotoxicity 
of the F-PEOSN was evaluated by measuring the in vitro viability of breast cancer 
cells (MDA-MB-231) using MTS assay. Figure 5.9 shows that the cell viability of the 
MDA-MB-231 cells are close to 100%, even at very high concentration of MEH-PPV 
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loaded F-PEOSN (8.0 mg/mL) after incubation for 24 hours, suggesting that the F-
PEOSN are non-cytotoxic and of great potential as fluorescent probes.   
 
 
Figure 5.9 Viability of MDA-MB-231 cells upon being incubated with various concentrations of MEH-
PPV loaded F-PEOSN for 24 hours.  
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Figure 5.10 Confocal images of MDA-MB-231 cells after incubated with different concentrations of 
MEH-PPV loaded F-PEOSN for 24 hours.  
 
To examine the possibility of employing F-PEOSN as fluorescent probes, MDA-MB-
231 cells were cultured in the presence of different concentrations of MEH-PPV 
loaded F-PEOSN for 24 hours. After incubation, the cells were washed and fixed with 
their nuclei stained with DAPI, which is a fluorescent dye that gives out blue emission 
for the nuclei image. The cellular uptake of the MEH-PPV loaded F-PEOSN by 
MDA-MB-231 cells was then evaluated by using confocal laser scanning microscopy 
(CLSM), the results of which are displayed in Figure 5.10. It is observed that red 
fluorescence appears in the cytoplasm region surrounding the nucleus of the cells, 
indicating that the MEH-PPV loaded F-PEOSN were successfully internalized by the 
MDA-MB-231 cells. Meanwhile, the intensity of the red fluorescence increases with 
increase in the concentration of the MEH-PPV loaded F-PEOSN, suggesting that the 
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cellular uptake is a dose dependent process. To confirm the internalization behavior 
above, a z-scan study was performed by taking a series of confocal images from the 
bottom to the top surface of the cells, which are shown in Figure 5.11. The concurrent 
appearance of the blue fluorescence of nuclei and red fluorescence of MEH-PPV at 
the middle section of the cells clearly verifies that the MEH-PPV loaded F-PEOSN 
were indeed internalized by the MDA-MB-231. Hence, these results evidently 
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Figure 5.11 Confocal images z-section of MDA-MB-231 cells cultured with 4.0 mg/mL MEH-PPV 
loaded F-PEOSN. The images were acquired with a step size of 0.58 μm from the bottom to the top 
surface of the cells. 
 
For cellular imaging, it is important not only to develop a safe and bright fluorescent 
probes but also to functionalize them with appropriate targeting ligand to image 
specific cells. To demonstrate the targeting imaging capability of the F-PEOSN, folic 
acid (FA) was conjugated on the surface of the MEH-PPV loaded F-PEOSN and their 
uptake behavior was studied with MDA-MB-231 cells, which are known to over-
express folate receptors on their cell membrane.
[54]
 Folic acid is chosen as the 
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targeting ligand in this study because it has high binding affinity towards folate 




 which could lead to effective internalization of their 
conjugates by cancer cells through the receptor-mediated endocytosis.
[56]
 Moreover, 
normal tissues have low expression of folate receptors in comparison to those of 
cancer cells, such as ovarian, breast, and prostrate cancers. This means that folic acid 
and its conjugates can be used to achieve high specificity in targeting some cancerous 
tissues.
[57]
    
 
 
Scheme 5.2 A diagram illustrating the preparation of folic acid conjugated F-PEOSN via the 
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Figure 5.12 NMR spectrum of the folic acid-conjugated F-PEOFSN. The proton NMR was recorded in 
DMSO-d6.  
 
In order to realize the objective above, carboxylic acid functionalized F-PEOSN was 
first prepared by substituting a part of the employed F127 block copolymer with 
dicarboxylic acid modified F127 that contain two carboxylic acid groups at the end of 
the polymeric chain. The carboxylic acid functionalized F-PEOSN was then 
conjugated to aminated-folic acid by using the standard N-Hydroxysuccinimide 
(NHS) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) coupling 
reaction, which facilitate the formation of amide bond between the carboxylic acid 
group and amine groups of the aminated-folic acid. This conjugation procedure is 
summarized and illustrated in Scheme 5.2. The conjugation of folic acid onto the F-
PEOSN was then ascertained by using NMR and the resultant spectrum is shown in 
Figure 5.12. The presence of sharp peak at 1.0 ppm and broad peak at 3.5 ppm can be 
assigned to the PPO and PEO moieties of the F127, respectively. Meanwhile, the 
presence of folic acid is reflected by the appearance of the small peaks at 6.6 and 7.6 
ppm (attributed by the aromatic proton) and at 8.5 ppm (attributed by the peridine 






To evaluate the potential of targeting imaging of the thus prepared folic acid (FA) 
conjugated F-PEOSN, MDA-MB-231 cells were incubated with the FA MEH-PPV 
loaded F-PEOSN under the same experimental conditions as those of pure MEH-PPV 
loaded F-PEOSN. The cells were then observed by using CLSM and the acquired 
images are presented in Figure 5.13. From a qualitative point of view, it can be 
appreciated that there is a significant increase in the intensity of red fluorescence 
observed in the confocal images of the MDA-MB-231 treated with FA MEH-PPV 
loaded F-PEOSN (Figure 5.13) as compared to those of pure MEH-PPV loaded F-
PEOSN (Figure 5.10). These results thus suggest that more MEH-PPV loaded F-
PEOSN were uptaken by the MDA-MB-231 cells upon conjugation with folic acid, 
demonstrating the targeting capability of the FA MEH-PPV loaded F-PEOSN 
developed in this project. 
 
 
Figure 5.13 Confocal images of MDA-MB-231 cells cultured with different concentrations of folic acid-








Fluorescent PEOlated silica nanocapsules (F-PEOSN) has been successfully 
synthesized by using the bioinspired silification approach developed in this project. 
The strategy is based on entrapping the conjugated polymer chains inside the cores of 
the silica nanocapsules, which is driven by hydrophobic interactions during the 
micellization process. As such, the procedure is easily extended to encapsulate 
different conjugated polymers and allow for the formation of multi-color F-PEOSN 
across the visible spectrum. Considering that conjugated polymers are commercially 
available, the bioinspired silification can be used as a general and facile strategy for 
development of water-dispersible conjugated polymer nanoparticles.     
 
The surface of the F-PEOSN is designed to intrinsically possess a layer of free PEO 
chains, which endow them the desired colloidal stability and low cytotoxicity. 
Moreover, the F-PEOSN exhibit high quantum yield and large absorption coefficient, 
suggesting their potential as fluorescent probes for cellular imaging. Upon incubation 
of F-PEOSN with MDA-MB-231 breast cancer cells, bright fluorescence was 
observed in the cytoplasm region surrounding the nuclei of the cells. By substituting a 
small portion of the employed F127 block copolymer with dicarboxylic acid modified 
F127, folic acid was successfully conjugated on the surface of F-PEOSN by using the 
carbodiimide coupling chemistry. These folic acid-conjugated F-PEOSN show a 
higher degree of cellular uptake by MDA-MB-231 cells, which are known to over-
express folate receptors on their cell membrane. These results therefore demonstrate 
the feasibility of employing F-PEOSN for targeted imaging of cancer cells, which is 
highly useful for early detection of cancers.  
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Chapter 6  
BI-FUNCTIONAL SILICA NANOCAPSULES OF 
FLUORESCENT CONJUGATED POLYMERS AND 
SUPERPARAMAGNETIC NANOCRYSTALS FOR DUAL-




The development of multi-functional nanostructures, combining different 
functionalities into a single nano-object, has attracted a significant amount of research 
interests in recent years.
[1-3]
 Synthesis of bi-functional nanomaterials having 
fluorescent and magnetic functionalities, in particular, are currently under intensive 
investigation because of their wide range of potential applications in biomedical 
fields, such as cellular imaging, diagnostic, bioseparation, and therapeutics.
[4-7]
 
Specifically, the main objective in developing bi-functional magnetic fluorescent 
nanostructures is to produce a multi-purpose tool. For example, the magnetic domain 
enables a pre-operative diagnosis of tumor cells via magnetic resonance imaging 
(MRI) while the fluorescence signal allows for improvement in the spatial resolution 
during surgery, which could facilitate total removal of tumor cells, and thus minimize 
damage to the surrounding healthy tissues.
[4,8]
 Furthermore, the delivery of the bi-
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Numerous efforts have been made in aiming at developing bi-functional magnetic 
fluorescent nanostructures with organic dyes
[5,10]
 and semiconductor quantum dots 
(QDs)
[11-13]
 as the most commonly employed emitting component. The resultant bi-
functional nanostructures, however, inherit the inherent drawbacks of the 
fluorophores. For example, small molecular organic dyes suffer from poor 
photochemical stability,
[4,14]
 whereas QDs are of potential concern for their 
cytotoxicity since they are composed of heavy metal ions (e.g: Cd, Se, Hg, As, Pb), 
which are known to cause acute and chronic toxicities to living organisms.
[15]
 Thus, it 
is of importance to investigate a new fluorescent emitting agent that exhibits high 
photostability and low cytotoxicity for development of efficient and biocompatible bi-
functional magnetic fluorescent nanostructures. 
 
Conjugated polymers are a unique class of polymers that exhibit semiconducting and 
fluorescent properties as a result of their conjugated structure, where alternating single 
and double bonds give rise to the delocalization of the π-electrons along the polymer 
chains, forming a band structure. Recently, water-dispersible fluorescent nanoparticles 
have been successfully prepared based on conjugated polymers.
[16-22]
 The water-
dispersible conjugated polymers nanoparticles were found to exhibit high quantum 
yield, large absorption cross-section, and high photostability,
[16-19,21]
 which are ideal 
optical characteristics for biological imaging applications. Indeed, they were shown to 
be an excellent fluorescent labelling agent for both fixed and live cell imaging.
[16-22]
 
Furthermore, they don‟t show significant photobleaching after being imaged over an 
extended period of time,
[16,21]
 which makes them an excellent candidate for long-term 
cell tracking probe. More importantly, there was no cytotoxicity observed in the cell 
viability studies of these water-dispersible conjugated polymer nanoparticles, 
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indicating that conjugated polymers are biocompatible for biological applications.
[16-
22]
 As a result, conjugated polymers are currently recognized as a new promising class 
of fluorescent labelling agents for cellular imaging studies. It is therefore of both 
fundamental and practical interest to combine this emerging class of fluorophores with 
magnetic materials to form novel bi-functional nanohybrids and widen the 
applications of conjugated polymers in biomedical field. 
 
Superparamagnetic iron oxide nanocrystals (SPIONs), such as magnetite (Fe3O4) and 
hematite (γ-Fe2O3), are the most commonly employed magnetic materials in the 
development of bi-functional magnetic fluorescent nanostructures.
[4-5,10-13]
 On top of 
the biocompatibility, SPION are selected because they have been extensively studied 
for various biomedical applications, such as hypherthermia, magnetic guided drug 




To integrate the fluorescence and magnetism functionalities into a single nano-object, 
several different synthesis strategies have been devised over the past few years, which 
can be broadly classified into: (i) covalent conjugation of the fluorophores onto 
magnetic nanocrystals via small organic molecules,
[24-25]
 (ii) direct bonding between 
the fluorophores and magnetic nanocrystals through inorganic synthesis,
[26-27]
 and (iii) 





 Among them, silica encapsulation appears to be one of the 
most versatile integration strategies since it has been used in the preparation of 
different types of bi-functional magnetic fluorescent nanomaterials. Silica 
encapsulation has been reported to offer biocompability, chemical inertness, and 
mechanical stability to the components encapsulated within.
[28-30]
 In addition, silica 
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encapsulation provides several other benefits, such as facilitating bioconjugation via 





In line with the objectives above, it would be of considerable value to develop a new 
type of bi-functional magnetic fluorescent silica nanocapsules (hereafter denoted as 
BMFSN), by employing conjugated polymers as the fluorescent emitter and SPION as 
the magnetic constituent, both of which are encapsulated inside the nanocore of thin 
silica shell. In principle, the BMFSN can be prepared via the bioinspired silification 
that has been successfully developed in this project. It is a process of forming silica 
nanocapsule by using a template of Pluronic
®
 F127 polymeric micelles at room 
temperature and near-neutral pH condition, mimicking the behavior of marine 
organisms. Having successfully developed the BMFSN, systematic investigations into 
their physical and optical properties, cell viability, as well as their magnetic resonance 
enhancement behavior are performed. As detailed below, the results reveal that the 
BMFSN are uniform in size with excellent dispersion in water, exhibit low 
cytotoxicity, and demonstrate the dual functionality of fluorescence and 
superparamagnetism in a single entity. Cellular uptake studies show that the BMFSN 
are successfully internalized by liver cancer cells. The dual functionality of the 
BMFSN enables the cells to be observed via dual mode cellular imaging, namely 
fluorescence and magnetic resonance imaging. Moreover, targeted cellular imaging by 
using external magnetic field is demonstrated, showing the potential to harness 
superparamagnetic behavior of the BMFSN for targeting biomedical applications. 
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diylbithiophene) (PDHFBT) and poly(2-methoxy-5-(2-ethyl-hexyloxy)-1,4-phenylene 
vinylene) (MEH-PPV) were synthesized following previous reports
[32-36]
 and kindly 
provided by Dr Chen Zhikuan. Block copolymer Pluronic
®
 F127 
(PEO106PPO70PEO106), tetramethylorthosilicate (TMOS; 98%), tetrahydrofuran 
(THF), iron (III) acetylacetonate (Fe(aca)3), benzyl ether, oleylamine, oleic acid, 1,2-
hexadecanediol, and potassium bromide were procured from Sigma Aldrich. CellTiter 
96 AQueous Non-Radioactive Cell Proliferation Assay MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) was purchased 
from Promega. Fetal Bovine Serum (FBS) was obtained from Hyclone. Dulbecco‟s 
Modified Eagle‟s Medium (DMEM) containing glucose, sodium pyruvate, L-
glutamin, Penicilin, and Streptomycin were obtained from PAA Laboratories GmbH, 
Austria. Ferucarbotran, a clinical MRI contrast agent, was purchased from Bayer 
Schering Pharma AG, Berlin, Germany. Vectashield aqueous mounting medium 
containing 4',6-diamidino-2-phenylindole (DAPI) was procured from Vector 
Laboratories. 10× PBS was obtained from 1
st
 Base and 1× PBS was prepared by 
diluting the 10× PBS with Milli-Q deionized water. All chemicals were used as 
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6.2.2 Synthesis of bi-functional magnetic fluorescent silica nanocapsules (BMFSN) 
 
Firstly, the SPION were synthesized by following the procedure that was dscribed in a 
published report
[37]
 and briefly mentioned in section 4.2.2. Subsequently, stock 
solutions of PDHF, BP-PPV, PDHFBT, and MEH-PPV in THF were prepared by 
dissolving the respective conjugated polymers in THF to a concentration of 2.0 
mg/mL. 125 μL of the conjugated polymers THF stock solutions was then mixed with 
15 mg of F127, 375 μL of the hydrophobic SPION stock solution and 400 μL of THF. 
The mixture was stirred at room temperature for 12 hours prior to the addition 23 μL 
of TMOS. Subsequently, the mixture solution was vortexed for 1 minute and injected 
slowly into 10 g of deionized water while being stirred at 1000 rpm. The stirring was 
continued for an additional four days to evaporate the THF and ensure a complete 
hydrolysis of TMOS to form the silica shell of BMFSN. The resultant aqueous 
dispersion of BMFSN was then dialyzed against deionized water extensively for 24 
hours using an MWCO 8000 dialysis tube to remove the un-condensed silica 
precursors. 
 
6.2.3 Cytotoxicity study 
 
The cytotoxicity of the BMFSN was evaluated by determining the viability of HepG2 
hepatocellular carcinoma (HCC) cells using MTS assay by following the experimental 
protocol that has been described in section 4.2.6. The concentration of the BMFSN 
used in this study is 0, 30, 60, 120, 240, and 350 μg/mL.  
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6.2.4 Confocal fluorescence imaging study 
 
The potential for the BMFSN to be used in cellular imaging was studied by using 
confocal laser scanning microscopy with HepG2 cells. The HepG2 cells were cultured 
with MEH-PPV loaded BMFSN and grown according to experimental protocol 
described in section 5.2.7 at nanocapsules concentrations of 30, 60, and 120 μg/mL. In 
addition, to study the magnetic targeting capability of the BMFSN, a separate set of 
experiments was conducted by placing a small permanent magnet at the bottom of the 
cell culture chamber. 
 
6.2.5 MRI relaxivity measurement 
 
MR relaxivity of the BMFSN was evaluated at 25 °C by using a 9.4 Tesla MR scanner 
(Varian; Palo Alto, USA). To measure the T1 and T2 relaxivities of the MEH-PPV 
loaded BMFSN, the bi-functional silica nanoparticles were dispersed in water with Fe 
concentrations ranging from 0 to 0.10 mM. As a comparison, the T1 and T2 relaxivities 
of ferucarbotran was measured under same condition. T2 relaxation times were 
determined by using a multi-echo spin-echo sequence (20 echoes; repetition time 
(TR): 10000 ms; echo times (TE): 5.69 ms). Meanwhile, T1 relaxation times were 
determined by using inversion recovery spin-echo sequence (8 TRs; TR: 7500 ms; TE: 
6.2 ms). To study the colloidal stability of the BMFSN under 9.4 T magnetic field, the 
relaxation time measurement was performed again after the BMFSN dispersions were 
kept inside the magnetic field for 12 hours. The longitudinal and transverse 
relaxivities were obtained from linear least-squares determination of the slope of 1/T1 
or 1/T2 vs molar [Fe] concentrations plots. 
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6.2.6 In vitro MRI study 
 
HepG2 cells were grown in a single chamber at a density of 350,000 cells/well using 
the same cell culture condition for confocal fluorescence imaging study described in 
section 5.2.7. After 24 hours of incubation, the culture medium was replaced by fresh 
DMEM containing MEH-PPV loaded BMFSN at nanocapsules concentrations of 0 
and 60 μg/mL. In addition, a separate set of experiment was conducted by placing a 
small permanent magnet at the bottom of the chamber of the HepG2 cells cultured 
with 60 μg/mL MEH-PPV loaded BMFSN. After 24 hours of incubation in the 
presence of the nanocapsules, each well was washed with 1× PBS for three times. The 
cells were then transferred into a 0.2 mL eppendorf tube and fixed with 4% 
paraformaldehyde solution.  
 
MR imaging of the HepG2 cells above were obtained by using a 7.0 Tesla MR 
scanner (Bruker Clinscan system). Prior to imaging, a phantom was prepared by 
centrifuging the cells in the eppendorf tube at 500 G. Each tube was then placed inside 
a 50.0 mL Falcon centrifuge tube, which was subsequently filled with 1% agarose 
solution. T2-weighted images of the HepG2 cells were then acquired using a spin-echo 
pulse sequence (TR: 4000 ms; TE: 6.7 ms; number of acquisition: 1; flip angle: 180 °; 
point resolution: 0.23 × 0.23 mm
2




The BMFSN thus synthesized were characterized by using TEM, DLS, XRD, VSM, 
FTIR, and ICP-AES. The experimental procedures for these characterizations have 
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been described in section 4.2.8. In addition, the magnetization behavior of the 
BMFSN was analyzed by using the Langevin equation,
[38]
 which is well known to 
describe the magnetization of superparamagnetic particles.
[39]
 The analysis procedure 
is described in section 4.2.9. The fluorescence spectra of the BMFSN were measured 
by using a fluorescent spectrophotometer (Perkin-Elmer LS55) at room temperature. 
 
6.3 Results and discussion 
6.3.1 Preparations and characterizations of BMFSN 
 
 
Figure 6.1 (a) TEM image of the as-synthesized SPION and (b) the high-resolution image of a single 
SPION. 
 
In order to ensure that both the conjugated polymers and the SPION are enclosed 
together inside the core of the polymeric micelles, both constituents must be 
hydrophobic and well dispersed in an identical solvent. Hydrophobic SPION was 
prepared through high-temperature decomposition of iron salts in long chain alcohol 
solvent, according to previous reports.
[37]
 The transmission electron microscopy 
(TEM) image of the as-synthesized SPION in Figure 6.1 shows that the particles are 
relatively uniform with an average particle diameter of 6.5 ± 1.3 nm. The particles are 
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also highly crystalline as shown by the presence of lattice planes in the high-




Scheme 6.1 A schematic illustrating the formation of BMFSN via the bioinspired silification approach.  
 
Scheme 6.1 depicts the bioinspired silification route to prepare the BMFSN 
encapsulating fluorescent conjugated polymers and SPION in this chapter. Initially, 
the conjugated polymers are mixed together with the as-synthesized hydrophobic 
SPION and F127 block copolymers in THF, which is a desirable solvent for all 
components. Upon complete dissolution, tetramethylorthosilicate (TMOS), a silica 
precursor, is added into the mixture solution. When the mixture solution is injected 
into water under stirring, the rapid change in polarity of the solvent induces the 
formation of F127 polymeric micelles, each of which consists of a PPO core and a 
PEO corona. During the micellization process, the hydrophobic conjugated polymers, 
SPION and TMOS are simultaneously encapsulated inside the core of the F127 
micelles due to the hydrophobic interactions between the PPO chains of F127 and the 
conjugated polymers, SPION, and TMOS. As a consequence of this encapsulation, the 
hydrolysis reaction of TMOS is limited to occur at the interface region between the 
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core and corona of the F127 micelles, which gives rise to the formation of a thin silica 
shell surrounding the core of the F127 micelles with free PEO chains at the outer 
surface. As a result, both the fluorescent conjugated polymers and SPION are 
encapsulated inside the silica nanocapsules that are covered by free PEO chains, 
leading to the formation of BMFSN. 
 
 
Figure 6.2 Optical micrographs of the aqueous dispersions of PDHF, BP-PPV, PDHFBT, and MEH-
PPV loaded BMFSN (from left to right) under (a) white light and (b) UV light.    
 
To demonstrate the universality of employing fluorescent conjugated polymers as the 
fluorophores for the preparation of BMFSN in combination with SPION, four 
different conjugated polymers were selected, namely poly(9,9-dihexylfluorenyl-2,7-
diyl) (PDHF), poly(2-(2‟-phenyl-4‟,5‟-di(3”-methyl-butoxy)-phenyl-1,4-
phenylenevinylene)) (BP-PPV),  poly(9,9-dihexylfluorenyl-2,7‟-diylbithiophene) 
(PDHFBT) and poly(2-methoxy-5-(2-ethyl-hexyloxy)-1,4-phenylenevinylene) (MEH-
PPV). The four conjugated polymers emit blue, green, yellow, and red color, 
respectively. The resultant aqueous dispersions of BMFSN encapsulating different 
fluorescent conjugated polymers are shown in Figure 6.2. The BMFSN dispersions are 
clear and stable with no precipitates being observed. This indicates that both the 
conjugated polymers and SPION are well encapsulated inside the silica nanoshell, 
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otherwise they would precipitate out in water due to their highly hydrophobic 
characteristics.
[19,38]
 Under UV illumination (λex = 365 nm), strong fluorescent 
emission was observed from the BMFSN dispersions, displaying vibrantly the color of 
respective encapsulated conjugated polymers. 
 
 
Figure 6.3 Transmission electron micrographs of (a) PDHF, (b) BP-PPV, (c) PDHFBT, and (d) MEH-
PPV loaded BMFSN. 
 
The morphology of the as-synthesized BMFSNs was studied by using TEM and their 
images are shown in Figure 6.3. TEM studies show that the BMFSNs are near 
spherical in shape with core-shell structure, corresponding to SPION as the core and 
silica as the shell. The SPION appear darker in the TEM micrographs because they 
possess higher electron density than silica. There is no appreciable change in the size 
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and shape of the encapsulated iron oxide nanocrystals in the BMFSNs when compared 
to the as-synthesized SPION. The crystallinity of the SPION is also well preserved, as 
indicated by the presence of lattice planes of magnetite structure in the high resolution 
TEM image of BMFSN, as shown in Figure 6.4. Meanwhile, the presence of 
conjugated polymers in the core of the BMFSN cannot be observed in the TEM 
micrographs because the electron density of the polymeric chains, which are carbon-
based material, are significantly lower than that of SPION or silica. To show the 
presence of conjugated polymer chains in the BMFSN, confocal laser scanning 
microscopy (CLSM) was used to capture the fluorescence and transmission image of 
MEH-PPV loaded BMFSN suspension and the images are shown in Figure 6.5 (a) and 
(b), respectively. The fluorescence image of the BMFSN suspension clearly shows the 
characteristic red emission of MEH-PPV while the transmission mode displays the 
suspension as bright dots. The excellent overlap between the red dots of fluorescence 
image and the bright dots of transmission image in Figure 6.5 (c) indicates that the 
MEH-PPV polymeric chains are indeed encapsulated inside the BMFSN, otherwise no 
red color emission could be observed from the droplets, as shown in Figure 6.5 (d) to 
(f). The average particle size of the BMFSN encapsulating different conjugated 
polymers is measured by TEM studies and summarized in Table 6.1. It can be seen 
that the average outer diam eterof the various BMFSN are quite close to one another, 
which is about 25 nm, irrespective of the type of the conjugated polymers 
encapsulated. 
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Figure 6.4 High-resolution transmission electron micrograph of a BMFSN showing the lattice planes of 
the encapsulated SPION and the amorphous characteristic of the silica shell. The lattice spacing is 
measured and indexed according JCPDS 19-926. 
 
 
Figure 6.5 Confocal microscope images of (top) MEH-PPV loaded BMFSN and (bottom) PEOlated 
Fe3O4@SiO2 nanoparticles (PEOFSN) suspension cast on a glass substrate: (a) and (d) fluorescence 
images, (b) and (e) transmission images, whereas (c) and (f) merged fluorescence/transmission images. 
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Table 6.1 Physical characteristics of the BMFSN loaded with different fluorescent conjugated 
polymers. 
 PDHF BP-PPV PDHFBT MEH-PPV 
Average outer diameter (nm) 
[a]
 26.7 24.3 25.1 22.9 
Standard deviation (nm) 
[a]
 6.7 5.8 4.8 4.6 
Z-average (nm) 
[b]
 65.4 51.4 62.3 51.3 
Polydispersity index 
[b]
 0.169 0.143 0.180 0.168 
[a] The particle size and standard deviation are determined from TEM. [b] The Z-average and 
polydispersity index are determined using DLS. 
 
In addition to the TEM studies, the particle size and size distribution of the BMFSN 
were also investigated by using dynamic light scattering (DLS), the results of which 
are summarized in Table 6.1. The Z-average hydrodynamic diameter of the BMFSNs 
is ranging from ca. 50 to 60 nm with a relatively narrow size distribution, as indicated 
by their low polydispersity index, from 0.14 to 0.18. These results of the DLS 
corroborate the TEM observation above, where no significant difference in the particle 
size was obtained from different BMFSN. In comparison to the particle size measured 
by TEM, these hydrodynamic diameters are slightly larger in general. This is because 
the DLS measurement takes into account of the hydrated size of the nanocapsules, 
which includes not only the conjugated polymeric chains, SPION and silica shell but 
also the PEO chains dangling on the surface of the silica shell.  
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Figure 6.6 (a) XRD spectra of the as-synthesized SPION and MEH-PPV loaded BMFSN (upper and 
bottom). The crystal structure index is based on the cubic structure of magnetite according to JCPDS 
19-629, while the * indicates the amorphous band of silica. Lines shape of the (311) diffraction peak of 
magnetite of (b) as-synthesized SPION and (c) MEH-PPV loaded BMFSN. The full curves are fit to a 
Gaussian distribution. 
 
The XRD spectrum in Figure 6.6 (a) shows the formation of crystalline cubic structure 
of magnetite (Fe3O4) in the as-synthesized SPION, as reflected by their characteristic 
peaks of (220), (311), (400), (422), (611), and (440) planes. The cubic structure of the 
magnetite is also reflected in the XRD spectrum of the MEH-PPV loaded BMFSN, as 
a typical example, confirming that there is no deleterious effect on the Fe3O4 
nanocrystals during the encapsulation process of the bioinspired silification. In order 
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to corroborate this inference, the Scherrer equation was used to calculate the average 
crystallite size of the Fe3O4 nanoparticles from the fwhm of (311) peak of magnetite in 
each spectrum. The fwhm was obtained by fitting the (311) peak according to a 
Gaussian distribution, as shown in Figure 6.6 (b) and (c). The results of the fitting are 
summarized in Table 6.2. Indeed, the calculation reveals a similar average crystallite 
size of the Fe3O4 nanoparticles in the as-synthesized SPION and the MEH-PPV 
loaded BMFSN, which are about 5.3 nm, and therefore supporting the deduction 
above. In addition to the magnetite reflections, a broad reflection is observed at 
around 2θ = 23° in the MEH-PPV loaded BMFSN‟s XRD spectrum, which suggests 
the existence of amorphous silica in the sample. The presence of the silica was further 
confirmed by the appearance of characteristic bands of silica around 465, 805, 956, 
and 1100 cm
-1
 in the FTIR spectrum of the MEH-PPV loaded BMFSN, which is 
shown in Figure 6.7.
[40]
 The characteristic band of magnetite (600 cm
-1
) was also 
detected,
[41]
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Table 6.2 The results of X-ray diffraction and field-dependent magnetization curves of SPION and 
MEH-PPV loaded BMFSN. 



















1.64 5.1 5.6 5.9 × 10
-17
 6.3 
[a] The full width half maximum (FWHM) of (311) peak of magnetite structure determined from fitting 
according to Gaussian distribution. [b] The saturation magnetization (Ms), average magnetic moment 
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6.3.2 Optical and magnetic behavior of BMFSN 
 
 
Figure 6.8 Photoluminescence spectra of the aqueous dispersions of PDHF, BP-PPV, PDHFBT, and 
MEH-PPV loaded BMFSN (solid lines) in comparison to respective fluorescent conjugated polymer 
solutions in THF (dashed lines). 
 
Figure 6.8 presents the photoluminescence (PL) spectra of the BMFSN dispersions in 
water (solid lines) in comparison to those of respective fluorescent conjugated 
polymer solutions in THF (dashed lines). The emission peak of the BMFSN aqueous 
dispersions exhibit red-shift, albeit at different degrees for different conjugated 
polymers. The red-shift is caused by close packing of the conjugated polymer chains 
within the silica nanocapsule as a result of the encapsulation process. The close 
proximity between the polymeric chains inside the nanocapsules inadvertently results 
in an increased interactions among segments of the conjugated polymer chains, which 
allows for energy transfer to low energy chromophores and weakly fluorescent 
intrachain aggregate states, and thus causes the red-shift.
[42-43]
 This red-shift behavior 
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is in agreement with the optical properties of previously synthesized fluorescent 
PEOlated silica nanocapsules (F-PEOSN).
 
In view of the large number of 
commercially available conjugated polymers, these experimental results thus 
demonstrate that the bioinspired silification can be used as a universal approach to 
prepare various colored BMFSN by simply encapsulating specific conjugated 
polymers, emitting at the desired wavelength. 
 
The magnetic behavior of the MEH-PPV loaded BMFSN was investigated by using 
vibrating sample magnetometer (VSM), in comparison to that of the as-synthesized 
SPION. Both samples exhibit superparamagnetic behavior, as shown by the absence 
of hysteresis loop in their field-dependent magnetization curves at room temperature 
in Figure 6.9. Neither coercivity field nor remanent magnetization is present. Table 
6.2 summarizes the saturation magnetization (Ms) value of both samples obtained 
from VSM measurement. For the MEH-PPV loaded BMFSN, a saturation 
magnetization value of 5.6 emu/g is measured, which is significantly lower than that 
of the as-synthesized SPION (50.2 emu/g). It is noteworthy to mention that the 
magnetization values are expressed as per unit of total mass of the sample (emu/g), 
which means that the lower magnetization value of the BMFSN is due to lower 
magnetic component content in the nanocapsule structure as compared to that of 
SPION. In order to support this argument, each magnetization curves was further 
analyzed by fitting to the Langevin equation, which is known to describe magnetic 
behavior of superparamagnetic material.
[38]
 The average particle size of the magnetic 
component (dLv) in each sample was then calculated from the average magnetic 
moment (μ) thus obtained and the result is presented in Table 6.2. It is clear that the 
average particle size of the magnetic component in the MEH-PPV loaded BMFSN is 
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very similar to that of the as-synthesized SPION, which is about 6.3 nm. Considering 
that the magnetization value of Fe3O4 nanocrystals is known to scale with their 
particle sizes,
[44]
 these results prove that the lower magnetization value of the MEH-
PPV loaded BMFSN is indeed due to the fact that the Fe3O4 nanocrystals only 
represent a fraction of the nanocapsules, or else a smaller magnetic moment and 
particle size of the Fe3O4 nanocrystals would be obtained from the fitting process of 
the MEH-PPV loaded BMFSN magnetization spectrum. Moreover, these fitted 
particle sizes are in good agreement with those results obtained from TEM and XRD. 
 
 
Figure 6.9 Field dependent magnetization curves of (a) as-synthesized SPION and (b) MEH-PPV 
loaded BMFSN measured at room temperature by using a VSM (empty symbol). The full curves are fit 
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6.3.3 Magnetic resonance behavior of BMFSN 
 
 
Figure 6.10 a) T2-weighted MR images and b) relaxation rates (1/T1 and 1/T2, s
-1
) of the aqueous 
dispersion of MEH-PPV loaded BMFSN as a function of iron molar concentration (mM) in a magnetic 
field of 9.4 T. The full curves are the results of linear regression fitting. 
 
To investigate the magnetic resonance (MR) enhancement effect of the BMFSN, MR 
images of the aqueous dispersion of the MEH-PPV loaded BMFSN were obtained 
using a 9.4 T MR scanner. Figure 6.10 (a) shows the T2-weighted MR images of the 
aqueous dispersion of the MEH-PPV loaded BMFSN at different Fe concentrations 
ranging from 0 to 0.1 mM. It can be seen that with increasing Fe concentration, the 
signal intensity of the MR images decreases dramatically, which is expected for a T2 
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contrast agent. This result shows that the BMFSN are able to generate high magnetic 
field to enhance the transverse (T2) relaxation process of water protons. Figure 6.10 
(b) shows the relaxation rate, 1/T1 and 1/T2, as a function of the iron molar 
concentration for the BMFSN aqueous dispersion. The relaxation rate varies linearly 
with the iron concentration, according to the following equations: 
1/T1 = 1/T1([Fe]=0) + r1 [Fe]                                     (6.1) 
1/T2 = 1/T2([Fe]=0) + r2 [Fe]                                (6.2) 
where 1/T1([Fe]=0) and 1/T2([Fe]=0) are the relaxation rates of pure water without addition 
of contrast agent. Meanwhile, r1 and r2 are the longitudinal and transverse relaxivities, 
respectively. The relaxivities represent the efficacy of the nanoparticles as a contrast 
agent in enhancing proton relaxation process. The r1 and r2 of the BMFSN were 




Fe, respectively. These values compare 
extremely well with that of ferucarbotran, a clinical MRI contrast agent, measured 
under the same condition, which is shown in Figure 6.11. The longitudinal (r1) and 





Fe. This suggests that the BMFSN can perform at least as well as ferucarbotran 
as a MRI contrast agent. Since colloidal stability is an important parameter for 
injectable MRI contrast agent, the stability of the BMFSN in water was studied by 
placing the BMFSN dispersions in the 9.4 T MR scanner for 12 hours and the T2 
relaxation rate was re-measured. As shown in Figure 6.10 (b), there is no apparent 
variation in relaxation rate of the BMFSN after being kept in 9.4 T magnetic field for 




Fe, as compared to the initial 




Fe.  This stability is attributed to the hydrophilic 
characteristics of the PEO chains on the surface of the BMFSN, which can reduce the 
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Figure 6.11 T1 and T2 relaxation rates (1/T1 and 1/T2, s
-1
) of Ferucarbotran as a function of iron molar 
concentration (mM) measured using a 9.4 T MR scanner. 
 
6.3.4 Cytotoxicity and cellular imaging studies 
 
The physical behavior described above clearly demonstrate the dual functionality of 
fluorescence and superparamagnetism of the BMFSN, which make them attractive for 
dual mode cellular imaging, namely MRI and fluorescence imaging. Prior to the 
application of the BMFSN as a cellular labeling agent, it is important to assess the 
potential cytotoxicity of the BMFSN. In this study, HepG2 cell line, derived from 
human hepatocellular carcinoma, was chosen for cytotoxicity evaluation using a 
standard MTS assay and the result is presented in Figure 6.12. It can be seen that there 
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is no appreciable cytotoxicity to the HepG2 cells after being cultured with the MEH-
PPV loaded BMFSN for 24 hours with the nanocapsule concentrations up to 350 
μg/mL. The result suggests that the synthesized BMFSN are non-cytotoxic and 
suitable for biomedical applications. 
 
 
Figure 6.12 Cell viability of HepG2 cells incubated in the presence of MEH-PPV loaded BMFSN at 
different concentrations using MTS assay. 
 
The applicability of the BMFSN as a cellular labeling agent was studied by incubating 
HepG2 cells with MEH-PPV loaded BMFSN for 24 hours, after which the cells were 
thoroughly washed and fixed. Meanwhile, to determine the location of the 
nanocapsules within the cells, the nuclei of the cells were stained by DAPI, a small 
fluorescent dye molecule that prefers to bind to double-stranded DNA in the nucleus 
and produces strong blue fluorescence for nucleus image. The cellular uptake of the 
MEH-PPV loaded BMFSN by HepG2 cells was then observed by using confocal laser 
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scanning microscopy (CLSM) and their images are shown in Figure 6.13. These 
images show red fluorescence in the cytoplasm region of the HepG2 cells surrounding 
the nuclei (blue), indicating that the MEH-PPV loaded BMFSN were successfully 
uptaken by HepG2 cells. It is noted that all images in Figure 6.13 were taken under 
conditions where no appreciable cellular autofluorescence was observed from the 
control (without addition of the BMFSN), which means that the red emission indeed 
originates from the uptaken MEH-PPV loaded BMFSN. The intensity of the red 
emission increased with increasing concentration of the MEH-PPV loaded BMFSN, 
suggesting that the cellular uptake is a dose responsive process.  
 
 
Figure 6.13 Confocal microscopy images of HepG2 cells incubated at different concentrations of MEH-
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Figure 6.14 Z-scan confocal images of HepG2 cells cultured uptaking MEH-PPV loaded BMFSN. The 
images were acquired with an optimized step size of 0.38 μm.  
 
To verify that the MEH-PPV loaded BMFSN were indeed uptaken by the HepG2 
cells, a z-scan study using CLSM was performed. A series of images were taken from 
the bottom of the cells and moving up along the z-axis with the optimized step size of 
0.38 μm and the result is presented in Figure 6.14. A strong red fluorescence of MEH-
PPV and blue fluorescence of DAPI were observed concurrently at the middle height 
of the cells with a gradual decrease in the intensity of both fluorescence signal 
towards the top and bottom of the cells. These images thus clearly show that the 
MEH-PPV loaded BMFSN were indeed internalized by the HepG2 cells and not at the 
membrane surface of the cells.  
 
On top of using CLSM, the HepG2 cells that internalizing MEH-PPV loaded BMFSN 
can also be visualized by using MRI. As an example, MR image of the HepG2 cells 
cultured with 60 μg/mL of MEH-PPV loaded BMFSN was obtained by using a 7.0 T 
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MR scanner and compared to that of control, which is shown in Figure 6.15. It can be 
observed readily that there is a darkening in the MR contrast of the HepG2 cells 
cultured with MEH-PPV loaded BMFSN, whereas no MR contrast is observed for the 
control, showing the potential of BMFSN as a MRI contrast agent. Overall, these 
results evidently demonstrate that BMFSN can be used as dual mode contrast agent 
for fluorescence and magnetic resonance cellular imaging. 
 
 
Figure 6.15 T2-weighted MR images of the HepG2 cells were acquired by using a spin-echo pulse 
sequence in a 7.0 T MR scanner: (a) Control, whereas (b) and (c) were incubated with 60 μg/mL of 
MEH-PPV loaded BMFSN without and with the presence of external magnetic field, respectively. 
 
In addition, to demonstrate the magnetic targeting capability of the BMFSN, a 
separate set of HepG2 cells were cultured under the same cell culture condition but 
under the influence of an external magnetic field (~1.3 T) and their confocal 
microscopy images are illustrated in Figure 6.16 (bottom row). As expected, there is a 
marked increase in the red emission of CLSM images of the cells cultured with 
external magnetic field (bottom row) in comparison to that without the field (upper 
row), showing that the cellular uptake of the MEH-PPV loaded BMFSN was 
enhanced significantly upon the application of the external magnetic field. This is 
because there is a strong magnetic field gradient that attracts the MEH-PPV loaded 
BMFSN towards the bottom of the culture dish, which consequently results in a 
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higher concentration of the MEH-PPV loaded BMFSN near the cell surface in 
comparison to that of in the culture medium. Since the cellular uptake is a dose-
responsive process, the higher concentration leads to the increase in cellular uptake of 
MEH-PPV loaded BMFSN by HepG2 cells.  To verify this observation, the MR 
images of HepG2 cells cultured with 60 μg/mL of MEH-PPV loaded BMFSN without 
and with the influence of external magnetic field, as typical examples, were obtained 
by using a 7.0 T MR scanner and the results are shown in Figure 6.15 (b) and (c), 
respectively. These MR images agree well with the fluorescence observations above, 
where a darker MR contrast was observed for the HepG2 cells treated with the 
magnetic field as compared to that of the cells cultured without the field. These MR 
images thus confirm the magnetic targeting capability of the BMFSN. 
 
 
Figure 6.16 Confocal microscopy images of the HepG2 cells cultured with different concentrations of 
MEH-PPV loaded BMFSN (top) without and (bottom) with influence of external magnetic field. 
 
A potential concern is however that the increased cellular uptake of the MEH-PPV 
loaded BMFSN could lead to cytotoxicity towards the HepG2 cells. Indeed, it has 
been reported recently that an increased cellular uptake of iron oxide nanoparticles 
affected the functionality, viability, and proliferation of mammalian cells.
[45]
 In order 
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to alleviate such concern, MTS assay of HepG2 cells cultured with different 
concentrations of MEH-PPV loaded BMFSN and in the presence of external magnetic 
field was performed. As shown in Figure 6.17, there is no significant cytotoxicity of 
the HepG2 cells upon incubation with external magnetic field, confirming that the 
BMFSN are indeed not toxic and of potential for biomedical applications. 
 
 
Figure 6.17 Cell viability of HepG2 cells cultured with different concentration of MEH-PPV loaded 
BMFSN under influence of external magnetic field by using MTS assay. 
 
The observed increase in cellular uptake by the external magnetic field also further 
demonstrate the co-existence of the conjugated polymers and the SPION inside the 
BMFSN; otherwise the enhanced dark contrast observed in the MR images of the 
magnetic field treated HepG2 cells would not be accompanied by an increase in the 
red-fluorescence signal of the corresponding CLSM image. Additionally, the cellular 
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uptake study results reflect that there is minimal non-specific uptake of the MEH-PPV 
loaded BMFSN by HepG2 cells when no external magnetic field is applied. This 
phenomenon is attributed to the presence of PEO chains dangling on the surface of the 
nanocapsules, which are known to reduce non-specific uptake of nanoparticles,
[46]
 
indicating that the BMFSN exhibit the desired antifouling behavior. Such behavior is 
consistent with the previous result, where a low level of non-specific uptake of 
PEOlated Fe3O4@SiO2 nanoparticles (PEOFSN) by brain macrophage cells was 
observed. Hence, they suggest that the antifouling behavior of the BMFSN can be 





In this chapter of project, a new family of bi-functional magnetic fluorescent silica 
nanocapsules (BMFSN) has been successfully developed, where both fluorescent 
conjugated polymers and superparamagnetic iron oxide nanocrystals are combined in 
the nanocapsules via the bioinspired silification route, a highly facile and benign 
synthesis strategy. The synthesized BMFSN are in the nanometer range and 
colloidally stable in aqueous medium, which are the desired characteristics as a 
cellular labeling agent. The BMFSN demonstrate the desired dual functionality of 
fluorescence and superparamagnetism of the components being encapsulated. By 
varying the type of the conjugated polymers being encapsulated, the emission 
wavelength of the BMFSN can be tuned systematically across the visible spectrum, 
thereby highlighting their uniqueness and versatility.  
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The in vitro cellular studies in this chapter demonstrate that the BMFSN are of low 
cytotoxicity and can be used as dual mode cellular labeling agent for both 
fluorescence and magnetic resonance imaging. The in vitro studies also show that the 
BMFSN can be guided to the cancer cells by simply applying an external magnetic 
field, indicating their great potential for magnetic targeting biomedical applications. 
Furthermore, since the surface of the BMFSN is covered by a layer of free PEO 
chains, which are largely known to increase circulation lifetime of nanoparticles in the 
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Chapter 7  





In this project, a novel and highly benign bioinspired silification strategy has been 
successfully developed to prepare PEOlated silica nanocapsules (PEOSN) at room 
temperature and near-neutral pH aqueous environment by mimicking the process of 
silica skeleton formation of marine organisms in nature. The synthesis strategy was 
conducted by employing Pluronic
®
 F127 polymeric micelles, which consist of PPO 
core and PEO corona, as structure directing agent for the formation of the nanocapsule 
structure. The main idea behind the bioinspired silification is to confine the silica shell 
formation of the nanocapsules at the interface between the PPO core and the PEO 
corona of the F127 polymeric micelles, and therefore retaining part of the free PEO 
corona on the surface and provide steric stabilization as well as aqueous solubilization 
to the resultant silica nanocapsules. Such strategy is particularly important for 
development of silica nanocapsules as nanocarriers for biomedical applications 
because PEO is known to increase circulation time of foreign particles in vivo as it 
decreases detection and clearance from the body by reticuloendothelial system (RES).  
 
The key parameter in success of the bioinspired silification lies on the encapsulation 
of the hydrophobic silica precursor of TMOS inside the PPO core of the F127 
polymeric micelles. The encapsulation accordingly limits the hydrolysis reaction of 
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TMOS to occur at the interface between the core and the corona of F127 polymeric 
micelles, where water is available for the sol-gel reaction to proceed. In addition, the 
hydrogen bonding between the hydrolyzed silanol groups and the PEO moieties of 
F127 helps to confine the condensation reaction at the interfacial region, which 
subsequently form a thin silica shell surrounding the PPO core of F127 polymeric 
micelles. As a result, the silica nanocapsules thus synthesized are intrinsically covered 
by a layer of free PEO chains, which enable them to exhibit excellent colloidal 
stability both in aqueous environment and phosphate buffered solution containing 
proteins, demonstrating that the PEOSN are of potential nanocarriers for use in 
biomedical applications.  
 
To demonstrate those potentials, functional silica nanocapsules were prepared by 
incorporating functional hydrophobic compounds into the core of the nanocapsules. 
Superparamagnetic iron oxide nanocrystals (SPION), for example, were successfully 
loaded into the core of the silica nanocapsules via the bioinspired silification, forming 
PEOlated Fe3O4@SiO2 nanoparticles (PEOFSN). There were no detrimental effects 
on the SPION in terms of the size, morphology, crystallinity, and magnetic behavior 
upon encapsulation inside the core of the PEOSN, confirming that the bioinspired 
silification developed in this project is without a doubt a benign synthesis strategy. 
The PEOFSN thus derived exhibit the desired superparamagnetism with good 
colloidal stability in water and phosphate buffered solution containing proteins, all of 
which point out to the fact that PEOFSN are excellent candidate for magnetic 
resonance imaging (MRI) contrast agent. Indeed, its low cytotoxicity and high r2/r1 
ratio with long term stability under strong magnetic field clearly demonstrate that 
PEOFSN are an effective T2-type MR contrast enhancement agent. 
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As a further demonstration of the PEOSN as nanocarriers for biomedical application, 
the bioinspired silification was able to encapsulate hydrophobic fluorescent 
conjugated polymers inside the cores of the silica nanocapsules, forming fluorescent 
PEOlated silica nanocapsules (F-PEOSN). The emission wavelength of the F-PEOSN 
was tuned across the visible wavelength by changing the type of the encapsulated 
conjugated polymers. Considering the fact that conjugated polymers are largely 
commercially available, it is possible to prepare various color F-PEOSN by 
encapsulating conjugated polymer that emit at specific and desired wavelengths. The 
F-PEOSN developed in this project are demonstrated to possess large extinction 
coefficient and high quantum yield, suggesting that the F-PEOSN exhibit the required 
high fluorescence brightness for fluorescence cellular imaging application.  The in 
vitro studies of the F-PEOSN by using MDA-MB-231 breast cancer cells show that 
the F-PEOSN were successfully uptaken by the cancer cells and located at the 
cytoplasm region surrounding the nucleus of the cells. Furthermore, by conjugating 
folic acid on the surface of the F-PEOSN, their uptake by the MDA-MB-231 cancer 
cells was enhanced significantly, demonstrating the targeting capability of the folic 
acid-conjugated F-PEOSN to cancer cells. Hence, they suggest that the F-PEOSN are 
of potential to be used as targeting fluorescent probes for early cancer detection.  
 
The PEOSN were further demonstrated as an integration platform of two different 
functionalities into a single entity. As an example, SPION and fluorescent conjugated 
polymers were combined together inside the core of the silica nanocapsules to form a 
new class of bi-functional magnetic fluorescent silica nanocapsules (BMFSN). The 
BMFSN exhibit the desired dual functionality of fluorescence and 
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superparamagnetism of the encapsulated components, which enable them to be used 
as dual mode cellular imaging contrast agent. This was confirmed by performing in 
vitro cellular studies with HepG2 liver cancer cells. The results show that the HepG2 
cells internalizing BMFSN could be visualized through both fluorescence and 
magnetic resonance imaging. Moreover, it was demonstrated that applying an external 
magnetic field during the incubation period could enhance the cellular uptake of the 
BMFSN by HepG2 cells, indicating the potential of BMFSN for magnetic targeting 
biomedical applications. 
 
7.2 Recommendations for future work 
 
The investigations presented in this thesis clearly show that the bioinspired silification 
is not only a facile and benign strategy for preparation of pure PEOlated silica 
nanocapsules, but also a versatile platform for their functionalization for use in 
biomedical applications, particularly cellular imaging. The resultant silica 
nanocapsules are demonstrated to be highly uniform, non-cytotoxic, colloidally stable 
in aqueous environment as well as in simulated biological environment, and efficient 
contrast enhancement agent for use in diagnostic and imaging applications. On the 
basis of these results, the following future studies are therefore suggested, which can 
lead to further improvement in the design and performance of PEOSN as nanocarriers 
for various biomedical applications. 
 
At present, the PEOSN are synthesized mainly by using F127 polymeric micelles as 
template for the formation of the capsule structure. Considering that the key step of 
the bioinspired silification is the encapsulation of the hydrophobic TMOS silica 
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precursor in the hydrophobic core of the polymeric micelles, it is possible to employ 
other PEO based block copolymer micelles as templates for preparation of the 
PEOSN. It is of note, however, that the block copolymers to be employed should have 
long PEO segment, which is important not only to template the silica shell 
condensation but also to provide steric stabilization to the resultant silica 
nanocapsules. Among different available polymeric materials, PEO-based block 
copolymers with core segment composed of biodegradable polymers, such as 
poly(lactic acid) (PLA) and poly(ε-caprolactone) (PCL), are particularly interesting 
because they can be eliminated from body,
[1]
 which could minimize the long-term 
cytotoxicity issues. Such idea is further encouraged by the fact that amorphous silica 
was reported to dissolve in different aqueous environments,
[2-3]
 such as simulated 
body fluid (SBF) and buffer solution containing proteins, which indicate that it is 
viable to prepare biodegradable PEOSN by using biodegradable block copolymer 
micelles as the templates for the capsule formation.   
 
In addition to serve as carriers for hydrophobic SPION and conjugated polymers, the 
PEOSN are also suitable to be used as nanocarriers for anticancer drugs, such as 
doxorubicin and paclitaxel, because there drugs are highly hydrophobic, and therefore 
can be encapsulated inside the hydrophobic core of the PEOSN. It should be taken 
into consideration, however, that the encapsulation efficiency of any drug depends 
strongly on the compatibility between the hydrophobic block of the employed block 
copolymers and the drug.
[4]
 It is thus important to choose block copolymers that 
possess good compatibility with the employed drug in order to achieve high loading 
capacity. Upon successful encapsulation, it would be of interest to study the drug 
release behavior from the silica nanocapsules. It will also be of interest to investigate 
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the possibility of tuning the release behavior by varying the silica shell thickness or its 
degree of condensation. Moreover, it would be highly desirable to integrate the 
hydrophobic anticancer drug with SPION or conjugated polymers and study their 
capability as multi-functional nanosystem for cancer therapy and diagnosis.     
 
Apart from materials innovation, biocompatibility of the PEOSN would also need to 
be addressed thoroughly. Even though the in vitro cell viability studies performed in 
this study have shown that the synthesized PEOSN are of low cytotoxicity, these 
results are insufficient to justify the use of PEOSN in clinical setting. A range of in 
vitro test should thus be done to further investigate the potential biocompatibility 
issues of the PEOSN, for example cell proliferation assay, cell death assay (apoptosis 
or necrosis), metabolic assay (protein, DNA, and RNA), and hemolysis. If these in 
vitro studies yield positive result, the biocompatibility of the PEOSN could then be 
assessed through in vivo experiments, which include acute, chronic, reporoductive, 
and developmental toxicites. In addition, it is also important to study the bio-
distribution of the PEOSN after injection into animal body, which would give 
indication about the potential long-term toxicities arisen from using PEOSN as 
nanocarriers in human body. The result could also be used to evaluate the 
effectiveness of the PEOSN to reach the target tissues. It is only through completion 
of all these toxicities studies, the applicability of PEOSN for clinical applications can 
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